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Summary  
 
Background 
Zoonotic diseases account for more than half of infectious diseases of humans and three 
quarters of all emerging infectious diseases. Most of this burden lies with poor, rural 
communities who rely on livestock for nutrition and income. In order to advocate on 
behalf of these communities and reduce the disease burden, there is a need for high 
quality epidemiological data acquired through transdisciplinary approaches involving the 
natural, health and social science fields.  
 
Brucellosis is one of the most common zoonoses in the world. This bacterial disease has 
a major impact on human health, livestock production and the economy. In recent years, 
Q Fever has become a bacterial zoonosis of increasing interest, in part due to an 
unprecedented, large-scale outbreak in the Netherlands in 2007-2010. However, there is 
an absence of high quality epidemiological data from West Africa for both brucellois and 
Q Fever. 
 
Member countries of the Economic Community of West African States (ECOWAS) are 
required to permit free movement of people and goods across borders. This mobility is 
important culturally, socially and economically. However, mobile populations in sub-
Saharan Africa suffer from the least access to health services. Cross-border trade and 
seasonal transhumance are central to livestock production to West Africa, but these 
movements can facilitate the rapid spread of pathogens across large distances. The 
Savannah Region of northern Togo is the country’s main livestock raising area. This is a 
dynamic zone, with frequent movement of both people and livestock across its borders 
with Ghana, Burkina Faso and Benin. 
 
Aims 
 To assess the global burden of human brucellosis and identify data gaps 
 To provide the first data on the epidemiology of brucellosis and Q Fever in 
people and animals in Togo 
 To conduct the first quantitative assessment of cattle trade in Togo, including the 
potential impact on disease spread in West Africa 
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 To assess the mobility of people and livestock and the access to health care and 
other social services in northern Togo  
 To foster intersectoral collaboration and transdisciplinarity in Togo  
 
Methods 
A systematic review and meta-analysis of the burden of human brucellosis was 
undertaken in the framework of the Global Burden of Disease Study 2010. Additionally, 
primary data collection was conducted in the Savannah Region of northern Togo.  A 
brucellosis and Q Fever serosurvey was conducted in cattle, sheep, goats and people in 
25 randomly selected villages in 2011 and 18 transhumant herds from Burkina Faso in 
2012. The serological testing methods included the Rose Bengal Test (RBT), Enzyme-
linked Immunosorbent Assay (ELISA), Complement Fixation Test (CFT) and 
Immunofluoresence Assay (IFA). Multiple Loci Variable Number of Tandem Repeats 
Analysis (MLVA) was used to genotype Brucella strains isolated from bovine hygroma 
fluid. Semi-structured interviews were conducted in 2011 in parallel with the serosurvey 
to assess the mobility of the local population and their access to health care and other 
social services. In 2012, semi-structured interviews were conducted with cattle traders in 
the 9 principal cattle markets in the study zone. The data collected was used to simulate 
cross-border livestock flows and assess the potential risk of disease spread in West 
Africa through cattle trade. 
 
Principal Findings 
The systematic review quantified the severe and chronic impact of brucellosis on its 
sufferers and provided the first informed estimates of acute and chronic disability 
weights for brucellosis. Major knowledge gaps regarding the incidence of brucellosis are 
evident for Sub-Saharan Africa, Eastern Europe, the Asia-Pacific, and Central and South 
America.  
 
In Togo, the association between cattle seropositivity and a history of abortion in cows 
suggests that brucellosis and Q Fever have an important impact on livestock production. 
Given the absence of small ruminants seropositive for brucellosis, it is likely that only B. 
abortus, not B. melitensis, is circulating in the study zone. People of Fulani ethnicity 
were shown to have greater exposure to zoonoses than the rest of the population, 
suggesting that cultural factors may influence the disease epidemiology. These results 
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represent the first epidemiological data for zoonoses in linked human and animal 
populations in Togo. The impact of these diseases on human health and the economy 
warrants further investigation. 
 
The B. abortus strains isolated from cattle hygromas are among the first Brucella 
genotypic data available from West Africa. The identification of three distinct strains from 
only a small geographical area highlights the genetic diversity of circulating strains in the 
study zone. The two deletions detected in the BruAb2_0186 gene have important 
diagnostic and, possibly, epidemiological consequences. More molecular and 
epidemiological data are needed from the region, in order to better understand 
transmission patterns and develop more suitable diagnostic assays. The use of a 
chaotrophic buffer to preserve and inactivate DNA was both a safer and more sensitive 
diagnostic method than culture, and is of particular relevance to countries with poor 
laboratory biosafety. 
 
The first quantitive assessment of the risk of disease spread in West Africa through 
cross-border cattle trade demonstrated that surveillance for emerging infectious 
diseases as well as control activities targeting endemic diseases are likely to be 
ineffective if only conducted at a national level. The trade network in northern Togo 
extended into Burkina Faso, Ghana, Benin and Nigeria, with their epidemiological 
systems likely to be intimately linked to one another. There is a need for greater 
collaboration between countries at the regional level in order to strengthen disease 
surveillance and control efforts. 
 
In addition to the large number of foreign herdsmen undertaking transhumance in 
northern Togo every dry season, one third of local herds were reported to be seasonally 
transhumant. Women were also shown to be a more mobile sub-group of the local 
population, and further investigation of the needs of these mobile groups is warranted. 
Although the level of satisfaction with the local health centres was generally high, the 
cost of services was an exception and may reflect a financial barrier. Increased distance 
to the local health centre reduced the utilisation of skilled birth attendants by women, 
and may be an important barrier to accessing health care. Livestock herding duties of 
Fulani children resulted in poorer school attendance, and the impact on physical, 
intellectual and social development should be explored. 
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Conclusions 
This PhD thesis addresses the global disease burden of brucellosis, the regional mobility 
of livestock and people, and the local epidemiology of zoonoses and access to essential 
services. The research was conduced across the continuum of innovation-validation-
application that forms the basis of the activities of the Swiss Tropical and Public Health 
Institute. The findings provide a public health contribution that is valuable from the global 
to regional to national level. In addition to the direct, pratical applications of this 
research, it also provides a much needed evidence base on which to advocate on behalf 
of communities, develop more targeted research questions and, eventually, design 
public health interventions and policy. 
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Résumé  
 
Les maladies zoonotiques sont responsables de plus de la moitié des maladies 
infectieuses affectant l’homme, et de trois-quarts des maladies infectieuses émergentes. 
Le poids de ces maladies est le plus élevé parmi les communautés pauvres et rurales, 
pour lesquelles l’élevage est une source importante de protéines et de revenue. Afin de 
promouvoir des investissements plus importants pour le contrôle et la prévention des 
maladies affectant ces communautés, il est essentiel de collecter des données 
épidémiologiques de qualité à travers une approche transdisciplinaire impliquant les 
sciences naturelles, les sciences de la santé et les sciences sociales. 
 
La brucellose est l’une des zoonoses les plus répandues au monde. Cette maladie 
bactérienne a un impact majeur sur la santé humaine, la production animale et 
l’économie. Depuis quelques années, la fièvre Q, une zoonose bactérienne, a soulevé 
un intérêt croissant en partie dû à l’épidémie sans précèdent, de par son échelle, qui a 
touché les Pays-Bas entre 2007 et 2010. Néanmoins, il n’existe pas de données de 
qualité sur l’épidémiologie de ces deux maladies en Afrique de l’Ouest.  
 
Les pays membres de la Communauté Economique des Etats de l’Afrique de l’Ouest 
(CEDEAO) se sont engagés à permettre la libre circulation des biens et des personnes à 
travers leurs frontières communes. Cependant, les populations mobiles d’Afrique sub-
saharienne souffrent d’un accès réduit aux services de santé. Le commerce 
transfrontalier et la transhumance saisonnière sont des piliers de la production animale 
en Afrique de l’Ouest, mais de tels mouvements peuvent faciliter la dissémination rapide 
de pathogènes sur de longues distances. La région des Savanes, au nord du Togo, est 
la principale zone d’élevage de bétail du pays. C’est une zone avec de fréquents 
mouvements de personnes et de bétail au travers des frontières partagées avec le 
Ghana, le Burkina Faso et le Benin. 
 
Objectifs 
- Evaluer le poids global de la brucellose humaine et identifier les manques en 
matière de données. 
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- Fournir la première base de données épidémiologique sur la brucellose et la 
fièvre Q affectant les populations humaines et animales au Togo. 
- Effectuer la première évaluation quantitative des mouvements commerciaux de 
bovins au Togo, et de son impact sur la dissémination de maladies en Afrique de 
l’Ouest. 
- Evaluer la mobilité et l’accès aux services de santé et autres services sociaux 
des personnes et de leur bétail au nord du Togo. 
- Promouvoir la collaboration intersectorielle et transdisciplinaire au Togo. 
 
Méthodes 
Une revue systématique de la littérature et une méta-analyse du poids global de la 
brucellose humaines ont été réalisées dans le cadre du rapport sur la Charge Mondiale 
de Morbidité en 2010. De plus, une étude de terrain a été réalisée dans la région des 
Savanes au nord du Togo. Une étude de la séroprévalence de la brucellose et de la 
fièvre Q a été réalisée au sein des populations humaines, bovines, ovines et caprines 
dans 25 villages sélectionnés aléatoirement en 2011, et dans 18 élevages transhumants 
originaires du Burkina Faso en 2012. Les tests sérologiques employés comprennent le 
test au Rose Bengale (TRB), la méthode immuno-enzymatique ELISA, le test de fixation 
du complément (TFC) et l’analyse par immunofluorescence (AIF). L’analyse de plusieurs 
locus en répétition en tandem polymorphe (MLVA) a été utilisée pour caractériser le 
génotype des souches de Brucella isolées à partir du fluide d’hygromas de bovins. Des 
entretiens semi-structurées ont été effectuées en 2011 en parallèle de l’étude de 
séroprévalence afin d’évaluer la mobilité des populations locales et leur accès aux 
services de santé et aux autres services sociaux. En 2012, des entretiens semi-
structurées ont été réalisées avec les commerçants de bovins dans les cinq principaux 
marchés de la zone d’étude. Les données collectées ont été utilisées pour simuler les 
mouvements commerciaux transfrontaliers de bovins et évaluer le risque que ces 
mouvements représentent pour la dissémination de maladies en Afrique de l’Ouest. 
 
Principaux résultats 
La revue systématique de la littérature a permis de mettre en lumière le sévère et 
chronique impact de la brucellose pour les populations humaines infectées, et a permis 
de calculer les premières estimations du poids de l’incapacité aiguë et chronique de la 
brucellose. Les lacunes de connaissances sur l’incidence de la brucellose sont majeures 
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en Afrique sub-saharienne, en Europe de l’Est, dans la zone Asie-Pacifique, en 
Amérique Centrale et en Amérique du Sud. 
 
Au Togo, l’association entre la séropositivité du bétail et la survenue d’avortements 
parmi les animaux échantillonnés suggère que la brucellose et la fièvre Q ont un impact 
important sur la production animale. Etant donne l’absence de séropositivité des petits 
ruminants pour la brucellose, il est vraisemblable que B. abortus, et non pas B. 
melitensis, circule dans la zone d’étude. Les individus de l’ethnie Peul avaient des 
niveaux d’exposition aux zoonoses étudiées plus élevés que le reste de la population, 
suggérant que des facteurs culturels pourraient influencer l’épidémiologie de ces 
maladies infectieuses. Ces résultats représentent les premières données sur les 
zoonoses au sein de populations humaines et animales en interaction au Togo. 
L’évaluation de l’impact de ces maladies sur la santé humaine et l’économie requiert de 
plus amples investigations. 
 
Les trois souches de B abortus isolées à partir d’hygromas de bovins sont parmi les 
premières données génotypiques disponibles sur les souches de Brucella circulant en 
Afrique de l’Ouest. L’identification de trois souches distinctes dans une zone 
géographique de faible dimension met en lumière la diversité génétique des souches 
circulant dans la zone d’étude. Les deux délétions détectées dans le gène BruAb2_0186 
ont d’importantes conséquences en matière de diagnostic et, potentiellement, 
d’épidémiologie. Des données épidémiologiques et moléculaires supplémentaires sont 
nécessaires afin de mieux comprendre la transmission de la brucellose, et de 
développer des tests diagnostiques appropriés. L’utilisation d’une solution tampon 
chaotrophique pour préserver et inactiver l’ADN s’est avérée une méthode diagnostique 
plus sure et plus sensible que la mise en culture, et est pertinente pour des pays dont 
les laboratoires ont un faible niveau de biosécurité. 
 
La première évaluation quantitative du risque de dissémination de maladies en Afrique 
de l’Ouest par le commerce transfrontalier de bovins a démontré que la surveillance des 
maladies infectieuses émergentes, ainsi que les activités de contrôle ciblant les 
maladies endémiques sont vraisemblablement inefficaces si elles sont conduites au 
niveau national. Le réseau formé par les mouvements commerciaux de bovins au nord 
du Togo s’étendait également au Burkina Faso, au Ghana, au Bénin et au Nigéria, 
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vraisemblablement connectant les systèmes épidémiologiques de ces pays entre eux.  
Une plus grande collaboration entre pays au niveau régional est nécessaire afin de 
renforcer la surveillance et le contrôle des maladies. 
 
En plus du nombre important de bouviers étrangers transhumant dans le nord du Togo à 
chaque saison sèche, un tiers des troupeaux locaux ont été identifiés comme étant des 
troupeaux transhumants saisonniers. L’étude a identifié les femmes comme étant un 
sous-groupe plus mobile au sein de la population locale. De plus amples investigations 
ciblant ces sous-groupes sont nécessaires. Bien que le niveau de satisfaction des 
populations au sujet des centres locaux de santé était généralement élevé, ces 
populations trouvaient le coût des services élevé, ce qui pourrait constituer une barrière 
à l’accès aux soins. Le recours à un assistant d’accouchement était plus faible parmi les 
femmes habitant à une distance importante des centres de santé, suggérant que cette 
distance constitue une barrière à l’accès aux soins. Les tâches liées à l’élevage dont 
s’acquittent les enfants Peuls se traduisent par un absentéisme scolaire élevé. L’impact 
de cet absentéisme sur le développement physique, intellectuel et social de ces enfants 
doit être exploré. 
  
Conclusions 
Cette thèse de doctorat a traité du poids global de la brucellose pour la santé humaine, 
la mobilité régionale des personnes et du bétail, l’épidémiologie locale des zoonoses et 
l’accès aux services essentiels. Cette recherche a été menée à travers le continuum 
innovation-validation-application qui forme la base des activités de l’Institut Tropical et 
de Santé Publique Suisse. La contribution de ces résultats à la sante publique est 
précieuse tant à l’échelle globale, que régionale et locale. En plus des applications 
directes et pratiques de cette recherche, elle fournit également une base d’évidences 
pour promouvoir des investissements plus importants pour le contrôle et la prévention 
des maladies affectant ces communautés, développer des questions de recherche plus 
ciblées, et développer des mesures et des politiques de santé publique. 
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1 Introduction 
1.1 Impact and Burden of Zoonotic Diseases 
Zoonotic diseases account for more than half (61%) of pathogens known to infect 
humans and 75% of all emerging infectious diseases (Taylor et al. 2001; Jones et al. 
2008). In recent years, interest in zoonoses has increased due to high profile disease 
emergent events with an impact on global travel and trade, including Bovine Spongiform 
Encephalopathy, Highly Pathogenic Avian Influenza A H5N1 and Sudden Acute 
Respiratory Syndrome (SARS). However, it is the endemic diseases, rather than newly 
emerging pathogens, that threaten livelihoods and prevent communities from rising out 
of poverty (WHO 2006).  The major burden of endemic zoonoses lies with poor, rural 
communities, who rely on livestock for their nutrition (milk, meat), agricultural activities 
(traction, fertiliser), cash income, and cultural and ceremonial purposes (McDermott & 
Arimi 2002).  
 
These communities generally have poor access to health care and are overlooked by 
the global research and public health agenda. Only 0.6% of international global health 
assistance is dedicated to neglected tropical diseases, of which less than 10% is 
estimated to be allocated to neglected zoonotic diseases. Neglected zoonotic diseases 
constitute an open-ended list of underreported, often severe endemic diseases which 
have been largely eliminated from high income countries, and for which cost-effective 
control options often already exist (Figure 1). They have been very aptly described as 
the “poor cousins of the poor cousins” (WHO 2010).   
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Figure 1: Characteristics of neglected zoonotic diseases 
Source: (WHO 2010) 
 
In malaria-endemic countries, accurately diagnosing and treating zoonotic infections is 
particularly challenging. Fever cases are often treated with anti-malarial medicines 
without a definitive diagnosis. In sub-Saharan Africa, the policy of presumptive malaria 
treatment for childhood fever cases has been brought into question, given declining 
rates of malaria transmission (D’Acremont et al. 2009; D’Acremont et al. 2010). It has 
been estimated that more than half (57%) of children presenting with fever to 
government health services in Africa do not actually have malaria. In some countries, 
this proportion is greater than 90% (Gething et al. 2010). Poor people are less likely to 
seek medical care for the treatment of fevers, resulting in a delay in diagnosis and 
treatment. This is then compounded by misdiagnosis when/if assistance is eventually 
sought at a health facility (Amexo et al. 2004). Thus, many zoonotic infections remain 
undiagnosed and untreated, and the disease burden grossly under-estimated.  
 
There is a need for a high quality, comprehensive evidence base in order to advocate for 
greater investment in neglected zoonoses. The Disability-Adjusted Life Year (DALY) is 
defined as a “time-based measure that combines years of life lost due to premature 
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mortality and years of life lost due to time lived in states of less than full health” (WHO 
2013b). Although not without its criticisms (Mont 2007), the DALY provides policy-
makers, funding bodies and researchers with a comparative view of population health, 
guiding the decision-making process about where global health efforts should be 
directed (Horton 2012). Estimates for DALYs are given for 291 diseases in the recently 
released results of the Global Burden of Disease Study 2010, a consortium of seven 
partners: Harvard University, Institute for Health Metrics and Evaluation (IHME) at the 
University of Washington, Johns Hopkins University, University of Queensland, Imperial 
College London, University of Tokyo, and the World Health Organization (WHO) (Horton 
2012). Fifteen of these 291 are neglected tropical diseases, of which only several are  
neglected zoonoses; namely, rabies, echinococcosis, cysticercosis, leishmaniasis, and 
African trypanosomiasis (Murray et al. 2012).  
 
1.2 Tackling Zoonotic Diseases: Ecohealth and One Health Approaches 
The Millennium Ecoystem Assessment of the United Nations called for the preservation 
of the benefits provided by the natural environment to human health and well-being. 
Improved ecosystem management was identified as central to the strategy of achieving 
the Millennium Development Goals (WHO 2005). The concept of Ecohealth considers 
the health of an ecosystem as a whole, through transdisciplinary approaches involving 
the natural, health and social science fields. Local communities are engaged in the 
process of  developing sustainable solutions to health problems, whilst preserving the 
natural, social and cultural capital required for the health of future generations 
(International Association for Ecology & Health 2012).   
 
Embedded within Ecohealth is One Health, which extends the previous concept of One 
Medicine from a physiological and clinical focus to a broader public health approach 
including zoonotic disease epidemiology, food safety and health service delivery 
(Zinsstag et al. 2011). Mainstreaming One Health into the global health agenda would 
bring benefits not only to health, but also to conservation and development (Zinsstag et 
al. 2012). From an economic perspective, the World Bank’s cost-benefit study of a One 
Health approach to zoonotic disease prevention and control at a global level showed that 
benefits far exceeded costs in all plausible scenarios of disease prevalence and 
outbreak severity.  These benefits are the direct result of joint planning and 
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communication as well as the sharing of staff, facilities and equipment  (The World Bank 
2012).  
 
In order to safeguard human health, any zoonotic disease control strategy must address 
disease in the animal reservoir. Thinking should be shifted away from unisectoral 
benefits of disease control activities towards the overall benefits to society as a whole 
(Zinsstag et al. 2007a). These include economic benefits, such as in Mongolia where a 
mass vaccination campaign of livestock against brucellosis was shown to be a highly 
cost-effective disease control intervention only when all beneficiaries were considered. 
These benefits included not only improved livestock productivity but also a reduction in 
public and private health spending, which in turn protected household incomes (Figure 
2) (Roth et al. 2003). 
 
Figure 2: Distribution of benefits of mass vaccination of livestock against 
brucellosis in Mongolia 
Source: (Zinsstag et al. 2005) 
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A combined approach to zoonotic disease epidemiology increases the efficiency and 
capability of disease surveillance and response activities. For example, in Mauritania, 
presumed outbreaks of Yellow Fever were only correctly diagnosed as Rift Valley Fever 
when contact was made with livestock authorities who reported abortion storms in 
livestock due to Rift Valley Fever (Zinsstag et al. 2005; Zinsstag et al. 2007a). Similarly, 
integrated human health and veterinary systems for preventive interventions may be 
more successful at achieving the desired health outcomes, as well as being more cost-
effective.  The sharing of transport and equipment between health and veterinary sectors 
in Chad in a joint vaccination achieved higher vaccination coverage of nomadic children 
than via a conventional, unisectoral approach, as well as a 15% reduction in operational 
costs (Zinsstag et al. 2005; Schelling et al. 2007). Closer cooperation between the two 
sectors not only strengthened each health system, but resulted in a synergy (Schelling et 
al. 2005).  
 
1.3 Epidemiology, Impact and Burden of Brucellosis 
1.3.1 Animal Brucellosis 
The Brucella genus includes both zoonotic and non-zoonotic species. These 
intracellular, Gram negative bacteria can infect a range of land and marine mammals, 
but do exhibit some host-specificity. In terms of livestock production, the most important 
species are B. abortus adapted to cattle, B. melitensis in sheep and goats and B. suis in 
pigs, all of which are zoonotic. In livestock, the most common outcomes of brucellosis 
infection are abortions, usually in the second half of gestation, reduced milk yield, and 
arthritis, often manifested by joint hygromas (WHO et al. 2006; Seleem et al. 2010).  The 
disease has important implications for animal welfare, the economy and public health. 
The Food and Agricultural Organization of the United Nations (FAO) estimated in 2002 
that bovine milk and meat production in West Africa could increase by US$56-168 
million/year if brucellosis were eliminated (Mangen et al. 2002). Additionally, it should be 
remembered that the economic impact of brucellosis is not solely due to a reduction in 
animal productivity, but also the financial consequences of human infection (Roth et al. 
2003) and livestock export bans. 
 
Despite being one of the most common zoonotic diseases in the world, very little high 
quality data have been published regarding animal brucellosis in West Africa. Brucellosis 
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antibodies have been detected in livestock sera and/or milk samples in Burkina Faso 
(Gidel et al. 1974), the Gambia (Unger et al. 2003), Ghana (Kubuafor et al. 2000; 
Mensah et al. 2011), Guinea (Sylla et al. 1982; Unger et al. 2003), Guinea-Bissau 
(Unger et al. 2003), Ivory Coast (Pilo-Moron et al. 1979; Thys et al. 2005; Sanogo et al. 
2008), Mali (Tounkara et al. 1994; Bonfoh et al. 2002), Niger (Gidel et al. 1974), Nigeria 
(Cadmus et al. 2006), Senegal (Unger et al. 2003; Tialla 2012), and Togo (Sonhaye 
1980; Kponmassi 1991). However, most of these studies are limited by questionable 
quality or a lack of generalisability.  Some molecular data are available regarding the 
species and biovar of Brucella strains isolated in West Africa, but much of these data 
were collected more than 30 years ago (Sanogo et al. 2013). 
 
A major difficulty in interpreting cross-sectional serosurvey results is that serological 
testing methods are imperfect. Serological methods used in disease surveillance 
activities include the Rose Bengal Test (RBT) enzyme-linked immunosorbent assay 
(ELISA), complement fixation test (CFT), and fluorescence polarisation assy. The ELISA 
and milk ring test can also be used for bulk milk samples from cows. A positive test 
result should be confirmed using a complementary strategy (OIE 2009a; OIE 2009b). 
Brucella organisms can be cultured from aborted foetal tissues (Leyla et al. 2003; 
Muendo et al. 2012), vaginal fluid (Muendo et al. 2012), hygroma fluid (Bankole et al. 
2010) and milk (Schelling et al. 2003; Muendo et al. 2012). However, given the high risk 
of laboratory-acquired infection, with Brucella being classified by the US Centers for 
Disease Control and Prevention (CDC) in Atlanta as a potential Category B bioweapon 
(CDC 2013), laboratories in developing countries often do not have an adequate level of 
biosafety for safely performing microbiological culture. Loci with Variable Number of 
Tandem Repeats (VNTR) can be used as markers to discriminate Brucella strains. In 
this way, molecular typing by Multiple Locus VNTR Analysis (MLVA) can be used as a 
molecular epidemiology tool to understand transmission patterns and monitor 
surveillance and control programs (Le Flèche et al. 2006; Al Dahouk et al. 2007a). In 
Africa, MLVA has been performed on Brucella field strains from cattle in the Gambia 
(Bankole et al. 2010), Kenya (Muendo et al. 2012), Zimbabwe and Chad (Le Flèche et 
al. 2006), and from a camel in Sudan (Le Flèche et al. 2006).  
 
Some industrialised countries have successfully eliminated brucellosis. Vaccination, 
either implemented on mass or targeting only replacement stock, is a key component of 
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a brucellosis control strategy. In certain circumstances, vaccination should be combined 
with test-and-slaughter of adult animals. When disease prevalence is very low and there 
is no mixing between herds, an exclusive test-and-slaughter or stamping-out policy will 
lead to disease elimination if rigorously implemented (European Commission 2009; 
Minas 2006). Deciding whether disease control or disease elimination should be the goal 
in a given setting depends on the disease prevalence, structure of the livestock 
production system, mixing and mobility of the animal population, availability of economic 
and other resources, potential ramifications on international trade, and economic and 
public health impact (Benkirane 2006).   
 
1.3.2 Human Brucellosis   
Brucella can infect a human host through ingestion, particularly of unpasteurised dairy 
products, from inhalation, or via direct contact through skin abrasions (Franco et al. 
2007). Assisting the delivery of an aborted animal foetus poses a particular risk 
(Schelling et al. 2003; John et al. 2010). Infection with Brucella can cause a severely 
debilitating, disabling, chronic and relapsing illness in people. Brucellosis is a “great 
imitator”, with a wide spectrum of clinical presentations including fever, fatigue, weight 
loss, arthralgia and arthritis, myalgia, endocarditis, and neurological and respiratory 
symptoms (Franco et al. 2007). The chronic nature of the illness has important economic 
ramifications, through reduced household income and increased out-of-pocket spending 
on health care (Roth et al. 2003). Diagnosis can be challenging not only due to the broad 
clinical spectrum, but also because of imperfect serological tests (Franco et al. 2007). If 
a regimen of combination therapy of doxycycline with rifampicin or streptomycin for 
uncomplicated brucellosis is adhered to for at least 6 weeks, relapse may still occur 
(Ariza et al. 2007).  
 
The RBT is rapid and simple to perform in the field but indicates only previous exposure 
to Brucella, not necessarily active infection. Although it can be a very useful test in 
resource-poor settings, it can give false positive and false negative results (Diaz et al. 
2011). Additional confirmatory tests should be used and the results interpreted in light of 
the clinical status of the patient. These include the serum agglutination test, Coomb’s 
test, ELISA, immunochromatographic lateral flow assay, and immunocapture (Orduña et 
al. 2000; Serra & Viñas 2004; Araj et al. 2005; Gómez et al. 2008; Casanova et al. 2009; 
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2010). The sensitivity and specificity of these tests for diagnosing active infection vary 
according to the background level of exposure and antibodies in a given population. The 
cut-off thresholds of these tests may not, therefore, be appropriate for every 
epidemiological setting (Franco et al. 2007; Araj 2010). A novel indirect immunoassay 
using glycol-engineered antigen coupled with magnetic beads shows promise (Ciocchini 
et al. 2013). 
 
The gold standard for diagnosis of active brucellosis is culture and isolation of the 
organism from blood, joint fluid, cerebrospinal fluid, or other bodily fluids and tissues 
(Franco et al. 2007). However, laboratories in developing countries often do not have the 
capacity to safely perform microbiological culture. MLVA of human-isolated strains can 
assist trace-back analysis for identification of the origin of an infection (Le Flèche et al. 
2006; Al Dahouk et al. 2007a; Marianelli et al. 2007; Kattar et al. 2008; Nöckler et al. 
2009; Tiller et al. 2009; Valdezate et al. 2010; Kiliç et al. 2011; Ferreira et al. 2012).  
 
Despite being one of the most common zoonotic diseases in the world, brucellosis 
remains underdiagnosed and underreported (Franco et al. 2007) and may be an 
important cause of fevers of unknown origin in sub-Saharan. A study from rural Tanzania 
revealed that 1 in 5 patients diagnosed with brucellosis did not present to a health centre 
for assessment until more than one year after the onset of illness. Once at the health 
centre, nearly half (45%) were not diagnosed with brucellosis at their first visit (Kunda et 
al. 2007). Thus, diagnostic and therapeutic delays pose a major challenge to minimising 
the health and economic impact of this disease. This is particularly true in Sub-Saharan 
Africa, where the almost total absence of high quality data regarding the burden of 
human brucellosis (as shown in Figure 3) means that communities, health care workers 
and policy-makers are not aware of the disease.  
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Figure 3: Worldwide incidence of human brucellosis  
Source: (Pappas et al. 2006) 
 
In West Africa, no high quality, recent data are available regarding the incidence or 
prevalence of human brucellosis in the general population. Although some 
seroprevalence data are available from Senegal (Tialla 2012), Ghana (Kubuafor et al. 
2000), Benin (Audurier et al. 1987), Nigeria (Baba et al. 2001) and Mali (Tasei et al. 
1982), their usefulness is limited by questionable quality or a lack of generalisability. 
However, studies conducted in central and eastern Africa suggest that the disease could 
pose a public health problem in pastoral communities (Schelling et al. 2003; Regassa et 
al. 2009) and in high risk occupational groups, such as abattoir workers (Chantal et al. 
1996; Swai & Schoonman 2009). In Tanzania, 3.5% of febrile patients presenting to 
hospitals were determined to be unwell due to active brucellosis infection (Bouley et al. 
2012), suggesting that the disease should be considered as a differential diagnosis for 
fevers of unknown origin in sub-Saharan Africa. 
 
1.4 Epidemiology, Impact and Burden of Q Fever in People and Animals 
More than 75 years after being first identified, Q Fever, so named to reflect the “query” 
surrounding the organism, still poses many unanswered questions (de Valk 2012). Q 
Fever was predominantly considered an occupational disease, affecting abattoir workers 
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or farmers (Parker et al. 2006). However, a large-scale outbreak in the Netherlands 
which resulted in approximately 4,000 notified human cases from 2007-2010, revealed 
that the pathogenicity and transmissibility of the organism had been under-estimated (de 
Valk 2012). The inhalation of contaminated aerosols played an important role in disease 
transmission, with people living within a 2km radius of an affected goat farm having a 
much high risk of disease than people living 5km away or further (Schimmer et al. 2010).  
The underlying conditions which led to this unprecedented outbreak are not understood, 
but hypothesised factors include the high density of people and domesticated animals, 
particularly goat herds (Dijkstra et al. 2012), and the possible dissemination via infected 
rats (Reusken et al. 2011).  
 
Q Fever is caused by Coxiella burnetii, a Gram negative intracellular bacteria with a 
worldwide distribution. Reservoirs include a range of domestic and wild animals, as well 
as ticks.  In livestock, the disease is often sub-clinical but can cause reproductive 
problems, including aborting and infertility. Infected animals shed the organism in milk, 
birthing products, urine, and faeces. The most common route of infection to people is 
through the inhalation of dust contaminated by infected animal fluids, followed by 
ingestion, particularly of unpasteurised dairy products (Maurin & Raoult 1999; Porter et 
al. 2011). However, the role of dairy product consumption in C. burnetii transmission is 
not fully understood, and asymptomatic seroconversion without clinical illness has been 
reported (Benson et al. 1963; Cerf & Condron 2006). The organism is very 
environmentally resistant and, like Brucella, is classified by the Centers for Disease 
Control and Prevention (CDC) in Atlanta as a potential Category B bioweapon (CDC 
2013). 
 
In people, acute Q Fever usually presents as an influenza-like illness with non-specific 
symptoms similar to brucellosis, including fever, fatigue, weight loss, myalgia and 
arthralgia. Additionally, hepatitis, pneumonia, and abortions can also result from 
infection. Chronic disease can occur months or years after exposure and may manifest 
as endocarditis or chronic fatigue syndrome. However, exposure to the organism does 
not necessarily result in clinical disease, with as many as 50% of exposures estimated to 
be sub-clinical (Parker et al. 2006). 
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The reference method for diagnosis is the immunofluorescent assay (IFA), but other 
methods include ELISA and the CFT. The diagnosis of acute fever is based on elevated 
IgM and IgG antibodies against the Phase II organism, whilst chronic disease is 
characterised by high titres of IgG antibodies against Phase I. The presence of only high 
Phase II IgG antibodies indicates previous exposure or infection (Blaauw et al. 2012). 
Acute disease can be successfully treated with 2 weeks of doxycycline, but chronic 
disease may need 18 months of combination treatment (Parker et al. 2006).  
 
The limited serology data available for Sub-Saharan Africa have demonstrated that 
exposure is common in livestock (Vanek & Thimm 1976; Kponmassi 1991; Schelling et 
al. 2003; Scolamacchia et al. 2010) and people (Vanek & Thimm 1976; Dupont et al. 
1995; Julvez et al. 1997; Steinmann et al. 2005; Kobbe et al. 2008). However, given that 
many exposures are asymptomatic, understanding the clinical impact of the disease 
requires education of health workers and an active surveillance system. In fever patients 
presenting to hospitals in Tanzania, 5% of cases were determined to be due to acute Q 
Fever (Prabhu et al. 2011), suggesting that the disease should be considered as a 
differential diagnosis for fevers of unknown origin in sub-Saharan Africa. 
 
Vaccines against C. burnetti exist for both livestock and people. During the 
aforementioned outbreak in the Netherlands, the vaccination of dairy goats and sheep 
reduced the disease prevalence and the bacterial load in bodily secretions in these 
species. This suggests that vaccination may reduce environmental contamination and 
human exposure to C. burnetti (Hogerwerf et al. 2011). In people, vaccination may be 
recommended for high-risk occupations such as veterinarians or abattoir workers. This is 
generally only practised in high income countries, as careful screening for previous 
exposure to the organism is essential in order to avoid adverse vaccine reactions in 
people with pre-existing immunity (Zhang & Samuel 2004). 
 
1.5 Livestock Production in Sub-Saharan Africa 
Livestock contribute to the livelihoods of at least 70% of the world’s poor (Ashley et al. 
1999). It is estimated that 50 million pastoralists and 200 million agro-pastoralists live 
within the drylands of Africa which cover 43% of Africa’s inhabited surface. Many of 
these pastoral populations rely on mobility to maximise livestock production, access 
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trading opportunities, or avoid drought, conflict, and even disease (IIED and SOS Sahel 
UK 2010a). Although newly arrived herds can place additional strain on already limited 
natural resources, resulting in conflict with the local population (Kohlhagen 2002; Fokou 
et al. 2004; Tezike & Dewa-Kassa 2008), potential benefits to these settled communities 
include meat and milk products and fertilisation of agricultural land (Macpherson 1995; 
Tezike & Dewa-Kassa 2008).  
 
Seasonal, semi-nomadic livestock movements, known as transhumance, are central to 
livestock production in West Africa. The Economic Community of West African States 
(ECOWAS) recognised the importance of transhumance in the Decision passed in 1998. 
This Decision legally protects cross-border transhumance between all member 
countries, provided that only predetermined routes are followed and the required 
documentation is shown at check-points (Ly 2007). However, implementation of this 
legislation at the national level is not necessarily straightforward. In Togo, a national law 
in place since 2008 has placed additional restrictions on transhumance activities, with 
economic and social repercussions for transhumant herdsmen (Grolimund 2010).  
 
Long-distance, cross-border cattle trade is culturally and economically important to West 
Africa, estimated to be worth US$150 million in 2000 (Williams et al. 2006). Traditionally, 
livestock have been raised in the semi-arid Sahel zone and traded with countries in the 
southerly forested zones (Williams et al. 2006). The spread of Trypanosoma brucei 
rhodesiense, one of the pathogens causing Human African Trypanosomiasis, through 
cattle trade in Uganda (Hutchinson et al. 2003) clearly demonstrated that livestock 
movements can facilitate the spread of pathogens across large distances. This is 
particularly a concern in resource-poor settings where veterinary services and 
surveillance systems are weak (Fèvre et al. 2006). 
 
1.6 Access to Health Care  
1.6.1 The Health Access Livelihood Framework 
Improving access to health care is central to the achievement of the Millennium 
Development Goals (United Nations 2000). Despite the recognised need for vast 
improvements in equity of access to health care, there are no formal international 
standards. A novel framework for analysing and improving access to health care has 
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been developed in the context of malaria treatment and care in Tanzania. The Health 
Access Livelihood Framework considers access within the broader context of livelihood 
insecurity (Obrist et al. 2007). The following five dimensions of access are considered: 
- Availability – the existing services and goods meet the client’s needs, with 
adequate supplies and appropriately skilled personnel 
- Accessibility – the location of services is convenient 
- Affordability – the prices of services meet the client’s ability to pay both direct and 
indirect costs 
- Adequacy – the organisation of health care meets client’s expectations in terms 
of opening hours, structure and cleanliness 
- Acceptability – the characteristics of health care providers match those expected 
by the client, in terms of social values and personality 
 
Improvements in access across these five dimensions depend on the interplay between: 
(i) health care services and the governing policies, institutions, organisations, and 
processes, and (ii) the livelihood assets that can be mobilised by people in particular 
vulnerability contexts. Outcomes of interventions aiming to improve access can be 
measured in terms of health status, patient satisfaction, and equity (Obrist et al. 2007). 
1.6.2 Health and Mobility in Sub-Saharan Africa 
More than half of the world’s nomadic and semi-nomadic populations live in Africa 
(Sheik-Mahomed & Velema 1999). Mobility can lead to the importation of diseases into 
communities and even across national boundaries, with the last documented case of 
smallpox infection transmitted by a nomadic Ethiopian child in Somalia. A mobile lifestyle 
can, however, also offer opportunities to avoid disease. A serosurvey in nomadic camps 
in Niger demonstrated a low transmission rate of measles with 15% of adults remaining 
unexposed (Loutan & Paillard 1992). Periodic movement away from accumulated waste 
as well as regular milk consumption may explain the lower burden of intestinal parasites 
in nomadic communities in Somalia compared to settled communities (Sheik-Mahomed 
& Velema 1999).  
 
Lowering barriers to movement and improving the treatment of mobile people could reap 
substantial benefits to human development (UNDP 2009). Mobile populations in sub-
Saharan Africa suffer from the least access to health services (Sheik-Mahomed & 
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Velema 1999; Fokou et al. 2004). Combining outreach veterinary and human health 
services has been shown to increase coverage amongst pastoral nomadic communities 
(Schelling et al. 2005). Novel strategies are being developed for baseline demographic 
and health-related surveillance (Weibel et al. 2008; Weibel et al. 2011), but there is a 
need for more practical interventions addressing the priorities of communities beyond 
the reach of conventional services.   
 
The national borders marked out by the previous colonial powers transect communities 
which share common cultural, ethnic and linguistic heritages. In order to overcome these 
divisions and to promote regional economic development, member countries of 
ECOWAS are bound to permit free movement of people and goods across borders 
(Adepoju 2005; Adepoju et al. 2007). The Fulani are the most dispersed ethnic group in 
West Africa and are traditionally associated with livestock production activities in the 
region. The previous 30 years have seen significant migration of Fulani pastoral 
communities from the Sudano-Sahelian zone into the more humid Sudano-Guinean 
savannahs of West Africa, as a result of social and agroecological adjustments (Oppong 
2002; Bassett & Turner 2007). This migration includes groups seeking permanent 
settlement as well as those following transhumance pathways (Diallo 2001).  
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2 Study Rationale and Design 
2.1 Research Needs 
One of the main barriers to reducing the impact of zoonotic diseases in developing 
countries is the absence of high quality epidemiological data. Not only is a sound 
evidence base needed for the design of appropriate disease control interventions, but 
also for advocating for greater commitment of funds and other resources by 
governments and international organisations. 
 
Given the cultural and economic importance of smallholder livestock production in West 
Africa, it is hypothesised that the zoonotic disease burden is significant. In order to fully 
assess the impact on health and livelihoods, more empirical, population-based research 
is needed. This includes investigation into disease prevalence and incidence, risk 
factors, transmission dynamics, clinical sequelae and economic outcomes. Conducting 
the research using an Ecohealth approach may foster closer collaboration between 
different sectors at the provincial and national levels by providing a practical example of 
transdisciplinarity in action. Based on the research findings, practical interventions 
appropriate for the local context could be designed and trialled in collaboration with 
stakeholders, and validated within the targeted communities. These outcomes could 
then be used as an advocacy tool at the national, regional and international levels.  
 
Given that most of West Africa is endemic for malaria, an issue of particular relevance is 
malaria misdiagnosis. Zoonotic diseases may contribute to a significant proportion of 
fevers of unknown origin. Training health care workers and strengthening laboratory 
capacity would be central to quantifying this. As most laboratory diagnostic tests have 
been developed and validated in industrialised countries, it may be necessary to modify 
to the protocols for different epidemiological settings. 
 
One factor that must be considered in any epidemiological study in West Africa is the 
movement of people and livestock within and between countries. This mobility is 
important culturally, socially and economically, occurring frequently across somewhat 
“porous” borders. Mobile population health is a developing field in Africa, but very little 
data are available regarding the way in which mobility influences disease epidemiology, 
as well as implications for accessing health care and other social services. There is a 
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need to develop practical disease control interventions and social infrastructure which 
explicitly account for mobile populations, whilst reaping mutual benefits for mobile and 
settled communities. 
 
2.2 Goal, Aims and Objectives 
2.2.1 Goal 
The overarching goal of this research was to generate high quality data on the burden 
and epidemiology of zoonotic diseases in livestock and people in West Africa, including 
consideration of mobile populations, and to use this evidence base for policy 
development and as an advocacy tool for greater investment in prevention and control 
activities in the region. 
2.2.2 Aims 
The aims of this PhD thesis were:  
 To assess the global burden of human brucellosis and calculate the DALYs for 
brucellosis  
 To provide the first high quality data on the epidemiology of brucellosis and Q 
Fever in Togo, and to use this evidence to provide guidance to policy-makers 
 To provide the first high quality data on cattle trade patterns in northern Togo, 
including the potential risk of disease spread in West Africa through trade, and to 
use this evidence to provide guidance to policy-makers 
 To foster intersectoral collaboration and transdisciplinarity in zoonoses 
prevention and control activities in Togo 
 To assess mobility and access to health care and other social services in 
northern Togo  
2.2.3 Objectives  
In order to address the objectives of this PhD research, a combination of desk-based 
review, cross-sectional field surveys, laboratory analyses, and statistical analyses and 
modelling were used. The objectives were: 
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Objective 1: Global burden of human brucellosis  
- To perform a systematic review and meta-analysis of human brucellosis within 
the framework of the Global Burden of Disease Study 2010 in collaboration with 
the Foodborne Disease Burden Epidemiology Reference Group (FERG) of WHO  
- To determine regional and global estimates of the incidence of human brucellosis 
- To assess the morbidity due to human brucellosis and specify a disability weight 
which could be used for a future calculation of the DALYs due to brucellosis 
 
Objective 2: Burden and epidemiology of brucellosis and Q Fever in northern Togo 
- To determine the burden of brucellosis and Q Fever in people and livestock, 
including transhumant populations 
- To assess the performance of different serological tests such as ELISA, RBT, 
CFT and IFA and to provide diagnostic training to laboratory staff 
- To describe the epidemiology of brucellosis and Q Fever, including molecular 
aspects such as MLVA, and assess the risk posed to human health and 
livelihoods 
- To communicate the findings to the medical and veterinary sectors and other 
stakeholders, and to develop practical recommendations together for reducing 
the impact of zoonotic diseases on human health and livelihoods 
 
Objective 3: Livestock movements in northern Togo 
- To quantitatively assess the scale of cross-border cattle trade through Togo  
- To estimate the impact of this trade on the risk of disease spread in West Africa 
- To communicate these findings to veterinary authorities and other stakeholders 
and to develop practical recommendations together for reducing the risk of 
regional disease spread through trade 
 
Objective 4: One Health in Togo 
- To put the concept of One Health into practice by providing practical training to 
nurses and animal health workers in the field 
- To provide an environment for intersectoral dialogue regarding public health 
priorities in Togo, in the form of a stakeholder workshop 
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Objective 5: Mobile populations and access to health care 
- To describe the mobile populations of northern Togo 
- To assess their access to healthcare and other social services and identify 
barriers 
- To identify priorities of mobile populations in relation to health care and other 
social services 
- To develop practical recommendations and interventions addressing these 
priorities, in consultation with stakeholders 
 
2.3 Study Design 
2.3.1 Study Site  
Primary data collection was originally planned for northern Côte d’Ivoire in the Savannah 
Region (Région des Savanes), bordering Mali and Burkina Faso. However, due to 
political instability, the field site was relocated during the second year of the PhD and all 
data collection took place in Togo.  
 
Togo is a small, narrow country in West Africa, bordered by Ghana to the west, Burkina 
Faso to the north and Benin to the east. From its southern limit at the Gulf of Guinea, it 
extends northwards from a tropical coastal plain to a semi-arid savannah. A national 
census conducted in November 2010 estimated the population to be 5,753,324 people, 
of which more than half (62.6%) lived in rural areas (Direction Générale de la Statistique 
et de la Comptabilité Nationale 2010). The population includes 37 different ethnic groups 
(Central Intelligence Agency, USA 2013). Togo is classified by the World Bank as a low 
income country, its Gross National Income (GNI) at Purchasing Power Parity (PPP) per 
capita being one of the lowest in the world. In 2011, the GNI at PPP of Togo ranked 
201st out of 214 countries (The World Bank 2013). Its Human Development Index ranked 
162nd out of 187 countries, falling in the category of Low Human Development (UNDP 
2009). The life expectancy at birth is low, at just 57 years for men at 61 years for women 
in 2009 (WHO 2013a). 
 
All data were collected in the Savannah Region (Région des Savanes) of Togo, a semi-
arid ecosystem which is the northernmost of five administrative regions of Togo (Figure 
4). The population of the Region was estimated to be 776,710 in 2010, accounting for 
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13.5% of the total Togolese population (Direction Générale de la Statistique et de la 
Comptabilité Nationale 2010). The Savannah Region was selected because it is the 
country’s main livestock-raising zone and is known to be an area of significant cross-
border mobility (Tezike & Dewa-Kassa 2008; Grolimund 2010; Kulo & Kada 2011). 
Detailed livestock census data are not available, but the cattle population in the 
Savannah Region was estimated to be 138,000 in 2011 (personal communication, 
Direction de l’Elevage). Each dry season, the Region receives transhumant herds from 
the Sahel zone in search of watering sites and pasture, with the official period of 
transhumance being from January until May. In 2011, 47,000 cattle passed through 
official entry points in the Savannah Region, but it is likely that many more entered the 
country unofficially (personal communication, Direction de l’Elevage). Some of these 
remain in the Savannah Region whilst others descend further south. Additionally, 
internal transhumance within Togo is frequently undertaken by Togolese herds (Tezike & 
Dewa-Kassa 2008). The Savannah Region of northern Togo is, therefore, a highly 
dynamic zone. This mobility may have social, economic and health-related implications. 
 
Figure 4: Map showing the study site 
The Savannah Region in northern Togo is shaded red. 
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2.3.2 Field Activities 
In Côte d’Ivoire, scoping and planning activities were undertaken from May-August 2010 
and November 2010. This included conducting focus group discussions with 
stakeholders, developing and trialling data collection tools, and obtaining ethics 
approval.  
 
Following the decision to relocate the field site to Togo in February 2011, the first field 
visit took place from March – July 2011. During this time, a cross-sectional study of 
people and livestock was conducted in 25 randomly selected villages in the Savannah 
Region, in order to investigate the burden and epidemiology and brucellosis and Q 
Fever, as well as access to health care and other social services. Questionnaire data 
and serum samples were collected. The serological testing and questionnaire data 
analysis were performed in Switzerland. 
 
A second field visit took place from January – April 2012. The principal activity during 
this period was a cross-sectional survey of cattle traders in 9 cattle markets in the 
Savannah Region in order to investigate the cross-border trade network. Data were 
analysed in Switzerland. Additionally, a cross-sectional serosurvey of transhumant cattle 
from Burkina Faso was performed in order to determine the seroprevalence of 
brucellosis, complementing the survey conducted in the Togolese cattle population in 
2011. The serological analyses were performed in Togo at the Laboratoire Central 
Vétérinaire. Additionally, cows with joint hygromas suggestive of brucellosis were 
identified and joint fluid collected for microbiological culture in Switzerland. In November 
2012, a stakeholder workshop was held in Togo to share the research findings, discuss 
their application to policy and develop further research questions. 
 
2.3.3 Collaborating Partners 
This research project was undertaken within the framework of the National Centres of 
Competence in Research (NCCR) North-South, a research program focusing on global 
change and sustainable development, co-funded by the Swiss National Science 
Foundation and the Swiss Development Cooperation (NCCR North-South 2012). 
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Although headquartered in Bern, Switzerland, NCCR North-South encompasses 
partnerships with researchers from more than 40 countries. This PhD thesis contributed 
to the activities of Research Project (RP) 10, “Social services for mobile populations”, 
within Thematic Node 2, “Health, Services, Planning”.  
 
The research was a collaborative project implemented by three academic institutions in 
Switzerland, Togo and Côte d’Ivoire: Swiss Tropical and Public Health Institute in Basel, 
Ecole Supérieure d’Agronomie at the Université of Lomé, and the Centre Suisse de 
Recherches Scientifiques en Côte d’Ivoire. The local representations of the Ministry of 
Health and the Department of Livestock Production (Direction de l’Elevage) were 
partners in the field during the data collection phase. The Institute for Veterinary 
Bacteriology at the University of Bern, the Laboratoire Central Vétérinaire at the 
Direction de l’Elevage in Togo, and Vircell S.L. in Spain were collaborating laboratories. 
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3.1 Abstract 
Background: This report presents a systematic review of scientific literature published 
between 1990-2010 relating to the frequency of human brucellosis, commissioned by 
WHO. The objectives were to identify high quality disease incidence data to complement 
existing knowledge of the global disease burden and, ultimately, to contribute towards 
the calculation of a Disability-Adjusted Life Years (DALY) estimate for brucellosis. 
 
Methods/Principal Findings: Thirty three databases were searched, identifying 2,385 
articles relating to human brucellosis. Based on strict screening criteria, 60 studies were 
selected for quality assessment, of which only 29 were of sufficient quality for data 
analysis. Data were only available from 15 countries in the regions of Northern Africa 
and Middle East, Western Europe, Central and South America, Sub-Saharan Africa, and 
Central Asia. Half of the studies presented incidence data, six of which were longitudinal 
prospective studies, and half presented seroprevalence data which were converted to 
incidence rates. 
Brucellosis incidence varied widely between, and within, countries. Although study 
biases cannot be ruled out, demographic, occupational, and socioeconomic factors likely 
play a role. Aggregated data at national or regional levels do not capture these 
complexities of disease dynamics and, consequently, at-risk populations or areas may 
be overlooked. In many brucellosis-endemic countries, health systems are weak and 
passively-acquired official data underestimate the true disease burden.  
 
Conclusions: High quality research is essential for an accurate assessment of disease 
burden, particularly in Eastern Europe, the Asia-Pacific, Central and South America and 
Africa where data are lacking. Providing formal epidemiological and statistical training to 
researchers is essential for improving study quality. An integrated approach to disease 
surveillance involving both human health and veterinary services would allow a better 
understanding of disease dynamics at the animal-human interface, as well as a more 
cost-effective utilisation of resources.  
 
3.2 Author Summary 
Brucellosis is a bacterial disease transmitted to humans by consumption of infected, 
unpasteurised animal milk or through direct contact with infected animals, particularly 
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aborted foetuses. The livestock production losses resulting from these abortions have a 
major economic impact on individuals and communities. Infected people often suffer 
from a chronic, debilitating illness. This systematic review of the incidence of human 
brucellosis is the first ever conducted. Using strict exclusion criteria, 28 scientific articles 
published between January 1990 – June 2010 which included high quality data were 
identified. Half of these studies presented incidence data and half presented 
seroprevalence data which were converted to incidence rates. Data were only available 
from 15 countries in the regions of Northern Africa and Middle East, Western Europe, 
Central and South America, Sub-Saharan Africa and Central Asia. Brucellosis incidence 
varied widely between and within countries. Demographic, occupational and 
socioeconomic factors may play a role in these differences. In many brucellosis-endemic 
countries, health systems are weak, and official data are likely to underestimate the true 
disease burden. High quality research is needed, particularly from Eastern Europe, the 
Asia-Pacific, Central and South America and Africa. An integrated approach to disease 
surveillance involving both human health and veterinary services would allow a better 
understanding of the disease, as well as a more cost-effective utilisation of resources.  
 
3.3 Introduction 
Brucellosis is one of the most common zoonotic infections globally (Ariza et al. 2007), 
transmitted to humans through consumption of unpasteurised dairy products or through 
direct contact with infected animals, placentas or aborted foetuses. This bacterial 
disease causes a severely debilitating and disabling illness, with fever, sweating, fatigue, 
weight loss, headache, and joint pain persisting for weeks to months. Neurological 
complications, endocarditis and testicular or bone abscess formation can also occur 
(WHO et al. 2006). Additionally, brucellosis has major economic ramifications due to 
time lost by patients from normal daily activities and losses in animal production (Roth et 
al. 2003). In a review of 76 diseases and syndromes of animals, brucellosis lies within 
the top 10 in terms of impact on impoverished people (Perry 2002) 
 
In 1992, the World Bank commissioned the original Global Burden of Disease (GBD) 
study, providing a comprehensive assessment of 107 diseases and injuries and 10 risk 
factors in eight major regions (WHO 2006). This review did not include any neglected 
tropical zoonoses. Such diseases often do not attract the interest of health researchers 
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or sufficient resources for adequate control, yet they continue to impact significantly on 
human health and wellbeing, livestock productivity and local and national economies. 
There is a need for more accurate data relating to the burden of neglected zoonoses to 
facilitate more effective implementation of disease control interventions. In 2009, the 
Foodborne Disease Burden Epidemiology Reference Group (FERG) of the World Health 
Organization (WHO) commissioned a series of systematic reviews on the burden of 
neglected zoonotic diseases, with the aim of incorporating the findings into the overall 
global burden of disease assessments.   
 
This report presents a systematic review of scientific literature published between 1990- 
June 2010 relating to the frequency of human brucellosis. The objectives of this review 
were to identify high quality disease incidence data to complement existing knowledge 
(Pappas et al. 2006) of the global disease burden and, ultimately, to contribute towards 
the calculation of a Disability-Adjusted Life Years (DALY) estimate for brucellosis. A 
systematic review of scientific literature investigating the clinical manifestations of 
brucellosis is the subject of a companion paper (Dean et al. 2012a) 
 
3.4 Methods 
Searching 
Thirty three databases were searched for relevant articles using the search strings of 
both (brucellosis OR malta fever) and (brucellosis OR malta fever OR brucella melitensis 
OR brucella abortus) AND (symptom* OR sequelae* OR morbidity OR mortality OR 
transmission mode OR foodborne), with a publication limitation of 1990 - 30 June, 2010. 
The search term was adapted to the predominate language of the database. If a 
database did not allow the combining of Boolean operators, (18 of 33 databases), 
‘brucellosis’ was used as the sole term. 
 
Reference Manager bibliographic software was used to manage citations. Duplicate 
entries were identified by considering the author, the year of publication, the title of the 
article, and the volume, issue and page numbers of the source.  In questionable cases, 
the abstract texts were compared.  
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Selection 
The articles were sorted by a team of four reviewers with a combined fluency in English, 
German, French, and Spanish. Articles in other languages were noted for future 
translation, pending resources. 
 
All reports were classified into one of two categories, based on the abstracts: 
Category 1: Relevant - articles related to human brucellosis infection in populations (i.e. 
disease frequency) or cases of human brucellosis (i.e. disease morbidity); 
Category 2:  Irrelevant - articles related to non-human brucellosis; articles addressing 
topics not related to the current review, such as genetics, laboratory diagnostic tests, 
experimental laboratory animal studies 
 
The abstracts of studies belonging to Category 1 and meeting the following criteria for 
disease frequency were retained: published between 1990 and 30 June 2010, at least 
100 study subjects drawn from the general population, prevalence or incidence data 
included and some information relating to diagnostic tests provided.  The abstracts of 
studies meeting the following criteria for disease morbidity were also retained: published 
between 1990 and 30 June 2010, at least 10 study subjects, clinical 
symptoms/syndromes described and some information relating to diagnostic tests 
provided. The assessment and classification of morbidity articles will be the subject of a 
companion paper and will not be considered further here. 
 
Articles for which the necessary data for classification could not be obtained were 
identified for possible future assessment, according to availability of resources. In 
general, non peer-reviewed or review articles, conference proceedings and book 
chapters were excluded. 
 
Validity Assessment 
After applying the aforementioned screening steps, the full text of each selected article 
was retrieved for detailed analysis. Each article was reviewed by two or three reviewers, 
and classification discrepancies were resolved by discussion.  
 
Frequency studies were classified as prevalence studies if they stated a specified study 
population and area and an outcome expressed as the proportion of the study 
3   Global burden of human brucellosis: a systematic review of disease frequency                                                                                                                                           
 
- 27 - 
population identified as brucellosis seropositive (%); or as incidence studies if they 
presented the time period of observation, information about the study population size 
and area, and an outcome expressed as the number of new brucellosis cases per 
population at risk per time period.  
 
Articles were coded based on the following parameters: 
1) Study design  
- Longitudinal - clear start/end date with a study period of several months to 
years 
- Cross-sectional - a short study period of several weeks or, occasionally, 
several months 
- Routine data – data officially reported by health services or routine data 
recorded by a health facility or local authority 
 
2) Sampling methods 
The sampling approaches were defined in order of decreasing quality as: cluster 
sampling proportional to size, simple random cluster sampling, simple random sampling 
without clustering or non-random sampling. The method of case acquisition (active, 
passive) was also evaluated.  Studies not meeting any of these classifications were 
coded as “other”. 
 
3) Study level 
The study area was categorised in decreasing order of quality as: national, provincial, 
district or sub-district level. Studies not meeting any of these classifications were coded 
as “other”. 
 
4) Diagnostic methods 
 Tests were categorised in decreasing order of quality as:  
1. ELISA +/- Rose Bengal Test (RBT) or lateral flow assay only 
2. RBT only 
3. One of the following tests: microscopic agglutination test (MAT), complement 
fixation test (CFT), 2-Mercaptoethylamine test (2ME), standard tube agglutination 
test (STAT) of 1:160 or greater dilution, Wright agglutination test (WAT) or 
Huddleson test.  
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Studies diagnosing seropositives based on a STAT result of a dilution of less than 1:160 
were excluded. 
 
5) Study quality  
Studies were given an overall quality grade of 1, 2, or 3, as shown in Table 1. Quality 1 
studies had well described study design and methods. Their sampling approaches and 
study level were highly ranked, e.g. active sampling by cluster sampling proportional to 
size or simple random cluster sampling approaches at the national or provincial level. 
The diagnostic methods were also highly ranked, such as ELISA, lateral flow assay or 
RBT. Quality 2 studies contained some weaknesses in their sampling approach and/or 
diagnostic methods. Although data were extracted from Quality 3 studies, they were not 
included in the final analysis, due to either a lack of information about the methods and 
approaches preventing adequate assessment of the quality of the study or obvious 
biases in study design and implementation. 
 
Data Extraction  
The following information was extracted from each article, and they were grouped 
according to geographic region, as identified by the GBD consortium: 
 
Seroprevalence studies: study period, size of study population, seroprevalence as a 
percentage 
 
Incidence studies: study period, size of reference population, number of cases, 
incidence rate 
 
Data Analysis 
Seroprevalence data were multiplied by the duration of seropositivity, assumed to be 
10.9 years (Bonfoh et al. 2011a), to determine the proportion of the general population 
seroconverting each year due to brucellosis exposure. Using a conservative estimate of 
10% of seroconversions representing true clinical cases, these proportions were 
multiplied by 0.1 and converted to rates per 100,000 person-years for the general 
population. 
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Table 1: Grading of study quality based on study methodology criteria 
 Overall Study Quality Methodological Criteria 
Quality 1 Quality 2 Quality 3 
Sampling approach    
Cluster sampling proportional to size    
Simple random cluster sampling    
Simple random sampling without clustering    
Non-random sampling    
Case acquisition    
Active    
Passive    
Study level    
National    
Provincial    
District    
Sub-district    
Diagnostic methods    
ELISA with/without additional method    
Lateral flow assay with/without additional method    
RBT with additional method    
RBT only    
MAT, CFT, STAT, WAT, 2ME, Huddleson alone or in combination    
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Additional Targeted Searching 
Given that high quality data were also likely to be available through routine reporting 
systems in developed countries with strong public health systems, additional data 
sources were identified through a non-systematic, targeted search. 
 
3.5 Results 
Searching 
Table 2 lists the databases searched and the number of articles identified for each. A 
total of 28,824 articles were identified, of which 59% were duplicates, leaving 11,000 
original reports. 
 
Flow of Selected Studies 
Figure 5 shows a detailed flow diagram of the selection of articles included in the 
systematic review. In total, 275 frequency and morbidity studies were selected, for which 
full text was available for 153. However, 14 of these were in languages in which the 
team was not competent (Croatian (6), Turkish (4), Korean (2), Persian (1), 
Mandarin(1)), leaving 61 frequency studies for quality assessment. Three were classified 
as Quality 1 and 26 as Quality 2. Thirty-two were excluded from further analysis as 
Quality 3, due to either a strong possibility of bias, a study population not representative 
of the general population, or a lack of adequate information to allow a proper 
assessment of study quality. Except for two articles in Spanish, all Quality 1 and Quality 
2 studies were in English. 
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Table 2: Databases searched and number of hits 
Database Website No. 
hits 
Global databases 
Medline http://www.ncbi.nlm.nih.gov/sites/pubmed 6176 
ISI Web of Science http://isiwebofknowledge.com 3458 
EMBASE http://www.embase.com 4980 
Popline http://www.popline.org 55 
CAB http://www.cabdirect.org 3424 
ProMed http://www.promedmail.org 666 
The Cochrane Library http://www.thecochranelibrary.com 100 
BIOLINE http://www.bioline.org.br 37 
WHOLIS http://www.bireme.br 76 
Regional WHO databases 
African Index Medicus http://indexmedicus.afro.who.int 14 
Index Medicus for the Eastern Mediterranean Region http://www.emro.who.int/whalecom0/Library/Databases/wxis.exe/Library/
Databases/iah/ 
526 
Western Pacific Region Index Medicus http://www.wprim.org/ 96 
Index Medicus for the South-East Asia Region http://imsear.hellis.org/ 247 
Afro Library http://afrolib.afro.who.int/ 2 
Other regional databases 
Health Information Locator http://www.bireme.br 7 
Institute of Tropical Medicine, Antwerp, Belgium http://lib.itg.be:8000/webspirs/start.ws 122 
King's Fund Information & Library Service http://www.kingsfund.org.uk/library/ 0 
African Journals Online http://ajol.info/ 71 
LILACS http://www.bireme.br 538 
MedCarib http://www.bireme.br 9 
REPIDISCA http://www.bireme.br 29 
PAHO http://www.bireme.br 157 
IBECS http://www.bireme.br 148 
CUIDEN http://www.index-f.com/ 17 
Indian Medlars Center IndMed http://indmed.nic.in/ 84 
KoreaMed http://www.koreamed.org/SearchBasic.php 89 
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Figure 5: Flow of selected studies 
* Some frequency studies were also classified as morbidity studies. 
 
Study Characteristics 
Fifteen articles presented incidence data. Six of these were longitudinal prospective 
studies (Awad 1998; Crump et al. 2003; Avdikou et al. 2005; Jennings et al. 2007; Minas 
et al. 2007; Gargouri et al. 2009), with the remainder retrospectively reviewing data 
collected mainly in health centres (Doyle & Bryan 2000; Abu Shaqra 2000; Elbeltagy 
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2001; De Massis et al. 2005; Haghdoost et al. 2007; Al Dahouk et al. 2007b; Al Tawfiq & 
AbuKhamsin 2009; Jelastopulu et al. 2010).  Three incidence studies did not describe 
the diagnostic tests used but were included because they filled gaps in available data 
and had otherwise well-documented methods and results (Doyle & Bryan 2000; De 
Massis et al. 2005; Jelastopulu et al. 2010).  Seroprevalence data were presented in 
fourteen articles, from surveys conducted in communities (Alballa 1995; Al Sekait 1999; 
Karabay et al. 2004; Cetinkaya et al. 2005; Yacoub et al. 2006; El Sherbini et al. 2007; 
Vancelik et al. 2008) or from blood donor screening (Hernandez et al. 1999; Al-Ani et al. 
2004; Marder et al. 2005; Khorasgani et al. 2008). Due to a lack of data, several studies 
focusing on specific sub-groups of the general population where also included: two 
studies of nomadic communities (Schelling et al. 2003; Alavi et al. 2007) and one of 
school children (Idris et al. 1993).  
 
Studies of Quality 1 and 2 were only available for 15 countries from the following GBD 
geographic regions: Northern African and Middle East (17 studies) (Idris et al. 1993; 
Alballa 1995; Awad 1998; Al Sekait 1999; Abu Shaqra 2000; Elbeltagy 2001; Crump et 
al. 2003; Al-Ani et al. 2004; Yacoub et al. 2006; Alavi et al. 2007; El Sherbini et al. 2007; 
Haghdoost et al. 2007; Jennings et al. 2007; Hosseini et al. 2008; Khorasgani et al. 
2008; Al Tawfiq & AbuKhamsin 2009; Gargouri et al. 2009), Western Europe (8 studies) 
(Karabay et al. 2004; Avdikou et al. 2005; Cetinkaya et al. 2005; De Massis et al. 2005; 
Al Dahouk et al. 2007b; Minas et al. 2007; Vancelik et al. 2008; Jelastopulu et al. 2010), 
South and Central America (2 studies) (Hernandez et al. 1999; Marder et al. 2005), Sub-
Saharan Africa (1 study) (Schelling et al. 2003) and North America (1 study) (Doyle & 
Bryan 2000), as shown in Figure 6. One additional Quality 1 seroprevalence study from 
Central Asia (Bonfoh et al. 2011a) was identified through targeted non-systematic 
searching which, although not fulfilling the publication date criteria of the systematic 
review, was included in data analysis because it provided otherwise missing data. 
 
Study characteristics of Quality 1 and 2 seroprevalence and incidence articles are 
provided as Supplementary Information (Appendix 1, Tables 12 and 13), grouped by 
GBD geographic region. Confidence intervals for seroprevalence estimates were only 
provided in four articles (Schelling et al. 2003; Yacoub et al. 2006; El Sherbini et al. 
2007; Bonfoh et al. 2011a). The normal approximation to the binomial was used to 
calculate confidence intervals for the prevalence estimates of the remaining articles. 
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Although some studies used a cluster-based sampling approach, they did not present 
adequate information for the calculation of adjusted confidence intervals. 
 
Data Analysis 
Table 3 shows the incidence of brucellosis in the general population per 100,000 person-
years by country, including rates directly reported as well as those calculated from 
seroprevalences. The studies are classified as containing data from the national and/or 
sub-national level. Where incidence rates were reported for several years, only the most 
recent data are provided. 
 
A wide variation in reported brucellosis incidence is evident regionally, as well as within 
countries. In the North Africa and Middle East region, for example, incidences calculated 
from a seroprevalence study in Iraq ranged from 52.3 cases per 100,000 person-years in 
a rural area to 268.8 cases per 100,000 person-years in a semi-rural area (Yacoub et al. 
2006).   In Egypt, two prospective incidence studies incorporating a surveillance system 
for acute febrile illness in different rural areas provided rates of 18 (Crump et al. 2003) 
and 70 (Jennings et al. 2007) cases per 1000,000 person-years. Only 5.7% of these 
cases were detected through passive hospital-based surveillance (Jennings et al. 2007). 
 
Incidence rates in Western Europe and North America were generally much lower than 
in other regions, although some within-country variation was still evident. In Greece, for 
example, respective rates of 4 (Jelastopulu et al. 2010) and 32 cases (Minas et al. 2007) 
per 100,000 person-years were reported in western and central areas. The study in 
western Greece also identified that one quarter of these cases, although diagnosed in 
health facilities, were not officially reported to the provincial public health department. 
Although rates in the USA were very low, counties within 100km of the Mexican border 
had a higher disease incidence (0.18 compared to 0.02) than those in non-border states 
(Doyle & Bryan 2000).  
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Figure 6: Geographical distribution of selected studies 
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Table 3: Brucellosis incidence by country (cases per 100,000 person-years) 
 
 
º includes one study of a nomadic community 
* children only 
+
 nomadic community 
 
 
Additional Targeted Searching 
Surveillance data from the European Food Safety Authority were obtained, giving an 
overall incidence for the European Union of 0.08 cases per 100,000 person-years, three 
Country Study level 
Incidence per 100,000 per 
year 
North Africa and Middle East 
Egypt Sub-national 0.28-70.00 
Iraq Sub-national 52.29-268.81 
Iran Sub-nationalº 0.73-141.60 
Jordan National 25.70-130.00 
Oman Sub-national* 11.01 
Palestine Sub-national 8.00 
Saudi Arabia National 137.61 
 Sub-national 6.00-149.54 
Turkey Sub-national 11.93-49.54 
Sub-Saharan Africa 
Chad Sub-national+ 34.86 
Western Europe 
Germany National 0.03 
Greece Sub-national 4.00-32.49 
Italy National 1.40 
Central Asia 
Kyrgyzstan National 88.00 
Central and Southern Latin America 
Argentina Sub-national 12.84 
Mexico Sub-national 25.69 
North America 
USA Sub-national 0.02-0.09 
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quarters of which were reported by Greece, Spain, and Portugal (European Food Safety 
Authority & European Centre for Disease Prevention and Control 2009). Global data 
obtained non-systematically from various sources including health ministries, 
international organisations and scientific articles has been previously summarised 
according to continent and country by Pappas, and a global map was produced (Pappas 
et al. 2006). 
 
3.6 Discussion 
The epidemiology of human brucellosis evolved over the previous 15 years, as a result 
of socioeconomic factors, improved surveillance systems, animal-based control 
programs and international tourism (Pappas et al. 2006). Additionally, political changes 
have influenced disease epidemiology, with brucellosis emerging as a major human 
health problem in countries of the former Soviet Union following its dissolution in 1991 
(Roth et al. 2003).   
 
The current review complements previous assessments of brucellosis disease burden 
(Pappas et al. 2006) by presenting epidemiological data from scientific studies published 
between 1990 – June 2010 which have been quality screened according to strict criteria. 
There is an obvious lack of high quality scientific data relating to brucellosis incidence 
globally, with the majority of data coming from the North Africa and Middle East region. 
Major gaps exist for Eastern Europe and the Asia-Pacific, both of which had no available 
data, as well as for Central and South America (only two studies) and Africa (excluding 
Egypt, only one study). One of the major factors limiting the usefulness of the identified 
studies was the lack of clearly described methods, particularly in relation to sampling 
approaches and case definitions. For many studies, it was not possible to assess 
whether the study had been conducted in such a way to minimise the risk of bias, 
resulting in the exclusion of data that may have been of acceptable quality.   
 
Brucellosis incidence varies widely not only between countries but also within countries. 
Although it is not possible to rule out study biases as potential causes of these 
differences, rates differing by five times in one study in Iraq (Yacoub et al. 2006) or by 
four times in similarly designed studies in Egypt (Crump et al. 2003; Jennings et al. 
2007) suggest that demographic, occupational, and socioeconomic factors may play a 
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role. Aggregated data at national or regional levels cannot capture these complexities of 
disease dynamics and, consequently, at-risk populations or areas may be overlooked. 
A lower disease incidence is seen in developed countries when compared to low and 
middle income countries. However, brucellosis still targets specific sub-groups of these 
populations, such as Turkish immigrants in Germany (Al Dahouk et al. 2007b)  or 
Hispanic communities of low socioeconomic status in the USA (Doyle & Bryan 2000). 
Brucellosis clearly remains a disease of public health importance even in developed 
countries.  
 
Although grey literature can provide high quality data, data from well designed scientific 
studies are preferred. Passively acquired national data in many brucellosis-endemic 
countries are likely to underestimate the true disease burden. In an Egyptian study 
incorporating an active acute febrile illness surveillance system to identify and confirm 
suspected cases, brucellosis incidence in the study area was 70 cases per 100,000 
person-years. Only 5.7% of these cases were identified through hospital-based 
surveillance, from which the incidence rate would be calculated as 3.8 cases per 
100,000 person-years using a case definition based on laboratory confirmation or 6 
cases per 100,000 person-years using a clinical definition. Reliance on routine hospital-
based incidence data would have, therefore, underestimated incidence by 12-18 times 
(Jennings et al. 2007). Official data from the Ministry of Health provided an incidence 
rate of only 0.3 cases per 100,000 person-years (Pappas et al. 2006). 
 
Such underestimations of disease incidence could relate to barriers to accessing health 
care or to case mismanagement and misdiagnosis. A retrospective review of hospital 
records in western Greece identified an additional source of error in official passively 
acquired data, with a brucellosis under-reporting rate from hospitals to the public health 
department of 26% (Jelastopulu et al. 2010). Consequently, one quarter of cases 
diagnosed through the hospital system were not included in the official government data.  
Indeed, incidence rates identified in studies conducted between 1999-2005 in different 
regions of Greece ranged from 4-32.5 cases per 100,000 person-years, whereas 
aggregated data published by the European Food Safety provided a national incidence 
of just 0.9 cases per 100,000 person-years in 2009 (European Food Safety Authority & 
European Centre for Disease Prevention and Control 2009).  
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Research Agenda 
Strengthening public health systems would improve the quality of data captured through 
routine reporting. In many brucellosis endemic countries, however, health systems are 
weak and high quality research is needed. Brucellosis incidence and prevalence studies 
are notably lacking from Eastern Europe, the Asia-Pacific, Central and South America 
and Sub-Saharan Africa.  Researchers must have an adequate foundation in the 
principles of epidemiology and biostatistics to ensure that their studies are designed, 
implemented, and analysed in a manner which minimises bias and maximises the 
usefulness of the data. 
An integrated approach to disease surveillance involving both human health and 
veterinary services would allow a better understanding of disease dynamics at the 
animal-human interface, as well as a more cost-effective utilisation of resources 
(Zinsstag et al. 2005; Zinsstag et al. 2009). A checklist of requirements for 
representative seroprevalence and incidence studies is given in Table 4. 
 
Limitations 
Although test performance was considered in the initial ranking of each article and, thus, 
influenced study inclusion in the review, the individual results of each study were not 
adjusted for test performance. This is because test performance can vary significantly 
according to test manufacturer or laboratory protocol, and such detailed information was 
not available. 
 
The calculation of incidence rates from seroprevalence studies is based on two 
assumptions. The assumed duration of seropositivity of 10.9 years has been determined 
mathematically using Vensim software (Bonfoh et al. 2011a). The assumption that 10% 
seroconversions represent true clinical cases is conservative and is likely to 
underestimate the true burden of disease.  
 
Studies for which a title or abstract was not published in a language using the Latin 
alphabet, such as those published only in Chinese characters or Arabic script, may not 
have been identified during the original database search. Of the foreign language 
studies that were identified, those published in languages in which the team was not 
competent were excluded from the analysis. It is possible that some of these studies 
contained data that could have contributed to this global assessment of brucellosis 
3   Global burden of human brucellosis: a systematic review of disease frequency                                                                                                                                           
 
- 40 - 
frequency. Additionally, although studies in English were independently reviewed by 
three team members, this was not always possible for studies reviewed in other 
languages (German, French, Spanish). 
 
3.7 Conclusion 
This systematic review adds to the understanding of the global burden of brucellosis by 
identifying high quality data from scientific studies according to strict screening criteria. 
Disease incidence varied significantly within regions and within countries. Aggregated 
data do not capture the complexities of disease dynamics and at-risk populations may 
be overlooked. As many brucellosis-endemic countries do not have strong health 
systems, passively acquired official data likely underestimate the true burden. The 
brucellosis research agenda should focus on designing and implementing high quality 
studies to investigate disease seroprevalence and/or incidence, particularly in Eastern 
Europe, the Asia-Pacific, Central and South America and Africa.  
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Table 4: Key considerations for representative brucellosis seroprevalence and incidence studies 
 Seroprevalence Incidence 
Study population   
Defined study zone, geographically or in terms of an administrative unit   
Clear inclusion and exclusion criteria   
Study population representative of general population, not high risk groups alone   
Ongoing community education campaigns to raise disease awareness    
Sampling   
Sample size based on appropriate calculation, ideally including clustering of individuals   
Random sampling strategy, ideally using probability proportional to size    
Active surveillance system in health centres and/or in communities at household level   
Multidisciplinary study team to investigate disease dynamics at animal-human interface   
Diagnostic testing   
Clearly described testing methods, including details of manufacturer or developer    
Concise serological and clinical case definitions   
ELISA, lateral flow or RBT preferred testing methods   
Reporting   
STROBE checklist followed [40]   
Consideration of test performance in the analysis of results   
Consideration of sensitivity of the surveillance system in the analysis of results   
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4.1 Abstract 
Background: The objectives of this systematic review, commissioned by WHO, were to 
assess the frequency and severity of clinical manifestations of human brucellosis, in view 
of specifying a disability weight for a DALY calculation.  
 
Methods/Principal Findings: Thirty three databases were searched, with 2,385 articles 
published between January 1990 – June 2010 identified as relating to human 
brucellosis. Fifty-seven studies were of sufficient quality for data extraction.  Pooled 
proportions of cases with specific clinical manifestations were stratified by age category 
and sex and analysed using generalized linear mixed models. Data relating to duration 
of illness and risk factors were also extracted. 
Severe complications of brucellosis infection were not rare, with 1 case of endocarditis 
and 4 neurological cases per 100 patients. One in 10 men suffered from epididymo-
orchitis. Debilitating conditions such as arthralgia, myalgia and back pain affected 
around half of the patients (65%, 47% and 45%, respectively). Given that 78% patients 
had fever, brucellosis poses a diagnostic challenge in malaria-endemic areas. Significant 
delays in appropriate diagnosis and treatment were the result of health service 
inadequacies and socioeconomic factors. Based on disability weights from the 2004 
Global Burden of Disease Study, a disability weight of 0.150 is proposed as the first 
informed estimate for chronic, localised brucellosis and 0.190 for acute brucellosis. 
 
Conclusions: This systematic review adds to the understanding of the global burden of 
brucellosis, one of the most common zoonoses worldwide. The severe, debilitating, and 
chronic impact of brucellosis is highlighted. Well designed epidemiological studies from 
regions lacking in data would allow a more complete understanding of the clinical 
manifestations of disease and exposure risks, and provide further evidence for policy-
makers. As this is the first informed estimate of a disability weight for brucellosis, there is 
a need for further debate amongst brucellosis experts and a consensus to be reached.  
 
4.2 Author Summary 
Brucellosis is a bacterial disease transmitted to humans by consumption of infected, 
unpasteurised animal milk or through direct contact with infected animals, particularly 
aborted foetuses. The livestock production losses resulting from these abortions have a 
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major economic impact on individuals and communities. Infected people often suffer 
from a chronic, debilitating illness. This systematic review on the symptoms of human 
brucellosis is the first ever conducted. Using strict exclusion criteria, 57 scientific articles 
published between January 1990 – June 2010 which included high quality data were 
identified. Severe complications of brucellosis infection were not rare, with 1 case of 
endocarditis and 4 neurological cases per 100 patients. One in 10 men suffered from 
testicular infection, which can case sterility. Debilitating conditions such as joint, muscle, 
and back pain affected around half of the patients. Given that most patients had fever, 
brucellosis poses a diagnostic challenge in malaria-endemic areas where fever is often 
assumed to be malaria. More high quality data is needed for a more complete 
understanding of the clinical manifestations of disease and exposure risks, and to 
provide further evidence for policy-makers. 
 
4.3 Introduction 
Brucellosis is one of the most common zoonotic infections globally (Ariza et al. 2007). 
This bacterial disease causes not only a severely debilitating and disabling illness, but it 
also has major economic ramifications due to time lost by patients from normal daily 
activities (WHO et al. 2006) and losses in animal production (Roth et al. 2003). In a 
review of 76 diseases and syndromes of animals, brucellosis lies within the top ten in 
terms of impact on impoverished people (Perry 2002). A brucellosis disability weighting 
of 0.2 has been previously proposed for Disability-Adjusted Life Years (DALY) 
calculation, based on the pain and impaired productivity known to result from infection 
(Roth et al. 2003).  However, a more informed estimate is needed for an accurate 
assessment of disease burden. 
 
In 1992, the World Bank commissioned the original Global Burden of Disease (GBD) 
study, providing a comprehensive assessment of 107 diseases and injuries and 10 risk 
factors in eight major regions (Lopez AD et al. 2006). This review did not include any 
neglected tropical zoonoses. Such diseases often do not attract the interest of health 
researchers or sufficient resources for adequate control, yet they continue to impact 
significantly on human health and wellbeing, livestock productivity, and local and 
national economies (WHO 2006). There is a need for more accurate data relating to the 
burden of neglected zoonoses to facilitate more effective implementation of disease 
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control interventions. In 2009, the Foodborne Disease Burden Epidemiology Reference 
Group (FERG) of the World Health Organization (WHO) commissioned a series of 
systematic reviews on the burden of neglected zoonotic diseases, with the aim of 
incorporating the findings into the overall global burden of disease assessments.   
 
This report presents a systematic review of scientific literature published between 1990- 
June 2010 relating to morbidity from human brucellosis infection. The objectives of this 
review were to assess the frequency and severity of the clinical manifestations of 
brucellosis, the duration of disease, the associated disabilities and important risk factors, 
with a view to estimating an appropriate disability weight for calculation of the brucellosis 
DALY. A systematic review of scientific literature investigating the incidence and 
prevalence of brucellosis globally is the subject of a companion paper (Dean et al. 
2012b). 
 
4.4 Methods 
Searching 
Thirty three databases were searched for relevant articles using the search terms of 
(brucellosis OR malta fever OR brucella melitensis OR brucella abortus) AND (symptom* 
OR sequelae* OR morbidity OR mortality OR transmission mode OR foodborne), with a 
publication limitation of 1990 - 30 June, 2010. The search term was adapted to the 
predominate language of the database. If a database did not allow the combining of 
Boolean operators, (18 of 33 databases), ‘brucellosis’ was used as the sole term. 
 
Reference Manager bibliographic software was used to manage citations. Duplicate 
entries were identified by considering the author, the year of publication, the title of the 
article, and the volume, issue and page numbers of the source.  In questionable cases, 
the abstract texts were compared.  
 
Selection 
The articles were sorted by a team of four reviewers with a combined fluency in English, 
German, French, and Spanish. Articles in other languages were noted for future 
translation, pending resources. 
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All reports were classified into one of two categories, based on their abstracts: 
Category 1: Relevant – articles related to human brucellosis related to brucellosis 
infection in populations (i.e. disease frequency) or cases of human brucellosis (i.e. 
disease morbidity); 
Category 2:  Irrelevant - articles related to non-human brucellosis; articles addressing 
topics not related to the current review, such as genetics, laboratory diagnostic tests, 
experimental laboratory animal studies 
 
The abstracts of studies belonging to Category 1 and meeting the following criteria for 
disease morbidity studies were retained: published between 1990 and 30 June 2010, at 
least 10 study subjects, clinical symptoms/syndromes described, and some information 
relating to diagnostic tests provided. Articles relating to disease frequency and meeting 
the following criteria were also retained: published between 1990 and 30 June 2010, at 
least 100 study subjects drawn from the general population, prevalence or incidence 
data included, and some information relating to diagnostic tests provided.  The 
assessment and classification of frequency articles will be the subject of a companion 
paper and will not be considered further here. 
 
Articles for which the necessary data for classification could not be obtained were 
identified for possible future assessment, according to availability of resources. In 
general, non peer-reviewed or review articles, conference proceedings and book 
chapters were excluded. 
 
Validity Assessment 
After applying the aforementioned screening steps, the full text of each selected article 
was retrieved for detailed analysis. Each article was reviewed by two or three reviewers, 
and classification discrepancies were resolved by discussion.   
 
Using a pre-designed Access database, articles were coded according to the following 
parameters: 
 
1) Study type  
Studies were classified as a prospective case series, a retrospective case series, a 
case-control study, or of another type. 
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2) Study population 
The populations studied were grouped according to age category – children only (<15 
years), adults only (>15 years), or including both children and adults. Additionally, they 
were coded according to whether the study population represented the general 
population of brucellosis cases in the age category, or only a specific sub-group. 
 
3) Diagnostic methods 
Studies were classified according to their use of microbial culture to diagnose brucellosis 
patients. In order for studies to be included in the review, they had to not only mention 
culture in their methods but to also present laboratory results. 
 
4) Overall study quality  
Studies were given an overall quality grade of 1, 2, or 3. Quality 1 studies provided data 
drawn from general brucellosis cases, of which 75% or more were diagnosed by culture, 
and had well described study design and methods. Quality 2 studies also presented data 
from general brucellosis cases, utilised culture as a method and presented relevant 
laboratory results. However, unlike for Quality 1 studies, the majority of cases did not 
have to be diagnosed by positive culture in order to be included as Quality 2. Quality 3 
studies were either drawn from only a specific sub-group of brucellosis cases such that 
general conclusions could not be drawn, did not use culture as a diagnostic method or 
failed to present culture results, or had poorly described study design and methods such 
that the quality of the data could not be assured. 
 
Data Extraction   
Based on brucellosis literature (Madkour 2001) a comprehensive list of clinical 
manifestations associated with brucellosis cases was developed: 
 
- General:  documented fever, sweats, chills, fatigue, headache, malaise, weight 
loss, nausea/vomiting 
- Abdominal: abdominal pain, splenomegaly, hepatomegaly, hepatitis 
- Musculoskeletal: arthralgia, arthritis, myalgia, back pain, spondylitis, sacroiliitis 
- Specific organ involvement: epididymo-orchitis, abortion, endocarditis, respiratory 
and neurological signs, cutaneous changes  
 
4   Clinical manifestations of human brucellosis: a systematic review and meta-analysis 
 
- 48 - 
Numbers of subjects with each symptom/syndrome were recorded for each study, as 
well as the number of male and female patients. For the sex-related outcomes of 
epididymo-orchitis and abortion, the study population was considered to be only the 
male and pregnant female sub-groups of the study population respectively. Information 
relating to duration of disease prior to treatment and exposure to potential risk factors 
were also recorded wherever provided. 
 
Data Analysis 
To calculate the proportion of patients by sex, numbers of male and female patients 
were aggregated across all studies as well as within each age category. 95% confidence 
intervals were calculated using the normal approximation to the binomial. 
 
Where appropriate data were available from two or more studies, pooled proportions of 
patients with each clinical manifestation were estimated using generalized linear mixed 
models. Pooled estimates with 95% confidence intervals were calculated both within age 
categories and overall across all studies, using a Freeman-Tukey double arscine 
transformation. Homogeneity across studies was assessed using a Cochrane’s Q test 
and total variability due to between-study variation was reflected in the I2 index. The 
meta-analysis was performed with R statistical software (R Development Core Team 
2012) using the meta package (Schwarzer 2012). Additionally, in order to assess the 
impact of study design, the same analysis was conducted according to study type 
category.  
 
The pooled estimates for proportions of patients with each clinical manifestation were 
compared with the disability weights used in the GBD 2004 study (WHO 2004). A 
disability weight for brucellosis was then proposed. 
 
Median proportions of patients with exposure to particular risk factors were calculated. 
Data relating to duration of illness and diagnostic delay were recorded. In order to 
assess the duration of untreated illness, an additional, non-systematic search for data 
prior to the availability of appropriate antibiotics was undertaken by manually searching 
library records.  
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4.5 Results 
Searching 
Table 2 lists the databases searched and the number of hits obtained for each. A total of 
28,824 studies were identified, of which 59% were duplicates, leaving 11,000 original 
reports. 
 
Flow of Included Studies 
Figure 7 shows a flow diagram of the process for the selection of articles included in the 
review. In total, 289 frequency and morbidity studies were selected, for which full text 
was available for 153. However, 14 of these were in languages in which the team was 
not competent (Croatian (6), Turkish (4), Korean (2), Persian (1), Mandarin (1)),  leaving 
96 morbidity studies for quality assessment. Some articles contained both frequency and 
morbidity data and were thus counted in both categories. 
 
Of the 96 morbidity studies for quality assessment, five were classified as Quality 1 and 
52 as Quality 2. Thirty-nine were excluded from further analysis as Quality 3, one of 
which was due to duplication of data from another larger study. Two pairs of Quality 2 
studies were based on the same data (Colmenero et al. 1991; Colmenero et al. 1996; 
Pourbagher et al. 2006a; Pourbagher et al. 2006b). These studies were included 
because each provided some unique information; however, the duplicated data were 
only included once in the meta-analysis. Except for two articles in Spanish and one in 
French, all Quality 1 and 2 studies were in English. 
 
Study Characteristics   
The median number of study subjects was 143 (IQR: 85-283), ranging from 20-1028. 
Studies from high income countries such as Germany, France, and USA were generally 
situated at the lower end of the range (less than 60 subjects), although larger studies 
were reported from Spain, including one study of over 900 subjects. Of the 57 studies 
selected, 24 were from Turkey. The next most represented country was Saudi Arabia, 
with 8 studies, followed by Spain with 4 and Greece with 4. One or two studies each 
came from Cuba, France, Germany, Israel, India, Iran, Jordan, Kuwait, Tunisia, USA, 
Uzbekistan and Yemen. The geographic distribution of the selected studies is shown in 
Figure 8. 
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Figure 7: Flow of selected studies 
* Some morbidity studies were also classified as frequency studies 
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Figure 8: Geographical distribution of selected studies
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In terms of study type, 37 were classified as retrospective case series with data retrieved 
from medical records, and 19 as prospective case series. One study was a case-control. 
Seventeen studies provided detailed information about cases with specific syndromes, 
e.g. neurological brucellosis (McLean et al. 1992; Bodur et al. 2003; Yetkin et al. 2006; 
Karaoglan et al. 2008), epididymoorchitis (Bayram & Kervancioglu 1997; Yetkin et al. 
2005; Akinci et al. 2006; Colmenero et al. 2007), osteoarticular complications (Khateeb 
et al. 1990; Colmenero et al. 1991; Tasova et al. 1999; Pourbagher et al. 2006a), 
spondylitis (Bodur et al. 2004; Yilmaz et al. 2004), pulmonary brucellosis (Hatipoglu et al. 
2005), pancytopaenia (M. Karakukcu et al. 2004), and pregnant women (Khan et al. 
2001). As these studies also provided some information about proportions of general 
brucellosis cases with specific symptoms/syndromes, they were included in the review. 
 
Twenty-three studies included both children and adult participants (Khateeb et al. 1990; 
Shehabi et al. 1990; Colmenero et al. 1991; McLean et al. 1992; Zaks et al. 1995; 
Colmenero et al. 1996; Neau et al. 1997; Al Shamahy & Wright 2001; Khan et al. 2001; 
Gur et al. 2003; Al Dahouk et al. 2005; Fallatah et al. 2005; Troy et al. 2005; Pourbagher 
et al. 2006a; Pourbagher et al. 2006b; Andriopoulos et al. 2007; Colmenero et al. 2007; 
Savas et al. 2007; Bukharie 2009; Earhart et al. 2009; Buzgan et al. 2010; Alsubaie et al. 
2005). Twelve studies investigated only children (Galanakis et al. 1996; Gottesman et al. 
1996; Issa & Jamal 1999; Shaalan et al. 2002; Tsolia et al. 2002; Mantur et al. 2004; M. 
Karakukcu et al. 2004; Giannakopoulos et al. 2006; Afsharpaiman & Mamishi 2008; 
Shen 2008; Tanir et al. 2009; Citak et al. 2010), with an upper age limit ranging from 13 
years to 18 years. Of the 19 studies with an adult population of 15 years or older 
(Bayram & Kervancioglu 1997; Pérez et al. 1997; Tasova et al. 1999; Memish et al. 
2000; Elbeltagy 2001; Aygen et al. 2002; Bodur et al. 2003; Tasbakan et al. 2003; Bodur 
et al. 2004; Yilmaz et al. 2004; Yetkin et al. 2005; Akinci et al. 2006; Mantur et al. 2006; 
Yetkin et al. 2006; Kokoglu et al. 2006; Abdi-Liae et al. 2007; Hizel et al. 2007; 
Demiraslan et al. 2009; Zribi et al. 2009; Celen et al. 2010), five consisted of only male 
participants (Bayram & Kervancioglu 1997; Memish et al. 2000; Yetkin et al. 2005; Akinci 
et al. 2006; Celen et al. 2010). Three studies did not clearly state the age category 
(Barroso et al. 2002; Hatipoglu et al. 2005; Karaoglan et al. 2008) and were analysed as 
if containing data for both adults and children. 
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Data Analysis 
In studies consisting of only children, 64% patients (95% CI: 60-68%) were male. The 
proportion of male patients in adult studies was significantly lower, at 56% (95% CI: 55-
58%). In studies including both children and adult patients, 48% were male (95% CI: 46-
51%). Overall, 55% patients (95% CI: 54-56%) across all studies were male. 
 
Table 5 shows the pooled proportions of patients estimated by the random-effects 
model, according to clinical manifestations by age category. Forest plots are provided as 
Supplementary Information (Appendix 2, Figures 17-39). An analysis by study type did 
not show any significant changes or trends. 
 
Documented fever was common, with an estimated 78% of patients affected across the 
three age categories. Estimates of the proportions of patients with self-reported 
symptoms of sweats, chills, fatigue, headache, and malaise, were significantly lower in 
children, ranging from 9-24% depending on symptom, compared to 33-81% for adults. 
Weight loss in children, at 13%, was also lower than the 31% reported in adults. 
 
Abdominal-related manifestations of pain, splenomegaly and hepatomegaly were fairly 
uniformly distributed across age categories, with overall estimated proportions of 19%, 
26% and 23%, respectively. The number of studies reporting the presence of hepatitis 
was small, totalling only seven, with an estimated 4% patients affected overall. 
 
Arthralgia was common, affecting 65% patients overall, whereas arthritis affected only 
26% patients.  In adult patients, 56% and 49% suffered from myalgia and back pain, 
respectively. Only two studies reported myalgia and back pain in children. Overall, 
spondylitis and sacroiliitis were detected in 12-36% adults. 
 
In relation to reproductive problems, only one study reported abortion rates as a 
proportion of pregnant female participants, which was 46% (Khan et al. 2001). Overall, 
10% male patients had epididymo-orchitis. 
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* One study only, with a binomial 95% confidence interval 
Pooled proportions of patients with each manifestation are presented as percentages with 95% confidence 
intervals. The numbers of studies (n) contributing to each estimate are given. 
Table 5: Meta-analysis of clinical manifestations of brucellosis by age category 
Age Category  
Manifestation Children Adults All Ages 
All studies 
General n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
Fever 7 82 (69; 91) 10 73 (59; 85) 9 79 (49; 97) 26 78 (66; 87) 
Sweats 8 23 (11; 37) 14 55 (35; 74) 12 73 (60; 85) 34 54 (42; 66) 
Chills 4 18 (9; 29) 5 47 (34; 60) 7 60 (34; 83) 16 45 (30; 61) 
Fatigue 2 19 (13; 23) 2 33 (13; 100) 5 51 (27; 75) 9 39 (16; 65) 
Headache 6 9 (5; 15) 11 34 (19; 50) 11 52 (32; 72) 28 35 (24; 46) 
Malaise 2 24 (16; 34) 6 81 (71; 89) 8 74 (48; 93) 16 71 (57; 83) 
Nausea/vomiting 0 - 5 16 (5; 31) 6 26 (15; 38) 11 26 (15; 38) 
Weight loss 3 13(8;18) 4 31 (15; 50) 7 29 (15; 47) 14 26 (17; 36) 
         
Abdominal         
Abdominal pain 3 14 (1; 38) 4 9 (1; 22) 9 26 (13; 41) 16 19 (11; 29) 
Splenomegaly 9 31 (19; 43) 13 24 (18; 31) 14 25 (17; 34) 36 26 (21; 31) 
Hepatomegaly 1
0 
27 (15; 41) 13 22 (16; 26) 14 22 (15; 29) 37 23 (19; 27) 
Hepatitis 1 1 (0; 5)* 2 8 (1; 38) 4 3 (1; 6) 7 4 (1; 9) 
         
Musculoskeletal         
Arthralgia 9 71 (56; 84) 12 65 (49; 79) 16 62 (52; 70) 37 65 (58; 72) 
Arthritis 7 41 (18; 65) 5 13 (3; 28) 14 25 (17; 34) 26 26 (19; 34) 
Myalgia 2 18 (11; 26) 5 56 (38; 75) 8 49 (36; 63) 15 47 (38; 57) 
Back pain 1 10 (3; 21)* 11 49 (31; 67) 11 45 (31; 60) 23 45 (34; 56) 
Sacroiliitis 4 6 (3; 10) 3 32 (20; 46) 9 14 (7; 22) 16 15 (9; 22) 
Spondylitis 1 18 (1; 28)* 6 12 (7, 19) 9 11 (6; 18) 16 12 (8; 17) 
         
Specific organs         
Epididymo-orchitis 1 10 (1; 32)* 10 10 (7; 15) 10 9 (6; 13) 21 10 (7; 13) 
Endocarditis 2 3 (1; 6) 6 2 (1; 3) 7 1 (1; 2) 15 2 (1; 2) 
Neurological 5 2 (1; 4) 11 5 (3; 7) 10 4 (2; 6) 26 4 (3; 5) 
Respiratory 3 5 (1; 14) 5 2 (1; 5) 11 9 (4; 14) 19 6 (3; 9) 
Cutaneous 6 5 (2; 10) 4 4 (1; 11) 7 8 (4; 14) 17 6 (4; 9) 
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For more severe outcomes, endocarditis was reported in an overall 1% patients, and 
neurological manifestations in 4%. Neurological outcomes reported included motor 
deficits, cranial nerve deficits, sciatica, confusion and/or psychological disturbances, 
meningitis and seizures. 6% of patients suffered from respiratory manifestations, 
including cough, bronchopneumonia, pleural adhesion and pleural adhesion. Cutaneous 
changes were reported in 6% patients.  
 
As most studies were case series without a control group, an evaluation of the 
importance of risk factors was not possible. However, median proportions were 
calculated from 27 studies which provided some exposure history. Median proportions of 
brucellosis cases with exposure to a potential risk factor were 64% (IQR: 34-78%) for 
consumption of unpasteurised dairy products, 42% (IQR: 23-59%) for contact with 
livestock, and 6% (IQR: 3-19%) for occupational exposure, including veterinarians, 
butchers, and abattoir workers.  From fifteen studies, the median proportion of cases 
with a history of brucellosis in a family member was 20% (IQR: 17-46%). 
 
Only six studies included in the systematic review provided data regarding duration of 
illness prior to diagnosis and treatment (Al Shamahy & Wright 2001; Shaalan et al. 2002; 
Al Dahouk et al. 2005; Hizel et al. 2007; Shen 2008; Zribi et al. 2009). The age of the 
patient and the nature of the illness were influential factors. One study reported a longer 
duration of illness in adults compared to children under 15 years, averaging 8 weeks 
versus 4 weeks, respectively (Al Shamahy & Wright 2001). In another study, the average 
duration of illness prior to diagnosis and treatment was 40 days, but cases with 
osteoarticular disease generally experienced longer periods of illness, extending to 6 
months (Zribi et al. 2009).   
 
The GBD 2004 study estimated the disability weights for low back pain due to chronic 
intervertebral disc disease and osteoarthritis of the knee to be 0.121 (range 0.103-0.125) 
and 0.129 (range 0.118-0.147), respectively (WHO 2004).  Given the high proportion of 
patients in our systematic review with joint, back, or muscular pain, a disability weight of 
at least 0.150 is proposed as a minimum estimate for localised, chronic brucellosis.  
Generalised, non-specific clinical manifestations were also common. Acute, non-
localised brucellosis could be approximated by an episode of malaria, estimated to be 
0.191 (range 0.172 - 0.211) by the GBD 2004 study (WHO 2004).  
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4.6 Discussion 
The clinical picture of brucellosis presented in this systematic review is consistent with 
other literature (Franco et al. 2007).  Although a large amount of data are available 
regarding clinical manifestations of brucellosis, its geographical distribution is limited. No 
high quality studies were identified from Sub-Saharan Africa, Central and South America 
or South-East Asia. This could potentially reflect either a lower disease burden or a 
poorer brucellosis surveillance system.  
 
The proportion of male patients was greater than female patients amongst both children 
and adults. Although this difference was only small in adults, it was more pronounced in 
children. Possible explanations could be a greater risk of exposure amongst boys, with 
household responsibilities such as shepherding of livestock being preferentially 
delegated to boys, or gender-related differences in accessing to health care. 
 
Given the high proportion of brucellosis cases with fever, brucellosis should be 
considered as a differential diagnosis for fevers of unknown origin. In malaria-endemic 
countries, fever patients are often diagnosed and treated for malaria based solely on 
clinical findings (Amexo et al. 2004). Improved diagnostic capacity would reduce the 
diagnostic delay and facilitate prompt and appropriate treatment. These health service 
inadequacies are compounded by socioeconomic factors, with brucellosis affecting poor, 
marginalised communities who often do not have the means to seek treatment. Although 
studies included in this systematic review did not investigate health-seeking behaviour, a 
study from rural Tanzania revealed that 1 in 5 patients did not present to a health centre 
for assessment until more than one year after the onset of illness. Once at the health 
centre, nearly half (45%) were not diagnosed with brucellosis at their first visit (Kunda et 
al. 2007). In children, particularly, under-diagnosis of brucellosis is likely.  The lower 
proportions of reported general symptoms such as sweats, chills, fatigue, and headache 
in study populations consisting only of children in this systematic review could reflect 
difficulty in obtaining accurate case histories from this group.   
 
One in 10 men experienced epididymo-orchitis, the most common genitourinary 
complication of brucellosis infection. This can have serious repercussions such as 
abscessation and infertility. Although other severe outcomes were less common, 4 
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neurological cases and 1 endocarditis case per 100 brucellosis patients were reported, 
which is substantial.  
 
Arthralgia, myalgia, and back pain were common manifestations. The relative lower 
proportions of patients with sacroiliitis and spondylitis compared to those reporting back 
pain might reflect limitations in diagnostic capacity. Chronic pain has been shown to 
severely affect the quality of sufferers’ social and working lives (Breivik et al. 2006). As 
the majority of the brucellosis disease burden is in less developed countries, where 
livelihoods are often reliant on physical activities, the impact of musculoskeletal pain and 
impaired function in these settings may be even more serious.  
 
One study reported that patients with osteoarticular disease experienced a greater 
diagnostic delay than other cases (Zribi et al. 2009), reflecting the chronic debilitation 
that can result from brucellosis infection. Indeed, in an endemic area of Russia prior to 
the availability of effective antibiotic therapies approximately 40% of 1,000 brucellosis 
cases followed over a 20 year period continued to suffer from clinical manifestations two 
years after disease onset. In this study, cited by Wund in 1966, approximately 90% of 
cases had self-cured after 6 years. (Wundt 1968).  
 
Given the complexity of the clinical manifestations of brucellosis, summarising its impact 
into a single disability weight risks being too reductionist. However, a disability weight is 
required for an assessment of the global burden of disease which is, in turn, essential for 
engagement of policy-makers and funding bodies. Using the disability classes formerly 
used by the GBD 2004 study (Murray 1994), a disability weight of 0.2 has been 
previously proposed based on Mongolian patient data (Roth et al. 2003).  This estimate 
fell between Class 1 (0.096), which referred to a limited ability to perform at least one 
activity in the one of the following areas: recreation, education, procreation or 
occupation; and Class 2 (0.22), referring to a limited ability to perform most activities in 
one of the aforementioned areas.   
 
Based on this systematic review and meta-analysis, better informed estimates of 
disability weights are proposed: at least 0.150 for chronic, localised brucellosis and 
0.190 for acute brucellosis. However, as this is the first informed estimate of a 
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brucellosis disability weight, there is a need for further debate amongst brucellosis 
experts and a consensus to be reached. 
 
Research Agenda 
Morbidity could vary geographically according to epidemiological setting. Well designed 
epidemiological studies from regions under-represented in this review would greatly 
contribute to an overall assessment of the global disease burden. A surveillance system 
amongst fever patients in malaria-endemic countries could be particularly informative. 
Additionally, risk factors for disease should be investigated through case-control studies. 
This would provide invaluable information to guide disease control interventions and 
policy. 
 
Limitations 
Studies for which a title or abstract was not published in a language using the Latin 
alphabet, such as those published only in Chinese characters or Arabic script, may not 
have been identified during the original database search. Of the foreign language 
studies that were identified, those published in languages in which the team was not 
competent were excluded from the analysis. It is possible that some of these studies 
contained data that could have contributed to this global assessment of brucellosis 
morbidity. Additionally, although studies in English were independently reviewed by 
three team members, this was not always possible for studies reviewed in other 
languages (German, French, Spanish). 
 
There were likely some differences between the case definitions and diagnostic capacity 
of different studies. For neurological and respiratory syndromes, many studies provided 
only an overall aggregated estimate without details of the different disease forms. A 
respiratory case could potentially vary from a patient with only a cough to severe 
bronchopneumonia, or a neurological case from altered behaviour and confusion to 
nerve deficits, meningitis or seizures.  All patients were positive by culture in only 3 
studies. Given the complexity of brucellosis serology interpretation, it is possible that 
some patients in other studies were misdiagnosed as cases of active brucellosis. 
 
The studies provide data from brucellosis patients presenting to health centres. It is 
possible that cases that do not present to health centres are less severe. The results of 
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this review may, therefore, be biased towards more severe cases.  As with the 
estimation of other disability weights, the proposed brucellosis disability weight estimate 
assumes that a given clinical manifestation will result in the same disability in all settings, 
which is unlikely (Reidpath et al. 2003).   
 
4.7 Conclusion 
This systematic review adds to the understanding of the global burden of brucellosis, 
one of the most common and important zoonotic diseases worldwide. Brucellosis is 
shown to have a severe, debilitating, and often chronic impact on its sufferers. 
Significant delays in appropriate diagnosis and treatment are the result of both health 
system inadequacies and socioeconomic factors. Well designed epidemiological studies 
from those regions identified to be lacking in data would allow a better understanding of 
the clinical manifestations of disease and exposure risks and provide further evidence for 
policy-makers. Based on the findings of this systematic review and the disability weights 
from the 2004 Global Burden of Disease Study, a disability weight of 0.150 is proposed 
as the first informed estimate for chronic, localised brucellosis and 0.190 for acute 
brucellosis. As this is the first informed estimate of a disability weight for brucellosis, 
there is a need for further debate amongst brucellosis experts and a consensus to be 
reached.  
 
4.8 Acknowledgements 
This study was funded by the Foodborne Disease Burden Epidemiology Reference 
Group (FERG) of the World Health Organization (WHO) and the National Centre of 
Competence in Research North-South (NCCR North-South). JH received financial 
support from EU grant FP7-221948 ICONZ. FERG were involved in the design and 
ongoing supervision of the research, in the framework of their global burden of 
foodborne diseases project. All other funders had no role in study design, data collection 
and analysis, decision to publish, or preparation of the manuscript. We gratefully 
acknowledge the support provided by Dr Jalil Darkhan. 
 
5   Epidemiology of brucellosis and Q Fever in northern Togo 
 
- 60 - 
5 Epidemiology of brucellosis and Q Fever in linked 
human and animal populations in northern Togo 
 
Anna S. Dean1,2, Bassirou Bonfoh3, Abalo E. Kulo4, Aboudou Boukaya5, Moussa 
Amidou6, Jan Hattendorf1,2, Paola Pilo7, Esther Schelling1,2* 
 
1 Department of Epidemiology and Public Health, Swiss Tropical and Public Health 
Institute, Basel, Switzerland 
2 University of Basel, Basel, Switzerland 
3Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan, Côte d’Ivoire 
4 Ecole Supérieure d’Agronomie, Université de Lomé, Lomé, Togo 
5Direction de l’Elevage, Ministère de l’Agriculture, de l’Elevage et de la Pêche, Lomé, 
Togo 
6Directional Régional de la Santé - Savanes, Dapaong, Togo 
7Institute for Veterinary Bacteriology, Vetsuisse Faculty, University of Bern 
 
*Corresponding author, esther.schelling@unibas.ch 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Published in PLoS ONE 2013, 8(8): e71501  
 
5   Epidemiology of brucellosis and Q Fever in northern Togo 
 
- 61 - 
5.1 Abstract 
Background: Although brucellosis (Brucella spp.) and Q Fever (Coxiella burnetii) are 
zoonoses of global importance, very little high quality data are available from West 
Africa. 
 
Methods/Principal Findings: A serosurvey was conducted in Togo’s main livestock-
raising zone in 2011 in 25 randomly selected villages, including 683 people, 596 cattle, 
465 sheep and 221 goats. Additionally, 464 transhumant cattle from Burkina Faso were 
sampled in 2012. The serological analyses performed were the Rose Bengal Test and 
ELISA for brucellosis and ELISA and the immunofluorescence assay (IFA) for Q Fever 
Brucellosis did not appear to pose a major human health problem in the study zone, with 
only 7 seropositive participants. B. abortus was isolated from 3 bovine hygroma 
samples, and is likely to be the predominant circulating strain. This may explain the 
observed seropositivity amongst village cattle (9.2%, 95%CI:4.3-18.6%) and 
transhumant cattle (7.3%, 95%CI:3.5-14.7%), with an absence of seropositive small 
ruminants. Exposure of livestock and people to C. burnetii was common, potentially 
influenced by cultural factors. People of Fulani ethnicity had greater livestock contact 
and a significantly higher seroprevalence than other ethnic groups (Fulani: 45.5%, 
95%CI:37.7-53.6%; non-Fulani: 27.1%, 95%CI:20.6-34.7%). Appropriate diagnostic test 
cut-off values in endemic settings requires further investigation. Both brucellosis and Q 
Fever appeared to impact on livestock production. Seropositive cows were more likely to 
have aborted a foetus during the previous year than seronegative cows, when adjusted 
for age. This odds was 3.8 times higher (95%CI: 1.2-12.1) for brucellosis and 6.7 times 
higher (95%CI: 1.3-34.8) for Q Fever. 
 
Conclusions: This is the first epidemiological study of zoonoses in Togo in linked human 
and animal populations, providing much needed data for West Africa. Exposure to 
Brucella and C. burnetii is common but further research is needed into the clinical and 
economic impact. 
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5.2 Résumé  
Situation : Bien que la brucellose (Brucella spp.) et la fièvre Q (Coxiella burnetii) soient 
des zoonoses avec une importance au niveau global, très peu de données de bonne 
qualité existe pour l’Afrique de l’Ouest. 
 
Méthodes / principaux résultats: Une enquête de sérologie a été menée dans la 
principale zone d’élevage de bétail du Togo en 2011, dans 25 villages choisis 
aléatoirement, comprenant 683 personnes, 596 bovins, 465 moutons et 221 chèvres. De 
plus, 464 bovins transhumants provenant du Burkina Faso ont été échantillonnés en 
2012. Les analyses sérologiques employées comprenaient le Test de Rose Bengale et 
la méthode immuno-enzymatique ELISA pour la brucellose, un test 
d’immunofluorescence et la méthode immuno-enzymatique ELISA pour la fièvre Q. La 
brucellose ne semblait pas être un problème important pour la santé publique dans la 
zone d’étude, avec seulement 7 participants séropositifs. B. abortus, qui a été isolé à 
partir du liquide d’hygroma de 3 vaches, semble être la souche prédominante circulant 
dans la zone. Cela pourrait expliquer la séropositivité observée parmi les bovins 
sédentaires des villages (9,2%, IC95%: 4,3-18,6%) et les bovins transhumants (7,3%, 
IC95% : 20,6-34,7%), et l’absence de  séropositivité parmi les petits ruminants. 
L’exposition du bétail et des humains à C. burnetti était fréquente, peut-être influencée 
par des facteurs culturels. Les individus peulhs avaient des contacts plus fréquents avec 
le bétail. La séroprévalence au sein de cette ethnie était également plus élevée que pour 
le reste de la population (peulh : 45,5%, IC95% 37,7-53,6% ; non peulh : 27,1%, 
IC95% : 20,6-34,7%). L’adoption de seuils de détection appropriés pour les tests 
diagnostiques utilisés en zone d’endémie requiert de plus amples investigations. La 
brucellose et la fièvre Q semblaient avoir un impact important sur la production animale. 
Les vaches séropositives avaient plus de chance d’avoir eu un avortement pendant 
l’année précédente que les vaches séronégatives. L’odds ratio était 3,8 fois plus élevé 
(IC95% : 1,2-12,1) pour la brucellose et 6,7 fois plus élevé (IC95% : 1,3-34,8) pour la 
fièvre Q. 
 
Conclusions: Cette étude épidémiologique sur des  zoonoses est la première au Togo à 
l’interface entre populations humaines et animales, et fournit des données importantes 
pour l’Afrique de l’Ouest. L’exposition à Brucella et C. burnetii  est fréquente mais de 
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plus amples investigations portant sur leur impact clinique et économique sont 
nécessaires. 
 
 
5.3 Introduction 
Brucellosis is one of the most common zoonotic diseases globally (Ariza et al. 2007). 
Brucella spp are transmitted to people through the consumption of unpasteurised dairy 
products or direct contact with infected animals, particularly abortion materials (Corbel 
2006; Franco et al. 2007). This bacterial disease causes not only a severely debilitating 
and disabling illness (Dean et al. 2012a), but also has major economic ramifications due 
to time lost by patients from normal daily activities (Corbel 2006) and losses in animal 
production (Roth et al. 2003). High quality incidence data for human brucellosis are 
predominantly available from the Middle East and North Africa region (Dean et al. 
2012b) with no high quality data published from West Africa. Exposure to Brucella has 
been demonstrated in cattle populations in West Africa (Turkson & Boadu 1992; 
Tounkara et al. 1994; Thys et al. 2005; Bankole et al. 2010), with B. abortus isolated 
from bovine hygromas in Mali (Tounkara et al. 1994) and the Gambia (Bankole et al. 
2010). 
 
In recent years, Coxiella burnetii has become a bacterial zoonosis of increasing interest, 
due to an unprecedented, large-scale outbreak of Q Fever in the Netherlands from 2007-
2010 with approximately 4,000 notified human cases (Forland et al. 2012). The most 
common route of infection for people is the inhalation of dust contaminated by infected 
animal fluids, followed by ingestion, particularly of unpasteurised dairy products (Maurin 
& Raoult 1999; Porter et al. 2011). The global importance of Q Fever is unknown. In 
West Africa, there is evidence of exposure to the organism amongst fever patients in 
Mali (Steinmann et al. 2005), but more representative and comprehensive 
seroprevalence and clinical data are needed. 
 
A One Health approach to disease prevention and control not only fosters collaboration 
between human and animal health sectors, but also brings additional benefits to each 
(Zinsstag et al. 2005). The economic benefits include those generated through the 
sharing of resources such as vehicles or field equipment (Schelling et al. 2005; Schelling 
et al. 2007), or through a reduced burden on the health care system by controlling 
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diseases in the animal reservoir (Roth et al. 2003; Zinsstag et al. 2007b). The 
simultaneous assessment of exposure in people and animals provides a more complete 
picture of the disease epidemiology, deepening our understanding of disease risk and 
providing an important knowledge base for policy development. In resource-poor 
settings, an integrated human-animal health system is particularly needed in order to 
increase the cost effectiveness of disease prevention and control interventions, improve 
the efficiency of disease surveillance and response, and strengthen the health system as 
a whole (Zinsstag et al. 2009).  
 
In Togo, animal brucellosis was first documented in the 1960s (Domingo 2000). Although 
bovine brucellosis seroprevalence studies (Kponmassi 1991) and Brucella sp. 
identification (Verger et al. 1982) were conducted in the 1980s and early 1990s, 
simultaneous assessment of  exposure patterns in people and livestock was lacking.  
The Savannah Region is Togo’s principal livestock-raising zone.  Being the northernmost 
of five administrative regions, it is bordered by Ghana to the west, Burkina Faso to the 
north, and Benin to the east. Cross-border livestock movements are an inherent 
component of livestock management practices, via largely unregulated trade routes or 
semi-nomadic movements known as transhumance (IIED and SOS Sahel UK 2010b). 
Official policy for transhumance in West Africa was agreed upon in 1998 by member 
countries of the Economic Community of West African States (ECOWAS). Togo permits 
the entry of foreign herds in search of pasture and watering points from  January to May 
of each year. The Savannah Region of Togo is, therefore, a diverse epidemiological 
setting, with its livestock disease status likely to be linked to that of neighbouring 
countries.     
 
5.4 Methods 
Ethics Statement 
This study was approved by the Ethics Committee for Health Research (Comité de 
Bioéthique pour la Recherche en Santé) of the Ministry of Health of Togo (ref. 
0131/2011/MS/CAB/DGS/DPLET/CBRS) and the Livestock Division (Direction de 
l’Elevage) of the Ministry of Agriculture, Livestock Production and Fisheries of Togo. In 
Switzerland, approval was given by the Ethics Commission of the Cantons of Basel-
Stadt and Basel-Land (Ethikkommission beider Basel) (ref. 146/10) and the Research 
5   Epidemiology of brucellosis and Q Fever in northern Togo 
 
- 65 - 
Commission of the Swiss Tropical and Public Health Institute of Basel, Switzerland. 
Informed written consent was obtained from all literate participants or, in the case of 
minors, from their parents or guardian. For illiterate participants, informed consent was 
recorded with a fingerprint, which was witnessed and documented in writing by a literate 
acquaintance of the participant. Obtaining consent in this way was approved by the 
aforementioned ethics commissions. The collection of blood samples from animals was 
always supervised by a veterinarian. Animals were handled in manner aiming to 
minimise stress and suffering, and were only restrained for the shortest period of time 
necessary. 
 
Village Serosurvey 
Using a detailed regional map and MapInfo Professional® 7.0 SCP, 25 geographical 
coordinates were randomly selected from the Savannah Region, excluding national 
parks where settlements were prohibited. The 25 villages closest to each coordinate 
were visited in May - June 2011 and enrolled in the study after approval from the village 
chief (see Figure 9). A day was allocated for the study team to return to conduct the 
survey in each village. The study team included nurses from local health centres, as well 
as veterinary technicians and veterinarians.  Cluster sample sizes were calculated using 
the formula of Bennett (Bennett et al. 1991) with 95% confidence intervals according to 
Newcome (Newcome 2001).  
 
Household and participant selection 
Due to the absence of a household list, a central point in the village was identified and a 
direction selected by spinning a pen. The number of houses from the centre to the edge 
of the village was counted in this direction, and a number randomly selected between 1 
and the total number of houses. The household corresponding to this number was 
identified by counting the doors in this direction, moving away from the central point. The 
study was explained in the local language and one adult and one child aged between 5-
14 years of age were enrolled by randomly selecting from those household members 
willing to participate. The household with its door closest to the first selected household 
was also visited and a further two participants enrolled. The team then returned to the 
centre of the village to choose a second direction. An intraclass correlation coefficient of 
0.1 and an expected brucellosis seroprevalence of 3%  (Schelling et al. 2003) were 
assumed. A sample size of 15 people from 25 villages would achieve a precision 
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corresponding to a 95% confidence interval not wider than 6 percentage points. 
Consequently, the sampling procedure above was repeated until a total of 7-8 
households were enrolled in each village, i.e. 14-16 people.  
 
 
Figure 9: Map of study site  
The national borders of Togo are shown in red and the boundary of the Savannah 
Region is indicated by the dashed red line. The red points correspond to the 25 
randomly selected villages included in the survey. 
 
The majority of cattle herds in northern Togo are managed by people of Fulani ethnicity, 
pastoralist communities who represent the most dispersed ethnic group in West Africa 
(Oppong 2002; Bassett & Turner 2007).  Fulani communities represent only a very small 
proportion of the overall population of each village, and their households are often 
clustered at the edge of village. As the household selection procedure described above 
for the general population would not have provided an adequate sample size from the 
Fulani communities of each village, targeted sampling was conducted. Approval was first 
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sought from the Fulani chief and the community members were then gathered together 
to explain the aims and methods of the study. Participants were selected from those 
willing to participant by random number allocation. The planned sample size for the 
Fulani was 14-16 people, thus totalling 28-30 people per village (half of which were 
Fulani). 
 
Blood was collected from people by a trained nurse, in parallel with data relating to the 
presence of specific symptoms during the previous month (fever, headache, night-time 
sweats, sleeping difficulties, or muscle, joint or nerve pain). Basic data relating to 
demography (age, sex, ethnicity) and risk factor exposure were collected through 
structured interviews with participants or their parent/guardian. The risk factors assessed 
were the consumption of dairy products (from any species) that had not been subjected 
to heat treatment (boiling), and contact with either cattle or small ruminants, where 
contact was defined as living in a household that owned or looked after cattle or small 
ruminants. 
 
Animal sampling 
In each village, households owning cattle and/or small ruminants (sheep, goats) were 
identified through discussion with the village chief, the Fulani chief, and the local 
veterinary technician. In each village, these households were visited by the study team 
and invited to participate. Owners were requested in advance to keep their animals 
nearby their homes on the pre-selected sampling day. As a full census of the village’s 
livestock population was not available, sampling was distributed across all identified 
herds by dividing the total desired number per village by the number of herds/flocks to 
obtain the number of animals to be randomly sampled per herd/flock. Animals under 3 
months of age were excluded. An intraclass correlation coefficient of 0.1 (Otte & Gumm 
1997) and an expected brucellosis seroprevalence of 5% in cattle and 1% in small 
ruminants (Schelling et al. 2003) were assumed. A sample size of 20 cattle and 25 small 
ruminants from 25 villages would achieve a precision corresponding to a 95% 
confidence interval not wider than 7 percentage points for cattle and 4 percentage points 
for small ruminants.   
 
Blood collection was performed by a veterinarian and veterinary technician. Individual 
and herd data (age, sex, herd size, abortions during previous year, and abortions during 
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reproductive life for transhumant cattle only) were obtained through structured interviews 
with herd owners or herdsmen. 
 
Transhumant Serosurvey 
In February - March 2012, information about the location of transhumant cattle herds 
was obtained from key informants, including local livestock owners and herders, Fulani 
communities, and animal health personnel. Given the available resources and time 
period, a sample size of 15 herds was deemed to be realistic, with 25 animals per herd 
based on an expected brucellosis seroprevalence of 5% (Bennett et al. 1991; Newcome 
2001). Blood collection from cattle as well as structured interviews with herdsmen were 
conducted as per the village survey. Blood samples were not collected from the 
herdsmen. 
 
Serological Analyses 
After collection, all blood samples were immediately chilled on ice and centrifuged the 
same day. Serum was then collected and frozen at -20°C until analysis. Sera from the 
village survey were transported frozen according to international biosafety standards to 
the Swiss Tropical and Public Health Institute in Basel, Switzerland for serological 
analysis. Sera from the transhumant survey were analysed at the Central Veterinary 
Laboratory of the Ministry of Agriculture, Livestock and Fisheries in Lomé, Togo, and 
training was provided to the laboratory technicians. A sub-sample of the sera tested in 
Switzerland was re-tested in Togo for comparison, to ensure an agreement of results by 
the two laboratories.  
 
Brucellosis 
All human samples were tested by the Rose Bengal Test (RBT) (Brucella Rose Bengale, 
Bio-Rad Laboratories, CA, USA), using a serum:reagent ratio of 1:1 for 8 minutes. 
Positive sera were sequentially diluted with saline to obtain dilutions from 1/2 to 1/16, 
then retested as per the protocol of Diaz et al (Diaz et al. 2011). Additionally, all sera 
were tested by indirect IgG ELISA. Samples positive by IgG ELISA or RBT were also 
tested by IgM ELISA (Serion ELISA classic Brucella IgM/IgG, Institut Virion\Serion 
GmbH, Würzburg, Germany), in order to identify recent infections. Samples were 
classified as positive or negative according to the manufacturer’s recommended cut-off 
ranges and doubtful samples were re-tested. 
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All animal samples were tested by the RBT, using a serum:reagent ratio of 1:1 for cattle 
and 3:1 for small ruminants for 4 minutes, as per recommendations of the World 
Organisation for Animal Health (OIE) (OIE 2012).  Additionally, all samples were tested 
by indirect ELISA (CHEKIT Brucellose Serum ELISA Test Kit, IDEXX Laboratories, ME, 
USA) and classified as positive or negative according to the manufacturer’s 
recommended cut-off ranges. Samples positive by RBT but negative by ELISA were 
tested by the Complement Fixation Test according to OIE standards at the Institute for 
Veterinary Bacteriology, University of Bern. 
 
Q Fever 
A random sub-sample of human sera was tested using an indirect IgG Phase II ELISA 
(Coxiella burnetii ELISA IgG, Vircell SL, Granada, Spain). Samples were classified as 
positive or negative according to the manufacturer’s recommended cut-off ranges and 
doubtful samples were re-tested.  In order to assess the suitability of the ELISA cut-off 
value for the Togo samples, the immunofluorescent antibody test (IFA) for Phase II IgG 
was performed by Vircell S.L. in Spain (Coxiella burnetii IFA IgG, Vircell SL, Granada, 
Spain) (Blaauw et al. 2012). 
 
A random sub-sample of sera from village livestock was tested using an indirect IgG 
ELISA (CHEKIT Q-Fever Antibody Test Kit, IDEXX Laboratories, ME, USA). Samples 
were classified as positive or negative according to the manufacturer’s recommended 
cut-off ranges and doubtful samples were re-tested. 
 
Hygroma Fluid Sampling and Culture 
In March 2012, cattle with joint hygromas from study villages and neighbouring villages 
were identified through discussion with cattle owners or herders and local veterinary 
technicians. Fluid samples from joint hygromas were collected from nine cattle, six of 
which were from herds sampled within the village serosurvey. All hygromas were 
involving the carpus, except for one over the hock. After aseptic collection of joint fluid, a 
sterile swab tip was soaked in the fluid and sealed in liquid Amies transport medium. 
Two swabs were harvested per animal. The swabs were stored at 4°C before 
transportation to Switzerland, according to international biosafety standards, for 
microbiological culture at the Institute for Veterinary Bacteriology, University of Bern.  
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The swabs were cultivated on tryptic soy agar plates supplemented with 5% sheep blood 
(BD, NJ, USA) and on Brucella-selective agar (BSA). The BSA contained Brucella-
medium base (Oxoid, Basingstoke, UK), 5% inactivated horse serum and 7.5mL 
modified Brucella Selective Supplement (Oxoid, Basingstoke, UK). The plates were 
incubated for 10 days at 37°C in 5% CO2. Colonies from pure cultures were suspended 
in lysis buffer (0.1M Tris-HCl pH 8.5, 0.005% Tween 20, 0.24 mg/mL Proteinase K) and 
incubated for 60 minutes at 60°C and for 15 minutes at 95°C. The lysates were then filter 
sterilised. 
 
Identification of the genus Brucella was performed by realtime PCR according to the 
protocol of Hinic et al (Hinic et al. 2008). Multiple Loci Variable Number of Tandem 
Repeats Analysis (MLVA) was carried out over 16 loci (panel 1, panel 2A and panel 2B 
markers) for the isolated strains and for B. melitensis strain 16MT, as previously 
described (Al Dahouk et al. 2007a; Le Flèche et al. 2006). The PCR products were 
analysed with the Agilent 2100 Bioanalyzer using a DNA 1000 LabChip kit (Agilent 
Technologies, Waldbronn, Germany) according to the manufacturer's protocols, and 
compared with the results of De Santis et al [10]. Some of the PCR products were 
sequenced in order to confirm the exact size of the amplicons. The MLVA data were 
analysed using the Brucella aggregated database hosted on MLVAnet (http://mlva.u-
psud.fr/) developed by University Paris Sud in Orsay, France (Grissa et al. 2008). 
 
Data Analysis  
Data were entered in duplicate into an Access 2003 database (Microsoft, USA), in order 
to detect data entry errors, and compared using the Data Compare function of Epi Info 
3.5.3 (Centers for Disease Control and Prevention, USA). All statistical analyses were 
performed in Stata 10.1 (StataCorp LP, USA). 
 
As animals from the same village were observed to regularly mix at common grazing and 
watering points, the clustering level for livestock was considered to be the village rather 
than the household. The apparent seroprevalence was calculated using Generalised 
Estimating Equations (GEE) with a binomial distribution and an independent correlation 
structure. To adjust for test performance, a range of plausible values for sensitivity and 
specificity were specified (presented in the Results section) from which a value was 
randomly sampled for the calculation of an adjusted seroprevalence. The model was run 
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for 1,000 simulations, with the random selection of sensitivity and specificity for each 
simulation. The mean adjusted seroprevalence was then determined.  
Mixed effects logistic regression was used to calculate odds ratios to assess covariates 
such as demographic characteristics and potential risk factors for exposure, as well as 
the relationship between human and livestock seroprevalence at the village level.  To 
assess serological test performance for brucellosis, the level of agreement between the 
ELISA and RBT was determined by calculating the inter-rater agreement between two 
unique raters. For human Q Fever, ELISA sensitivity and specificity were calculated 
using IFA as the gold standard reference test (Maurin & Raoult 1999). 
 
5.5 Results 
Human Serosurvey 
From the 25 villages, 683 people participated in the survey, of which 255 (37.3%) were 
of Fulani ethnicity. The age and sex distribution are shown in Table 6.  Consumption of 
non-boiled dairy products was common, particularly amongst Fulani with almost all 
adults (95.6%) reporting consumption compared to less than two thirds (60.7%) of the 
rest of the population, hereafter referred to as non-Fulani. Most households reported 
owning or looking after cattle, sheep, or goats, with 96.9% Fulani and 83.4% non-Fulani 
households reporting this livestock contact.  Nearly three quarters (73.9%) of Fulani men 
listed livestock as a principal source of income, as opposed to 13.8% non-Fulani. 
 
Brucella Seroprevalence 
Seroprevalence results for Brucella spp. are presented in Table 7. Only five people were 
positive by IgG ELISA and three people by RBT. One person was positive to both tests. 
Of the three people positive by RBT, only one remained positive after sequential serum 
dilution. This person was also IgM ELISA positive. Overall, six of these 7 seropositive 
people were of Fulani ethnicity. The apparent seroprevalence for Fulani was 2.4% 
(95%CI: 1.0-5.6), compared to 0.2% (95%CI: 0.0-1.6) for the rest of the population, as 
shown in Table 7.  Seropositive participants were re-assessed by the study team for 
symptoms compatible with active brucellosis. These participants were not clinically 
unwell at the time of examination and none had a clinical history supporting active 
disease, including the IgM seropositive participant. They were provided with information 
about the disease and were monitored by their local nurse. 
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Table 6: Characteristics of study participants from 25 villages in northern Togo 
People 
Ethnicity n Male Age in years 
   Median (range) ≤15 
Fulani 255 118 (46.3%) 25.5 (5-85) 95 (37.3%) 
Non-Fulani 428 242 (56.7%) 26 (5-90) 195 (45.6%) 
Total 683 360 (52.7%) 26 (5-90) 290 (42.5%) 
 
Animals 
Species n Male Median age in 
years (range) 
- 
Cattle: from villages 596 201 (33.7%) 6 (0.3-16) - 
Cattle: transhumant* 464 93 (20.0%) 2 (0.5-15) - 
Sheep 465 52 (11.2%) 3 (0.3-12) - 
Goats 221 24 (10.9%) 2 (0.3-12) - 
 
*Transhumant cattle were sampled from 18 herds across 11 sites. 
 
C. burnetii Seroprevalence 
Two hundred and seventy-eight human sera (134 Fulani and 144 non-Fulani), 
representing 40.7% of the total sample, were randomly selected for IFA and ELISA. 
Serological evidence of exposure to Coxiella burnetii was common, with 100 people 
having Phase II IgG titres by IFA ranging from 1:32 to 1:256, in 23 of 25 villages. 
Assuming IFA to be the gold standard for Q Fever diagnosis (i.e. 100% sensitivity and 
specificity), the seroprevalence in non-Fulani was 26.9% (95%CI: 20.4-30.6%) and 
45.3% (37.6-53.3%) in Fulani using a cut-off value of 1:32 as evidence of serological 
exposure (de Rooij et al. 2012). The odds of being seropositive was 2.3 times higher 
(95%CI: 1.4-3.8) for Fulani compared to non-Fulani when adjusted for age and sex.  
Only 7 people had titres of 1:256 which, as a single Phase II IgG titre, could suggest 
recent or active infection (Fournier & Raoult 2003).  However, none of these cases 
reported symptoms during the previous month that clinically supported such a diagnosis.  
Owning or looking after livestock was associated with a greater odds of being 
seropositive using an IFA cut-off value of 1:32, although the 95% confidence intervals 
included 1. The odds ratios for seropositivity and contact with cattle or small ruminants 
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were 1.6 (95%CI: 0.9-2.9) and 1.3 (95%CI: 0.7-2.3), respectively. Consumption of non-
boiled milk did not increase the odds of seropositivity, with an odds ratio of 1.1 (95%CI: 
0.5-2.3). 
 
Table 7: Seroprevalence of brucellosis (Brucella spp) and Q Fever (Coxiella 
burnetii) in people and livestock 
 
Brucellosis 
Population n Seroprevalence (%) (95%CI) 
  Unadjusted Adjusted for ELISA 
performance 
Humans: Fulani 255 2.4 (1.0-5.6) - 
Humans: non-Fulani 428 0.2 (0.0-1.6) - 
Cattle: from villages 596 9.2 (4.3-18.6) 8.9 (7.0-10.7) 
Cattle: transhumant 464 7.3 (3.5-14.7) 7.1 (5.0-9.5) 
Sheep 465 0 - 
Goats 221 0 - 
Q Fever 
Humans: Fulani 134 45.5 (37.7-53.6)* - 
Humans: non-Fulani 144 27.1 (20.6-34.7)* - 
Cattle: from villages 242 15.7 (11.6-20.9) 14.5 (10.3-19.0) 
Sheep 207 16.4 (11.4-23.1) 15.0 (11.1-20.3) 
Goats 198 7.1 (3.3-14.6) 6.6 (3.5-9.6) 
 
   
*Using IFA cut-off of 1:32 for serological evidence of exposure 
 
Using the manufacturer’s recommended ELISA cut-off value, the sensitivity and 
specificity of the Phase II IgG ELISA were 84.8% and 63.0%, respectively, for evidence 
of serological exposure (IFA titre of 1:32).  However, for IFA titres of 1:256, which can be 
considered the threshold for recent or active infection, sensitivity increased to 100% and 
specificity to 69.4%. 
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Animal Serosurvey 
From the 25 villages, 596 cattle, 465 sheep, and 221 goats were randomly sampled. 
Additionally, serum was collected at 11 different sites from 464 transhumant cattle of 18 
herds originating from Burkina Faso. Owners of transhumant cattle at two sites refused 
to participate due to time constraints. The age and sex distribution of animal subjects are 
shown in Table 6. 
 
Brucella Serology 
Seroprevalence results for livestock are presented in Table 7. Cattle seropositive to 
Brucella spp by indirect IgG ELISA or RBT were only detected in half of the villages (13 
of 25). The apparent seroprevalence by ELISA using the manufacturer’s recommended 
cut-off value was 9.4% (95%CI: 4.6-18.4%), whereas the seroprevalence by RBT was 
lower at 5.7% (95%CI: 2.4-12.8%). Based on conservative estimates of indirect ELISA 
sensitivity and specificity of 94-98% and 97-99% respectively (Schelling et al. 2003; 
McGiven et al. 2003), the seroprevalence adjusted for ELISA performance was 8.9% 
(95%CI: 7.0-10.7%).  
 
In transhumant cattle, the apparent seroprevalence was slightly lower. The 
seroprevalence was 7.3% (95%CI: 3.5-14.7%) by ELISA and 4.5% (95%CI: 2.4-8.5%) by 
RBT. The seroprevalence adjusted for ELISA performance was 6.2% (95%CI: 4.4-8.2%). 
Overall, the two tests had an agreement of 95.9%.   
 
The odds of being seropositive by ELISA increased with age. When adjusted for age, 
cows had an odds of Brucella seropositivity that was 5.3 times higher (95%CI: 1.5-18.7) 
than bulls. Results of the univariate and age-adjusted analysis of predictors of 
brucellosis seropositivity are shown in see Table 8. Seropositive cows had a 3.8 times 
greater odds (95%CI: 1.2-12.1) of having aborted a foetus during the previous year than 
seronegative cows, when adjusted for age. 
 
All small ruminants were negative by indirect IgG ELISA. Eleven were positive by RBT 
but were negative by CFT. Thus, the apparent seroprevalence in sheep and goats was 
0%.  
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C. burnetii Serology 
For testing by indirect IgG ELISA, 242 cattle, 207 sheep, and 198 goat sera were 
randomly selected. In contrast to Brucella spp, C. burnetii seropositivity (meaning at 
least one seropositive animal) was detected in almost all villages (24 of 25).  In these 24 
seropositive villages, the mean village-level seroprevalence was 14.9% (range: 3.6-
37.5%). 
 
The apparent seroprevalence by ELISA using the manufacturer’s recommended cut-off 
value was 16.1% (95%CI: 8.8-21.5%) in cattle, 16.2% (95%CI: 11.1-23.0%) in sheep, 
and 8.8% (95%CI: 4.4-16.9%) in goats, using a GEE model with clustering at the village 
level. Based on conservative estimates of ELISA sensitivity and specificity of 90-94% 
and 97-99% respectively (Schelling et al. 2003; McGiven et al. 2003), adjustment of 
seroprevalence for test performance estimated seroprevalences to be 14.8% (95%CI: 
10.8-19.2%) in cattle, 14.4% (95%CI: 10.6-19.1%) in sheep, and 8.3% (95%CI: 4.2-
12.4%) in goats.  
 
Cows that had aborted a foetus during the previous year had an odds of being C. 
burnetii seropositive that was 6.7 times higher (95%CI: 1.3-34.8) than those that had not 
aborted (Table 8), when adjusted for age. This relationship was not evident for small 
ruminants. Sex and age were not predictors of seropositivity. There was only a very 
weak linear correlation between the village-level seroprevalence of people and livestock, 
with an adjusted R-squared value of 0.05.  
 
Hygroma Fluid Culture 
Although there was no growth on the BSA plates, mixed bacterial cultures grew on blood 
agar. Brucella-like colonies were then purified onto blood agar plates and isolates were 
recovered from hygroma samples from three cows, all of which were seropositive by 
RBT and ELISA. The genus Brucella was confirmed by realtime PCR. Assessment by 
MLVA-8 (panel 1) identified the isolates as B. abortus.  Each isolate had a distinct 
Variable Number of Tandem Repeats (VNTR) profile by MLVA-16 (panels 1, 2A and 2B). 
The full biotyping results will be presented in detail in a separate publication. 
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Table 8: Predictors of seropositivity to Brucella spp and Coxiella burnetii by ELISA 
in cattle  
Bovine Brucellosis (Brucella spp) 
Odds ratio (95%CI) Predictor Number of 
subjects 
(proportion 
seropositive) 
Univariate 
Analysis 
Adjusted for 
sex 
Adjusted for 
age 
11yrs-16yrs*o 48 (18.0%) 22.9 (7.2-73.3) 16.2 (4.9-53.4) - 
6yrs-10yrs*o 378 (12.2%) 5.7 (2.9-11.3) 4.4 (2.2-8.8) - 
3mths-5yrs* 613 (20.8%) - - - 
Cows 766 (11.2%) 9.8 (2.9-32.9) - 5.3 (1.5-18.7) 
Bulls 294 (1.0%) - - - 
Abortion 
during 
previous year+ 
32 (31.3%) 4.1 (1.4-12.3) - 3.8 (1.2-12.1) 
Bovine Q Fever (Coxiella burnetii) 
Abortion 
during 
previous year+ 
8 (16.0%) 6.3 (1.2-33.2) - 6.7 (1.3-34.8) 
 
  * Excluding animals for whom age was not known (n=21)  
   o The reference category for the odds ratios is 3mths – 5yrs.   
   + Excluding cows under 3 years of age. 
 
5.6 Discussion 
This is the first study of brucellosis and Q Fever in linked animal and human populations 
in Togo.  Simultaneous assessment of the exposure of people and animals provides a 
more complete epidemiological picture and deepens our understanding of infection 
patterns at the animal-human interface. The findings of this study are relevant not only 
for Togo, but also for neighbouring countries in West Africa, given the frequent cross-
border movement of livestock often occurring outside official channels.  
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Most published high quality data on the incidence of human brucellosis in Africa comes 
from northern Africa (Dean et al. 2012b), where B. melitensis has an important impact on 
human and animal health (Refai 2002). The findings of this study suggest a different 
disease epidemiology in northern Togo, with no evidence of circulation of B. melitensis. 
Despite the ownership/management of livestock and consumption of non-boiled dairy 
products being common, brucellosis does not appear to pose a major human health 
problem in the study zone. The disease may, however, still have a significant economic 
impact through a reduction in cattle productivity. The distinct VNTR profiles of the three 
B. abortus isolates obtained from the culture of bovine hygroma fluid suggests that the 
organism has been circulating in the study zone for some time. Cows that were 
seropositive for Brucella spp. or C. burnetii were more likely to have aborted a foetus 
during the previous year. Indeed, the Food and Agricultural Organization of the United 
Nations (FAO) estimated in 2002 that milk and meat production in West Africa could 
increase by US$56-168 million/year if brucellosis were eliminated (Mangen et al. 2002). 
 
Due to the absence of a perfect test, Brucella serology is notoriously difficult to interpret. 
All serological tests have limitations when used as screening tools (OIE 2009a). In this 
study, the apparent seroprevalence has been adjusted for the performance of the 
serological tests and the influence of age and sex. However, it remains only an 
approximation of the true disease seroprevalence in the population. Exposed but 
seronegative animals, for example, are not captured in the adjusted seroprevalence 
estimates. The OIE guidelines for brucellosis state that both the RBT and ELISA are 
suitable screening tests for the control of brucellosis at the local or national level. 
Positive reactions should be tested by a confirmatory strategy, such as the CFT (OIE 
2009a; OIE 2012). Given that the 11 small ruminants in this study that were seropositive 
by RBT and seronegative by ELISA remained negative when tested by CFT, the ELISA 
may be a more specific test than the RBT for brucellosis. It may also have a higher 
sensitivity, with more cattle diagnosed seropositive by ELISA than by RBT. However, an 
additional confirmatory test would be required in order to investigate this further. The 
levels of seropositivity of village and transhumant cattle were similar. Given the frequent 
cross-border movements and mixing of livestock in West Africa, these findings suggest 
that the livestock disease status in one country may be potentially linked to that of its 
neighbour. 
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Exposure of animals and people to C. burnetii was common, although the proportion of 
seroconversions representing clinical disease is not known. More research is needed 
into identifying appropriate cut-off values for diagnostic tests in endemic settings. 
However, given that 5.0% of 870 acute febrile patients presenting to health centres in 
Tanzania were diagnosed with acute Q Fever (Prabhu et al. 2011), it is indeed likely that 
the pathogen causes substantial morbidity in Togo.  
 
Cultural practices may influence zoonotic disease risk. The seroprevalence of both 
diseases were higher amongst the Fulani compared to the rest of the population, 
possibly reflecting their greater ownership or management of livestock and their 
increased consumption of non-boiled dairy products.  However, a positive association 
between the consumption of raw milk and seropositivity to C. burnetii could not be 
demonstrated in this study. The role of milk consumption in C. burnetii transmission is 
not fully understood, with asymptomatic seroconversion without clinical illness reported 
(Cerf & Condron 2006; Benson et al. 1963). 
 
General Recommendations 
This is the first joint human and animal zoonotic disease study in Togo, which is an 
important component of the broader One Health concept. A One Health approach to 
zoonotic diseases research should be encouraged in Togo, as it may guide disease 
prevention and control strategies, bring economic benefits to both sectors and 
strengthen the health system as a whole (Zinsstag et al. 2005).   
 
Community awareness of practices risking exposure to zoonotic diseases is needed. 
Given their higher levels of exposure, this is particularly important for Fulani 
communities. Boiling milk before consumption would reduce the risk of exposure to 
foodborne pathogens in general. The importance of avoiding contact with aborted 
materials, as well as basic hygiene practices including handwashing and environmental 
cleanliness (Bonfoh et al. 2006), should also be communicated. Given the low levels of 
literacy amongst study participants, appropriate methods include verbal communication 
of health messages by the local nurse or the village and Fulani chiefs, or the use of 
visual tools. In order to successfully engage communities, the support of both the village 
chief and the Fulani chief is essential. However, information, education and 
communication campaigns are costly to implement. These costs would need to be 
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assessed in relation to the expected combined benefits for human health and livestock 
productivity (Zinsstag et al. 2007b). 
 
Diagnosing and treating zoonotic diseases is particularly challenging in malaria-endemic 
countries (Amexo et al. 2004; D’Acremont et al. 2010). The screening of fever cases for 
differential diagnoses, including Q Fever, should be carried out in order to determine 
their role in febrile illness (Steinmann et al. 2005; Prabhu et al. 2011). This would first 
require training of health workers and laboratory staff, and strengthening of laboratory 
capacity. In terms of animal health, the higher odds of abortion by seropositive cows 
suggests that livestock productivity is affected by both brucellosis and Q Fever. Further 
investigation into the economic impact of these diseases would allow the identification 
and tailoring of cost-effective control strategies, such as vaccination. These strategies 
must be assessed in the context of overall benefits to public health, the livestock 
production sector, and household economies (Roth et al. 2003). There may be 
opportunities to combine the selected interventions with other livestock health programs, 
such as the anthrax vaccination campaigns which take place annually in the study zone. 
 
Study Limitations 
There are several limitations to this study. Firstly, the proportion of the total population 
sampled in each location is unknown, due to the unavailability of recent, comprehensive 
census data.  The age distributions of the human and animal study populations are 
unlikely to reflect the true age distribution of the general population. Secondly, the village 
survey was conducted during the transition period between the dry and wet seasons 
(May-June 2011), before road access became too difficult due to flooding. In some 
particularly dry areas, livestock left the village early in the morning in search of watering 
points and grazing pasture. These animals were not captured by the sampling strategy 
of the field team. Given the practicalities of conducting a field survey in remote, rural 
communities, this potential source of selection bias was unfortunately unavoidable. 
There may have also been temporal variations in pathogen exposure and clinical 
symptoms that were not captured by the cross-sectional study design. Finally, more 
detailed information about risk factors, including the dairy products consumed and the 
level of contact with livestock and abortion materials, would have allowed a more 
thorough assessment of exposure risk. 
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5.7 Conclusion 
This is the first epidemiological study of brucellosis and Q Fever in linked human and 
animal populations in Togo, providing much needed data for the West African region. 
Brucella spp and C. burnetii are shown to be circulating in the study zone, but further 
research is needed into their clinical and economic impact. Education of the community 
about practices risking exposure to zoonotic diseases is needed. 
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6.1 Abstract 
Three Brucella abortus strains were isolated from joint hygromas from cows in northern 
Togo. Two deletions in the 5’ side of the gene BruAb2_0168 were identified. As this 
gene is used for species identification, these deletions have consequences for 
diagnostic procedures. Multiple Locus Variable Number of Tandem Repeat (VNTR) 
Analysis was therefore performed for species identification. The strains showed unique 
VNTR profiles, providing some of the first genotypic data from West Africa. More 
molecular and epidemiological data are needed from the region, in order to better 
understand transmission patterns and develop suitable diagnostic assays. 
 
6.2 Résumé  
Trois souches de Brucella abortus ont été isolées à partir du liquide d’hygroma de 
vaches au nord du Togo. Deux délétions du côté 5’ du gène BruAb2_0168 ont été 
identifiées. Ce gène étant important pour l’identification de l’espèce, ces délétions ont 
des conséquences importantes pour les procédures diagnostiques. Par la suite, la 
procédure d’Analyse de plusieurs locus de répétition en tandem polymorphe (VNTR) a 
été réalisée afin d’identifier l’espèce. Ces souches ont montré des profils VNTR uniques, 
qui constituent quelques-unes des premières données génotypiques pour l’Afrique de 
l’Ouest. Des données moléculaires et épidémiologiques supplémentaires sont 
nécessaires afin de mieux comprendre la transmission de ce pathogène dans cette 
région, et élaborer des tests diagnostiques plus appropriés.  
 
6.3 Main Text 
Although brucellosis is one of the world’s most common zoonoses, there is a lack of data 
from sub-Saharan Africa (Dean et al. 2012b; Pappas et al. 2006). Brucellosis impacts on 
human and animal health (Dean et al. 2012a) and has important economic 
consequences (Roth et al. 2003). This report describes the isolation and genetic 
characterisation of Brucella abortus strains from Togo, which posed a diagnostic 
challenge due to deletions in a gene targeted by PCR and the inability to grow on 
selective medium. 
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During a brucellosis serosurvey in Togo (2011-2012) (Dean et al. 2013a), joint fluid was 
aspirated aseptically from 9 seropositive cows from 5 herds with hygromas in the 
carpi/hocks. Sterile swab tips were soaked in the fluid and sealed in liquid Amies 
medium. After storage and transportation at 4°C according to international biosafety 
standards, they were cultivated in Switzerland on tryptic soy agar plates supplemented 
with 5% sheep blood (BD, Allschwil, Switzerland) and on Brucella-medium base agar 
supplemented with 5% inactivated horse serum and modified Brucella selective 
supplement (Oxoid, Basingstoke, UK). The plates were incubated for 10 days at 37°C in 
5% CO2. All culture manipulations were performed under Biosafety Level 3 containment. 
Although there was no growth on Brucella-selective medium, mixed cultures grew on 
blood agar. Brucella-like colonies were purified and isolates were recovered from three 
cows from three different herds.  
 
Phenotypic testing of the strains was performed. The strains did not require CO2 for 
growth and grew in the presence of thionin (0.04 mg/ml and 0.02 mg/ml) and basic 
fuchsine (0.02 mg/ml).  They produced H2S, as detected by hydrogen sulfide test strips 
(Sigma Aldrich, Buchs, Switzerland) and were urease positive (Oxoid). These results 
indicated B. abortus biovar 3 (WHO et al. 2006). 
 
Molecular identification of the genus Brucella was performed by real-time PCR, as 
previously described (Hinic et al. 2008). As a species-specific signal for abortus or 
melitensis could not be obtained but B. abortus was suspected, it was decided to amplify 
a larger DNA segment of the target locus of the real-time PCR, which was specific for 
the species abortus, the BruAb2_0168 gene (BAbS19_II01580 in vaccine strain S19). 
The primer pair used was 0168_Babo_1F and 0168_Babo_1R. The PCR products were 
sequenced (primers in Table 9). Two deletions of 2678 and 263 base pairs were 
identified, from nucleotide positions 984-3662 and 4295-4558 of the sequence of B. 
abortus strain S19 (Figure 10) (GenBank accession number: KC847095). 
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Table 9: Primers used for the amplification and sequencing of the BruAb2_0168 
gene 
Primers Sequences (5’ to 3’) 
0168_Babo_1F GGCGTGTATGTTGTTGGTAA 
0168_Babo_2F AACATATCGGCGACGCAGTA 
0168_Babo_3F GTGACGGGGACGGGTTGGAC 
0168_Babo_4F TGCGGATAATAATCTGGGTGA 
0168_Babo_5F CGGTTAATGGCACGCTTGAA 
0168_Babo_6F CCTCAATGGTGCGTGGGACAA 
0168_Babo_7F CGGTTCTGGGTGGCACGGTTA 
0168_Babo_8F GCACGGGCAGTCTGACGAAG 
0168_Babo_9F GGCGGCACGACGACGGTTGATG 
0168_Babo_11F GGATACTGACGGCACGCTTGA 
0168_Babo_14F GAACTTCATATCGGTACTGGTG 
0168_Babo_15F CTTGGTGATGACAATTCCAAGA 
0168_Babo_16F GTCTTTTGTGCTCAAGAACAATC 
0168_Babo_17F TGTCGTCAATGGCGGGCGATGGA 
0168_Babo_18F GGGAGTGCAGGCAATCACAG 
0168_Babo_19F CAGGCACGCTGACGCTGA 
0168_Babo_20F ATACACTGACGCTTCAGAACA 
0168_Babo_1R ATCGCCACCAACCATCAGC 
0168_Babo_2R CGCCGTCAGACTGCCCTCCA 
0168_Babo_3R ACCGTCGTTGCGCCCGTA 
0168_Babo_4R AAGTGCCGCCGTTAAACGTCA 
0168_Babo_5R GTGCCTGTGCCGCTCTTCA 
0168_Babo_6R AATTATTCGCCGCATCCTCA 
 
The isolated strains displayed features that complicated diagnosis. Firstly, none grew on 
Brucella selective medium. As some B. melitensis and B. abortus strains are sensitive to 
the antibiotic concentrations in modified Brucella selective supplement, it is therefore 
advisable to concurrently inoculate a standard growth medium or modified Thayer-Martin 
plate (OIE 2009a). Secondly, the deletions in the BruAb2_0168 gene suggest that this 
may not be a suitable target for an abortus species-specific PCR. Samples for which a 
species-specific signal cannot be obtained should always be tested for a genus-specific 
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signal to ensure that Brucella sp is not missed. False negatives due to deletions in 
targets of diagnostic assays can have important public health consequences. In 
Sweden, a deletion of 377 base pairs in the target of a commercial PCR for the 
diagnosis of Chlamydia trachomatis was identified following a decrease in the number of 
human cases detected (Ripa & Nilsson 2006). Genomes can undergo modifications such 
as deletions, insertions or rearrangements, and this aspect of bacterial evolution must 
always be considered when performing PCR assays for detection and/or identification. 
Ideally, more than one target should be tested and unexpected results investigated. 
 
Loci with a Variable Number of Tandem Repeats (VNTR) can be used as markers to 
identify species belonging to the Brucella genus (panel 1 markers) and to discriminate 
among Brucella strains (panel 2A and 2B markers). Molecular typing by Multiple Locus 
VNTR Analysis (MLVA) over 16 loci can be used as a molecular epidemiology tool to 
assess brucellosis transmission patterns (Al Dahouk et al. 2007a; Le Flèche et al. 2006). 
 
MLVA was performed on the three culture lysates and on B. melitensis strain 16MT. For 
most loci, sequencing confirmed the exact PCR product length. However, five loci could 
not be sequenced (bruce06, bruce07, bruce09, bruce30, bruce55) and their length was 
determined by comparing the PCR product bands with those of B. melitensis 16MT on an 
agarose gel, and by the Agilent 2100 Bioanalyzer using a DNA 1000 LabChip kit (Agilent 
Technologies, Waldbronn, Germany) and comparing with the results of De Santis et al 
(De Santis et al. 2009). The MLVA data were analysed using the Brucella aggregated 
database on MLVAnet (http://mlva.u-psud.fr/) hosted by Université Paris-Sud (Grissa et 
al. 2008). This database compares queried strains to described strains and performs a 
clustering analysis using the categorical coefficient and unweighted pair group method 
with arithmetic mean (UPGMA). The resultant Newick strings were imported into R 
statistical software Version 2.12.2 (http://www.R-project.org) and a dendogram was 
drawn using the package ‘ape’ (http://ape.mpl.ird.fr). The three strains showed distinct 
VNTR profiles (Table 10) clustering with African strains of B. abortus biovar 3 (Figure 
11), confirming the phenotypic results. There is only one other genotyped strain of B. 
abortus reported from West Africa, isolated from the Gambia (Bankole et al. 2010). 
Furthermore, the three strains were obtained from a small geographical zone, the 
sampling sites being only 13-42km from one another. This demonstrates the diversity of 
the circulating strains. Given the importance of semi-nomadic herd management and 
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cross-border trade in Togo (Dean et al. 2013b), livestock movements likely play a role in 
this genetic diversity. 
 
Table 10: MLVA results for three Brucella abortus strains from Togo over 16 loci 
MLVA-16 loci*  
Strain 06 08 11 12 42 43 45 55 18# 19 21 04 07 09 16# 30 
1 3 5 3 11 2 2 3 3 8 41 8 4 2 3 6 4 
2 3 5 3 11 2 2 3 3 10 41 8 4 2 3 8 4 
3 3 5 3 11 2 2 3 3 8 41 8 4 2 3 5 4 
*The name of each locus begins with “bruce”, followed by the corresponding number. 
#The three strains differ at loci bruce18 and bruce16. 
 
In developing countries, culture is often not feasible due to inadequate laboratory 
biosafety. At the time of joint fluid collection, several drops were also added to 1mL of a 
chaotropic lysis buffer (Bürki et al. 2011). DNA extraction was performed in Switzerland 
as previously described (Cheng et al. 1995). Real-time PCR (Hinic et al. 2008) confirmed 
the Brucella genus for six cows, three of which were culture positive. The use of 
inactivated, buffered samples is therefore both safer and more sensitive than culture, 
and is recommended for resource-poor, remote areas. Given that DNA extraction and 
PCR were performed 10 months after collection, rapid sample processing is not 
required.  
 
More molecular data are needed from Sub-Saharan Africa, in order to develop more 
suitable diagnostic assays for brucellosis and better understand the epidemiology of this 
important disease. Incoherent diagnostic results should always be further investigated. 
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Figure 10: Locations of deletions 
Location of two deletions in the BruAb2_0168 gene of Brucella abortus strains from Togo compared to B. abortus vaccine strain S19. 
The DNA target for the PCR specific for the abortus species is shown to fall in the range of the first deletion.
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Figure 11: Dendogram showing the genetically closest strains to the three Togo strains 
The species and biovar are given, followed by the country in which the strain was isolated, the author and the strain reference from 
the MLVAnet. This analysis was performed using MLVA-8 (panel 1) loci plus bruce18 and bruce21, in order to assess large-scale 
population structure. 
* This strain is not listed in MLVAnet (Bankole et al. 2010). 
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7.1 Abstract 
Background: Transboundary animal movements facilitate the spread of pathogens 
across large distances. Cross-border cattle trade is of economic and cultural importance 
in West Africa. This study explores the potential disease risk resulting from large-scale, 
cross-border cattle trade between Togo, Burkina Faso, Ghana, Benin, and Nigeria for 
the first time. 
 
Methods and Principal Findings: A questionnaire-based survey of livestock movements 
of 226 cattle traders was conducted in the 9 biggest cattle markets of northern Togo in 
February-March 2012. More than half of the traders (53.5%) operated in at least one 
other country. Animal flows were stochastically simulated based on reported movements 
and the risk of regional disease spread assessed.  More than three quarters (79.2%, 
range: 78.1-80.0%) of cattle flowing into the market system originated from other 
countries. Through the cattle market system of northern Togo, non-neighbouring 
countries were connected via potential routes for disease spread. Even for diseases with 
low transmissibility and low prevalence in a given country, there was a high risk of 
disease introduction into other countries.  
 
Conclusions: By stochastically simulating data collected by interviewing cattle traders in 
northern Togo, this study identifies potential risks for regional disease spread in West 
Africa through cross-border cattle trade. The findings highlight that surveillance for 
emerging infectious diseases as well as control activities targeting endemic diseases in 
West Africa are likely to be ineffective if only conducted at a national level. A regional 
approach to disease surveillance, prevention and control is essential. 
 
 
7.2 Résumé  
Situation: Les mouvements transfrontaliers des animaux facilitent la dissémination des 
pathogènes sur de longues distances. Le commerce transfrontalier de bovins est 
important économiquement et culturellement en Afrique de l’Ouest. Cette étude évalue 
le risque potentiel de dissémination de maladies suite au commerce transfrontalier de 
bovins entre le Togo, le Burkina Faso, le Ghana, le Bénin et le Nigéria pour la première 
fois. 
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Méthodes et principaux résultats: Une enquête de questionnaire portant sur les 
mouvements commerciaux de bovins a été menée dans les neuf plus grands marchés 
de bovins du nord du Togo entre février et mars 2012. Deux cent vingt-six commerçants 
de bovins ont été interviewés. Plus de la moitié (53,5%) d’entre eux achetaient et/ou 
vendaient des bovins dans au moins un autre pays. Les mouvements d’animaux ont été 
simulés stochastiquement en utilisant les mouvements rapportés par les participants. Le 
risque de dissémination de maladies dans la région a été évalué. Plus de trois quarts 
(79,2%, gamme : 78,1-80.0%) des bovins entrant dans le système de marchés de la 
région des Savanes provenaient d’autres pays. A travers ce système de marchés, des 
pays non voisins étaient connectés par des routes le long desquelles des maladies 
pourraient se disséminer. Même des maladies caractérisées par une faible 
transmissibilité et une faible prévalence dans un pays donné, avaient un risque élevé de 
se répandre dans d’autres pays. 
 
Conclusions: A travers la simulation stochastique des données récoltées lors 
d’entretiens menés avec des commerçants de bovins dans le nord du Togo, cette étude 
a permis d’identifier les risques potentiels de dissémination régionale de maladies en 
Afrique de l’Ouest suite au commerce transfrontalier de bovins. Ces résultats soulignent 
le fait que la surveillance des maladies émergentes et les interventions ciblant les 
maladies endémiques en Afrique de l’Ouest seront inefficaces si elles sont conduites au 
niveau national. Une approche régionale pour la surveillance, la prévention et le contrôle 
des maladies est essentielle. 
 
 
7.3 Introduction 
Animal movements within countries and across borders can facilitate the rapid spread of 
pathogens across large distances (Fèvre et al. 2006). Recent examples include the 
spread of highly pathogenic avian influenza H5N1 globally (Kilpatrick et al. 2006) and of 
Trypanosoma brucei rhodesiense, one of the agents of Human African Trypanosomiasis, 
through cattle trade in Uganda (Hutchinson et al. 2003). In industrialised countries, this 
risk can be mitigated through strict importation controls. However, in developing 
countries, cross-border trade of live animals is often an important component of livestock 
production systems from both an economic and cultural perspective.  
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In West Africa, long-distance, cross-border cattle trade was estimated to be worth 
US$150 million in 2000 (Williams et al. 2006). Traditionally, livestock have been raised in 
the semi-arid Sahel zone and traded with countries in the southerly forested zones (De 
Haan & van Ufford 1999; Williams et al. 2006). These cross-border movements continue 
to occur frequently and often outside of official veterinary control. Similar trends exist in 
East Africa, where cross-border trade involving Somalia, Ethiopia, Sudan, Kenya, and 
Tanzania was estimated to be worth US$61 million per annum in 2009, with only 10% of 
trade occurring through official channels (Little 2009).  In South-East Asia, interviews 
with cattle traders uncovered trade routes involving Thailand, Laos, Cambodia, and 
Vietnam. Almost half (45%) of the 60 Cambodian traders interviewed admitted to trading 
animals which they suspected to be infected with Foot-and-Mouth Disease (FMD) virus 
(Kerr et al. 2010). 
 
Understanding the potential pathways and risk for regional spread of infectious diseases 
is essential for tailoring appropriate control interventions in West Africa. In this context, a 
questionnaire-based survey was undertaken with cattle traders operating in cattle 
markets in northern Togo in 2012, and the potential risk of regional disease spread 
through trade routes was assessed through stochastic simulations. 
 
7.4 Methods 
Ethics statement 
This research was a component of a larger study of zoonotic disease epidemiology in 
Togo (Dean et al. 2013a), and was approved by the Ethics Committee for Health 
Research (Comité de Bioéthique pour la Recherche en Santé) of the Ministry of Health 
of Togo. In Switzerland, approval was given by the Ethics Commission of the Cantons of 
Basel-Stadt and Basel-Land and the Research Commission of the Swiss Tropical and 
Public Health Institute of Basel, Switzerland. The information to be communicated to 
participants was provided as a written document to the interviewers and they received 
training regarding the consent process. Prior to interviewing, the study objectives, 
procedures and questionnaire content were explained to participants in their local 
language and they were assured that the questionnaire data would be treated 
anonymously. As the interviews were conducted in the cattle traders’ busy, outdoor 
workplaces, obtaining written consent was determined to be impractical in this setting. 
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Similar to previous cross-sectional surveys conducted with traders in marketplaces (Van 
Kerkhove et al. 2009; Fournié et al. 2012), all participants provided informed verbal 
consent before the interview, as approved by the aforementioned ethics and research 
commissions. The informed consent of each participant was recorded by the interviewer 
on the questionnaire form at the time of interview, and refusals to participate were 
recorded on a separate sheet. 
 
Study site 
The study was conducted in the northernmost region of Togo, the Savannah Region, 
which is bordered by Burkina Faso, Ghana, and Benin. The Savannah Region is a 
pastoral zone important for livestock raising, with approximately half of Togo’s cattle 
population found in this region, estimated to be 138,000 in 2011 (Direction de l’Elevage - 
Togo, personal communication). The area also receives a large number of transhumant 
(i.e. semi-nomadic) herds each dry season, the official period of transhumance being 
from January-May. These herds are mainly from Burkina Faso, as well as from Benin 
and Niger.  
 
Questionnaire survey 
Through discussion with regional veterinary services and livestock traders, the nine 
biggest cattle markets in the region were identified. Markets were open 1-2 days per 
week. The target population was traders of live cattle operating in markets in northern 
Togo. The survey was conducted in February-March 2012 and, in order to capture as 
many traders as possible, larger markets were visited up to 5 times.  
 
Structured questionnaire-based interviews were conducted by two trained interviewers. 
Although the questionnaire was in French, the official language of Togo, interviews were 
also conducted in four local languages. Traders were asked to name all of the sites that 
they visited to purchase or sell cattle during the current dry season and the previous wet 
season. The information recorded by the interviewers included the nature of the site 
(market or informal trading place), its full location (village, district, province and country), 
and the type of the stakeholders with whom they were trading (such as traders, farmers, 
or butchers). If the traders reported visiting markets, the frequency of their visits was 
recorded. For each location, traders were asked to specify the minimum and maximum 
number of cattle sold or purchased per month, if they visited that location every month in 
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a given season. If a location was visited only sporadically, they instead specified a 
minimum and maximum per season. Additionally, traders were asked whether they sold 
animals from, or bought animals for, herds that they personally owned. The locations of 
these herds, the minimum and maximum number of cattle sold/purchased and the 
frequencies of sales/purchases were recorded. As the definition of dry and wet seasons 
may vary between individuals, participants were asked to define the months 
corresponding to these periods. 
 
Additionally, the manager of each market was asked to estimate the number of traders 
operating in the market each open day in both seasons. In order to minimise data entry 
errors, all data were entered twice into a pre-designed Microsoft Access 2003 database 
and cross-checked for discrepancies using EpiInfo 3.5.3 (Centers for Disease Control 
and Prevention, USA). 
 
Market catchment area 
Locations where cattle were bought or sold by traders operating in the Savannah market 
system were visualised using MapInfo Professional Version 7.0. The centroid of each 
province was plotted in order to show the geographic distribution. 
 
Cattle flows through market system 
The analysis was conducted using R statistical software Version 2.12.2 (R Development 
Core Team 2012). Characterisation of the flows of cattle into and out of the market 
system of the Savannah Region could not be directly deduced from the empirical data, 
due to two constraints. Firstly, it was not possible to sample every trader operating in the 
market system during the course of the survey. Secondly, although the number of cattle 
purchased and sold in each location was known for each trader, information about the 
actual origin or destination of these animals was missing. In other words, the number of 
animals purchased by a trader from locations A and B was known, as was the number 
sold to locations C and D, but the proportions of cattle purchased in A or B that were 
then sold to C or D were unknown. Consequently, it was necessary to estimate the flows 
of cattle into and out of the Savannah market system through stochastic simulations. 
The simulation algorithm is described below, which was repeated over 10,000 
simulations. 
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In order to assess the proportion of the total trader population in the Savannah market 
system that was captured by the survey, the number of trader-days per season per 
market was first calculated from the market visit frequencies reported by the traders. 
This was compared with the estimate of the number of traders provided by the market 
manager. 
 
If the trader interview data gave a lower estimation of the number of trader-days per 
season than the market manager’s estimation for a given market, it was assumed that 
the trader sample did not capture the full trader population of the market. In these 
markets, the trader data were completed by randomly re-sampling from the group of 
traders visiting this market until the number of trader-days estimated by the manager 
was reached. This modified dataset was then used to reconstruct the flow of cattle 
between locations.  
 
Cattle movements were simulated for each individual trader as follows. The minimum 
and maximum numbers of cattle reported to be sold or purchased at each site by a given 
trader were summed over one season (dry or wet). These minimum and maximum 
values accounted for the monthly variability reported by traders as well as the 
uncertainty associated with the recall of the number of cattle traded. As traders were 
often livestock owners who bought and sold cattle for their own herds, the location of 
their herd was considered as the sale location for cattle which they purchased for 
themselves. For those traders selling cattle from their own herds, the location of the herd 
was considered as the purchase location. For each trader t, the number 
,t jS  of cattle 
sold in location j (with 1 j m≤ ≤ ) and the number 
,t iB  of cattle purchased in location i 
(with 1 i n≤ ≤ ) were then  randomly drawn from their respective ranges extending from 
the minimum to maximum value. In order to ensure that a given simulated trader t sold 
as many cattle as he purchased over an entire season, the total number tN  of cattle 
traded was randomly drawn from the range extending from the total of number sold, 
,t j
j
S∑ , and the total number purchased, ,t i
i
B∑ . The simulated number of cattle sold 
and purchased in each location was then defined as *
, , ,t j t j t t l
l
S S N S= ∑  and 
*
, , ,t i t i t t l
l
B B N B= ∑ , respectively.  
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The sold animals were attributed to an origin by exploring two different scenarios, 
Location Scenarios 1 and 2. In the first scenario, Location Scenario 1, the probability of 
an animal being sold in any of the sale locations did not depend on its purchase location. 
For each animal sold by a trader, an origin was allocated by randomly sampling from the 
locations given for the animals purchased by this trader, without replacement. In other 
words, each animal sold by a given trader was randomly matched with a unique animal 
purchased by this trader. The flows of cattle resulting from each individual trader were 
then summed. However, given the possibility that cattle may have been more likely to be 
sold at a site closer to the purchase location, an assumption of dependence of purchase 
and sale sites was also explored. In this second cattle flow scenario, Location Scenario 
2, cattle were preferentially sold in the same country as where they were purchased; or, 
for purchases in Togo, they were preferentially sold in the same administrative region. 
 
For each simulation, the number of cattle entering the market system did not necessarily 
equal the number leaving. The number of cattle flowing through the Savannah market 
system in each simulation was, therefore, assumed to be the greater of these two 
values. After running the algorithm over 10,000 simulations, the mean, minimum and 
maximum numbers of cattle flowing between locations was assessed. 
 
Market network 
A network of contacts between markets in the Savannah Region was simulated using R 
package sna (Schwarzer 2012), with markets as nodes and animal movements as 
edges, which were simulated according to the algorithm described above. The network 
was directed, meaning that the direction of animal movements was accounted for. Each 
directed edge connecting two markets was given a weight, equal to the number of cattle 
traded between these two locations. Network connectivity was assessed via the giant 
strongly connected component (GSCC) and giant weakly connected component 
(GWCC). The GSCC refers to the part of the network within which all nodes can reach 
one another through directed paths, whereas the GWCC includes nodes that can reach 
one another through undirected paths. The in- and out-degree distributions of the binary 
and weighted networks were assessed. For the binary network, the in- and out-degree 
referred to the number of Savannah markets sending cattle to and receiving cattle from a 
given Savannah market, respectively. For the weighted network, the in-degree referred 
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to the number of cattle being moved to a given Savannah market from other Savannah 
markets, with the out-degree being the converse.    
 
Cattle in the network were moved directly from their place of purchase to their place of 
sale based on the results of the cattle flow simulations described above. It is possible, 
however, that a trader visiting several markets may conduct his visits in a particular 
order. For example, a trader may purchase all of his cattle in market A, move these 
cattle to market B where some would be sold, and then finally visit market C to sell those 
remaining. Information about the order of market visits was not available, but could 
influence the distribution of links between markets. In order to explore this, an algorithm 
which stochastically ordered the market visits of each trader was run over 1,000 
simulations. Further information is given in Appendix 3. 
 
Risk of disease spread through market system 
The risk of cross-border disease spread through the simulated cross-border livestock 
flows was assessed for Location Scenario 1. The risk was defined as the probability of a 
disease invading an area j through importation of cattle from a disease-endemic area i 
within a one year period. The pathway was divided into two steps: firstly, the introduction 
of an infectious animal into area j from area i; secondly, the spread of disease within the 
cattle population of area j due to the introduction of this infectious animal. Given that 
border crossings rarely involve veterinary assessment, it is assumed that infectious 
animals would be able to cross into neighbouring countries without detection and 
quarantine. Therefore, the probability pi of exporting an infectious animal from an area i 
can be approximated by the prevalence of the disease in area i. The number 
,i jn  of 
animals moved from area i to j within the one year period was taken from the results of 
the simulations previously described.  
 
When an infectious animal has been introduced into an area j, the disease may either 
fade out or spread within the cattle population of area j. The basic reproduction number 
of a disease (R0) is the number of secondary cases resulting from the introduction of one 
infectious case into a fully susceptible population. It refers to a pathogen’s potential to 
spread in a given population. The cattle population in area j was assumed to be fully 
susceptible and to mix homogeneously. With 0 jR  being the reproduction number in area 
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j, the likelihood of disease extinction soon after the introduction of one infected animal 
into this population was equal to 01 jR  (Keeling & Rohani 2008), and the probability of a 
sustained outbreak was 01 1 jjp R= − . The risk P of disease invasion was therefore: 
( ) ,1 1 i jni jP p p= − −   
 
By varying 0 jR  and ip , the risk of an exotic disease invading the cattle population of the 
Savannah Region in Togo through cattle trade from Burkina Faso was explored. Here, 
ip  refers to the disease prevalence in Burkina Faso, and 0 jR  refers to the potential of a 
disease to invade the Savannah cattle population following the introduction of an 
infectious animal into one of its herds through the Savannah market system. The 
Savannah cattle population was assumed to mix homogeneously. 
 
Additionally, the probability of a disease invading at least three other countries through 
cattle trade from Savannah herds was investigated. Here, ip  refers to the disease 
prevalence in the cattle population in the Savannah region, and 0 jR  refers to the 
potential of a disease to invade a cattle population in a given country after the 
introduction of an infectious animal from the Savannah Region into the market system of 
this country. 0 jR  was assumed to be the same in all countries trading with the Savannah 
Region and, in each given country, the local cattle population and cattle traded through 
the local market system were assumed to mix homogeneously. This assumption was 
necessary because data relating to flow of cattle from the market systems into herds in 
these countries were not available.
 
  
7.5 Results 
Descriptive analysis of empirical data 
Two hundred and twenty-six traders were interviewed, with a refusal rate of 12%, mainly 
due to lack of time to participate. In each of the nine markets, 9-55 traders were 
interviewed (median 20, IQR: 11-36). For three markets, the number of trader-days 
calculated from the trader interview data accounted for only 24-77% of the trader-days 
estimated by the market manager, requiring modification (inflation) of their datasets. For 
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the other six markets, the market manager estimated less trader-days than the trader 
interview data and modification of the dataset was not required. Only 8.4% of traders (19 
of 226) transported their animals between locations solely by vehicle, with the remainder 
herding their animals by foot, either exclusively or in combination with road transport. 
The majority of traders defined the dry season as extending from October – April, and 
the wet season from May – September. 
 
Given the higher number of cattle traded at a greater number of locations during the dry 
season compared to the wet season, these data will be presented in detail below. The 
corresponding information for the wet season is provided in Appendix 4. Most 
interviewees (193/226) not only acted as traders, but also bought and sold cattle for their 
own private herds. However, the proportions of their purchases and sales that involved 
their own herds were small. In the dry season, the median proportion of their purchases 
that represented cattle taken from their own herds was only 1.1% (IQR: 0.7-1.8%), and 
the proportion of their sales corresponding to cattle being added to their own herds was 
1.5% (IQR: 1.0-2.3%). In the dry season, cattle were sold from 179 herds. Most of these 
herds (146 of 179) were located in the Savannah Region, as well as other areas of Togo 
(5 of 179), Burkina Faso (23 of 179) and Ghana (5 of 179). Similarly, most of the 175 
herds which received purchased cattle during the dry season were in the Savannah 
Region (141 of 175), as well as other areas of Togo (5 of 175), Burkina Faso (23 of 175), 
Ghana (4 of 175), Benin (1 of 175) and Niger (1 of 175).  
 
The distribution of the average number of cattle traded per trader during the dry season 
was right-skewed. While the median was 500 (IQR: 173-639), as many as 2,916 cattle 
were reported to be traded by a single trader during the season. The median numbers of 
purchase and sale locations of the traders were 4 (IQR:3-5) and 3 (IQR:2-4), 
respectively, regardless of season, with a maximum of 8. Most of these sites were cattle 
markets within the Savannah Region. The median number of Savannah markets in 
which traders operated for purchase or sale was 3 (IQR: 2-4) in the dry season.   
 
Nearly three quarters of traders (166 of 226, 73.5%) in the dry season bought cattle in at 
least one Savannah market and sold cattle in at least one other Savannah market. 
Around half of the cattle purchases and sales reported by traders (55.2% and 51.4%, 
respectively) took place in Savannah markets, whilst 35.8% and 21.6% of purchases 
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and sales, respectively, took place in another country. Of all the cattle purchases and 
sales taking place in the 28 Savannah markets, 83% and 82% respectively took place in 
only 4 markets. Outside of Togo, most of the foreign cattle purchases (85.3%) were 
conducted in Burkina Faso, and 38.4% of foreign cattle sales took place in Nigeria. The 
number of traders operating at different purchase and sale locations as well as the 
numbers of cattle traded at these sites are summarised for the dry season in Table 11. 
 
The market catchment area is shown in Figure 12, with traders operating in the 
Savannah market system also operating in Burkina Faso, Ghana, Benin, Nigeria, and 
Niger, as far as 500km from the Savannah Region. Overall, more than half of the traders 
(121 of 226, 53.5%) operated in at least one other country outside of Togo. Among those 
traders operating in multiple countries, only one quarter (32 of 121, 26.4%) conducted 
both purchase and sale activities in at least two countries.  In the dry season, almost two 
thirds of the traders operating in Burkina Faso (49 of 81, 60.5%) conducted only 
purchases in Burkina Faso, without any sales. Half (11 of 22, 50.0%) of traders 
operating in the dry season in Ghana, three quarters (27 of 37, 73.0%) of traders 
operating in Benin and all (31 of 31, 100%) of the traders operating in Nigeria only sold 
cattle in these countries, without purchasing.  
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Figure 12: Study Zone in West Africa 
The study zone, the Savannah Region of northern Togo, is shaded red. The centroids of the other districts where the interviewed 
traders also bought or sold cattle are shown as red dots. 
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Table 11: Empirical data from interviews with 226 cattle traders - dry season 
This table shows the number of traders purchasing from, and selling to, different locations over the dry season. The proportion of the 
total number of traders interviewed is given in brackets as a percentage. The minimum and maximum numbers of cattle purchased 
and sold in these locations are presented for the dry season, expressed in brackets as percentages of the average number of cattle 
purchased or sold.  Markets and herds located outside of the study zone, the Savannah Region, are referred to as “Other Togo 
markets” and “Other Togo herds”. No butchers were located outside of the Savannah Region. 
 
*This is the median value of the proportion of each trader’s purchases or sales+ taking place in the given locations, as a percentage. 
Traders that did not purchase in a given location were excluded.  
Purchase and sale locations 
 
Savannah 
markets 
Savannah 
herds 
Savannah 
butchers 
Other Togo 
markets 
Other Togo 
herds 
Benin Burkina 
Faso 
Ghana Niger Nigeria 
No. of traders 
purchasing or selling 
226 (100%) 172 
(76.1%) 
39  
(17.3%) 
91  
(40.3%) 
7  
(3.1%) 
37 
(16.4%) 
81 
(35.8%) 
22 
(9.7%) 
2 
(0.09%) 
31 
(13.7%) 
No. of traders 
purchasing  
202 
(89.4%) 
163 
(72.1%) 
0 16 
(7.1%) 
6 
(2.7%) 
10 
(4.4%) 
79 
(35.0%) 
11 
(4.9%) 
0 0 
No. of traders selling 190 
(84.1%) 
152 
(67.3%) 
39  
(17.3%) 
80  
(35.4%) 
5  
(2.2%) 
34 
(15.5%) 
32 
(14.2%) 
18 
(8.0%) 
2 
(0.09%) 
31 
(13.7%) 
No. of cattle 
purchased, ranging 
from min. to max. 
58334-
66285  
(55.2%) 
6605-7370 
(6.2%) 
0 2761-3094 
(2.6%) 
299-327 
(0.3%) 
2480-
2908 
(2.4%) 
32776-
36067 
(30.5%) 
3120-
3391 
(2.9%) 
0 0 
Median proportion 
(%) of total cattle 
purchased per 
trader*  
(IQR) 
77 .0 
(53.0-99.0) 
2  
(1.0-18.5) 
0 28.5  
(19.0-34.5) 
2.5  
(1.3-13.5) 
33.5  
(27.0-
38.0) 
55  
(29.0-
95.0) 
29  
(18.5-
49.5) 
0 0 
No. of cattle sold, 
ranging from min. to 
max. 
54675-
61312 
(51.4%) 
2519-2806 
(2.4%) 
2961-3388 
(2.8%) 
23177-
26084 
(21.8%) 
67-72 
(0.1%) 
6422-
6997 
(5.9%) 
2933-
3533 
(2.9%) 
4796-
5282 
(4.5%) 
36-36 
(<0.1%) 
8779-
9914 
(8.3%) 
Median proportion 
(%) of total cattle 
sold per trader+  
(IQR) 
83.5  
(50.0-99.0) 
2.0  
(1.0-4.0) 
15.0 
(10.0-22.0) 
45.0 
(30.8-61.3) 
2.0 
(1.0-2.0) 
26.5 
(21.0-
32.8) 
5.0 
(1.0-
27.0) 
26.0  
(20.3-
39.3) 
6.5 
(4.3-
8.8) 
28.0 
(19.0-
35.0) 
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Simulated livestock flows 
The 10,000 model simulations gave means of 32,370 cattle (range: 31,070-34,180) 
flowing into the Savannah market system during the dry season and 28,860 (range: 
27,940-29,970) during the wet season. Location Scenario 2 with non-independence of 
buying and selling locations did not have a notable impact on the results, with a mean 
cattle flow into the Savannah market system during the dry season of 28,260 (range: 
26,810-29,500) and 24,900 (range: 23,670-25,930) in the wet season. Overall trends of 
animal flows were the same regardless of season. Given the greater cattle flows during 
the dry season, these data will be presented in detail below. Results from the wet 
season are provided in Appendix 4. A summary of results for Location Scenarios 1 and 2 
for both the dry and wet seasons is provided as a table in Appendix 5. 
 
Figure 13 shows the mean proportions of animals entering into and leaving the 
Savannah market system obtained by the simulations for the Location Scenario 1 for the 
dry season. More than three quarters (79.2%, range: 78.1-80.0%) of cattle flowing into 
the Savannah market system during the dry season originated from other countries, with 
68.0% (range: 65.2-70.2%) of inflow coming from Burkina Faso, 7.6% (range: 7.2-8.0%) 
from Ghana and 3.6% (range: 3.1-4.7%) from Benin. Half of the cattle leaving the 
Savannah market system in the dry season (49.3%, range: 47.0-51.7%) were sent to 
Togolese markets outside of the Savannah Region. The majority (93.7%, range: 92.7%-
94.5%) of these were sent to one large market near the coastal capital city of Lomé, 
where animals are generally slaughtered for meat consumption. One third of the cattle 
(38.8%, range: 36.7-40.7%) leaving the Savannah market system moved into other 
countries, with 7.8% (range: 7.3-8.4%) of outflow into Ghana, 12.3% (range: 11.1-
13.8%) into Benin and 14.7% (range: 13.5-15.9%) into Nigeria. The results of Location 
Scenario 2 did not demonstrate any major differences in flow, as detailed in Appendix 5. 
 
In the dry season, 2,992 (range: 2775-3284) cattle flowed into herds in the Savannah 
Region, equating to 2.2% (range: 2.0-2.4%) of the estimated total cattle population size 
in the Savannah Region. Given that most herds likely breed their own replacement 
animals, many more animals flowed in the reverse direction from Savannah herds into 
the market system. There was a mean of 13,633 cattle (range: 9,096-24,506) leaving 
herds in the dry season, equating to 9.9% (range: 6.6-17.8%) of the estimated total 
cattle population size. Location Scenario 2 produced similar results with 2,989 cattle 
7   Potential risk of regional disease spread in West Africa through cross-border cattle trade 
 
- 104 - 
(range: 2,733-3,305) flowing into herds and 13,730 (range: 9,408-23,940) leaving herds. 
Flows into and out of the Savannah herds followed the same trends as the 
aforementioned market system flows. 
 
 
Figure 13: Simulated flows of cattle into and out of the market system of 
Savannah Region, Togo.  
These simulated mean flows are shown for the six month dry season period, as a 
proportion of total flow into or out of the Savannah market system. The range of 
simulated values from minimum to maximum are shown as black bars. 
 
Market network 
In the dry season, the market system consisted of 28 markets. They formed a well 
connected network incorporating all but one of the markets. The GWCC, estimating the 
upper bound of the maximum epidemic size, was 27. Nearly half of these markets (13) 
formed the GSCC, estimating the lower bound of the maximum epidemic size. When 
using the alternative algorithm for reconstructing the order of market visits, the GSCC 
was even higher, with a median of 20 markets (range: 14-23). Further details of this 
algorithm are provided in Appendix 3.  
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Figure 14 shows the distribution of markets during the dry season as a function of their 
binary and weighted in- and out-degrees. The majority of markets (17 of 28) received 
cattle from at least two other markets, with a maximum of 13 other markets. 
Approximately half of the markets (15 of 28) sent cattle to at least two other markets, 
with a maximum of 14 other markets. However, most cattle movements within the 
Savannah market network were mediated by a small number of markets: 4 markets 
accounted for 73.7% and 78.6% of the total weighted in- and out-degrees, respectively. 
The markets with the highest degrees were those included in the survey, shown as blue 
circles in Figure 3. The Savannah market network for the wet season is presented in 
Appendix 4.  
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Figure 14: Market network of the Savannah Region of Togo and degree distributions  
The graph on the left shows the binary in-degree as a function of the binary out-degree, and the graph on the right shows the 
weighted in-degree as a function of the weighted out-degree, during the dry season. The 9 markets where the survey was conducted 
are  coloured blue and the other 19 are red. 
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Disease risk 
Figure 15 shows the average probability over the course of one year that a disease 
present in Burkina Faso will be introduced through the Savannah market system into 
Togolese herds and result in an outbreak. For a hypothetical disease, even at a low 
prevalence of less than 1% in Burkina Faso and low transmissibility with an R0 of around 
1.25, there was a high probability (80%) of an outbreak in Togo. When disease 
prevalence is higher, between 1-10%, this probability reaches 100%. Similarly, if a 
hypothetical disease with an R0 of around 1.25 is present in Savannah herds at a 
prevalence of less than 1%, the probability of disease being introduced into at least 3 
other countries in the region through the Savannah market system is also 80% (Figure 
16).  
 
Figure 15: Probability of a disease invading the cattle population of the Savannah 
Region in Togo through cattle trade from Burkina Faso. 
The probability of a disease invading the cattle population of the Savannah Region is 
shown as a function of the disease prevalence in Burkina Faso and the basic 
reproduction number of the disease, R0. Here, R0 relates to the potential of a disease to 
invade the Savannah cattle population following the introduction of an infectious animal 
into one of its herds. 
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Figure 16: Probability of a disease invading at least three other countries through 
cattle trade from Savannah herds 
The probability of disease invasion is shown as a function of the disease prevalence in 
the cattle population in the Savannah region and the basic reproduction number of the 
disease, R0. Here, R0 relates to the potential of a disease to invade a cattle population in 
a given country, after the introduction of an infectious animal into the market system of 
this country. 
 
7.6 Discussion 
Although livestock market networks and implications for disease spread have been 
described in detail in developed countries (Bigras-Poulin et al. 2006; Natale et al. 2009), 
few data are available from developing countries and are not captured by official 
datasets such as FAOSTAT from the Food and Agricultural Organization of the United 
Nations (FAO) (FAO 2012). This study quantitatively captures the potential disease risk 
resulting from large-scale, cross-border cattle trade between Togo, Burkina Faso, 
Ghana, Benin, and Nigeria for the first time. The findings will serve as the basis for 
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further research hypotheses and should lead to strengthened collaboration at the 
regional level in the planning of disease control measures. The number of animals 
flowing into the northern Togolese Savannah market system during the dry season 
equals nearly one quarter of the resident cattle population. Although more than half of 
these animals were reported by sellers as having been purchased in Burkina Faso, it is 
possible that some animals originated from further afield, such as Mali or Niger. Through 
the cattle market system of northern Togo, non-neighbouring countries are potentially 
epidemiologically connected via trade routes. 
 
The GSCC of a network is an estimate of the lower bound of the maximum epidemic 
size for a given disease, whilst the GWCC estimates the upper bound (Kao et al. 2006). 
The Savannah market network displayed high connectivity, with nearly half of the 
markets being incorporated into the GSCC and all but one forming the GWCC. In the 
alternative algorithm for reconstructing the sequence of market visits (Appendix 3), the 
GSCC was higher, incorporating the majority of markets. This suggests that a disease 
introduced into one market could rapidly spread to other markets. The market network of 
northern Togo is, therefore, a potential conduit for disease spread between West African 
countries. Although no data are available, it is likely that the scale of cross-border trade 
through the Togolese market network is not a unique scenario, but is rather the norm for 
West Africa. 
 
These findings are relevant not only to the surveillance and control of newly emerging 
diseases, but also endemic diseases. Cross-border cattle trade and transhumance may 
have contributed to the genetic diversity of Brucella abortus strains circulating in the 
study zone (Dean et al. 2013a). These cross-border movements could also potentially 
explain the overlapping distribution of FMD serotypes O, A, SAT1 and SAT2 across 
West African countries (Perry et al. 2011; The Pirbright Institute 2012; Tounkara et al. 
2012), particularly given that wildlife play a less important role in disease transmission 
than in East Africa. The results of this study are of direct relevance to the effective 
implementation of the Global FMD Control Strategy of the FAO and the World Animal 
Organisation for Animal Health (OIE) announced in 2012, a 15 year program which 
seeks to reduce the global impact of this devastating livestock disease (FAO & OIE 
2012). Estimates of the R0 of FMD in sub-Saharan Africa are not available. However, the 
R0 of Rinderpest, a viral disease of cattle officially eradicated in 2011, has been 
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estimated to range between 1.2 - 4.4 in Somalian and Sudanese cattle populations 
(Mariner et al. 2005; Tempia et al. 2010). The R0 of Contagious Bovine 
Pleuropneumonia, a severe respiratory disease of cattle in Africa, is estimated to fall 
between 3.2 - 4.6 in pastoral herds of southern Sudan (Mariner et al. 2006). Therefore, 
the R0 range of 1 - 4 used in this study to assess the risk of disease spread through 
regional cattle trade in West Africa is appropriate. 
 
In addition to animal movements through trade, the Savannah Region of northern Togo 
also receives a large number of transhumant herds from the Sahel zone in search of 
grazing pasture and water sources during the dry season. Members of the Economic 
Community of West African States (ECOWAS) are legally bound to permit seasonal 
cross-border movements of herds (Ly 2007). In 2011, 47,000 transhumant cattle entered 
the Savannah Region through official Togolese government check points (Direction de 
l’Elevage - Togo, personal communication), although it is likely that an even greater 
number entered the country unofficially. The risk of regional disease spread in West 
Africa through trade is, therefore, further compounded by transhumance. In northern 
Togo, there is evidence that anthrax outbreaks occur along the routes followed by 
transhumant herds. As many herds do not follow the official routes designated by the 
Togolese authorities, conducting disease surveillance in this zone is particularly 
challenging (Kulo & Kada 2011). According to the market managers, the higher cattle 
flow through markets during the dry season reflected contributions from transhumant 
herds temporarily visiting Togo. 
 
This study highlights the importance of a regional approach to disease control activities 
in West Africa. Prior to the annual childhood polio vaccination campaign implemented in 
20 countries in Central and West Africa in March 2012, health care providers of border 
districts in the Savannah Region met and discussed with their counterparts in 
neighbouring countries. The animal health sector should also invest in cross-border 
disease prevention activities, such as synchronised vaccination campaigns or formal 
systems for the communication of unusual animal health events.  
 
Limitations 
The questionnaire was written in French, the official language of Togo, Burkina Faso, 
and Benin. However, interviews were predominantly conducted orally in local languages 
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by two trained multilingual interviewers. Occasionally, interpreters were also required. 
Due to the linguistic complexity of the study zone, data errors due to incorrect 
interpretation are possible. As the survey results are based on estimations of cattle 
transactions by traders, rather than witnessed transactions, there is a risk of recall bias. 
 
The flow of cattle through the Savannah market system was reconstructed using 
simulations. While it is possible that the complexities of the market system have not 
been fully captured, these are unlikely to have a major impact on the results: estimates 
obtained when assuming independence or dependence of purchase and sale locations 
(Location Scenarios 1 and 2) were similar. This is likely due to the fact that when 
operating in locations outside of the Savannah region, most traders either purchased or 
sold cattle, not both. However, the data only capture cattle trade through the formal 
market system. Given that informal trade also occurs, the scale of cross-border cattle 
trade is likely to have been underestimated. Furthermore, small ruminant cross-border 
trade has not been considered in this study. Although further data collection would 
improve the accuracy and applicability of the study findings, substantial investment of 
resources would be required. 
 
The order in which traders visited markets in the Savannah Region was not known and 
the network of cattle movements between these markets had to be reconstructed. While 
the GSCC size varied, it was always greater than 45% of all markets, meaning that all 
simulated networks displayed high connectivity. Moreover, most of the purchases and 
sales were always mediated by only a few markets. These dominant markets were those 
where the interviews were conducted. This may suggest that the sampling approach 
may have potentially introduced bias. However, given that these markets were identified 
by the local veterinary services as the largest markets in the Savannah Region, the 
constructed network may indeed reflect the true structure.  
  
The estimations of the risk of disease spread through the market system assumed a 
homogenously mixing population, simplifying animal contact patterns and the underlying 
disease dynamics. Collecting further information on cattle population dynamics in this 
region would be useful for refining this estimate. Moreover, pathogen amplification within 
herds and within markets was not accounted for. If such amplification did occur, this 
would only serve to further increase the risk of disease spread. 
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7.7 Conclusions 
By stochastically simulating data collected by interviewing cattle traders in northern 
Togo, this study identifies potential risks for regional disease spread in West Africa 
through cross-border cattle trade. The findings highlight that surveillance for emerging 
infectious diseases as well as control activities targeting endemic diseases in West 
Africa, such as FMD, are likely to be ineffective if only conducted at a national level. A 
regional approach to animal disease surveillance, prevention and control is essential.  
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8.1 Abstract 
Background: Seasonal, transhumant movements are important to livestock production in 
West Africa. The Fulani are the most dispersed ethnic group in West Africa and are the 
main livestock keepers in Togo. There is no high quality information available regarding 
the access of communities in Togo to health care and other social services, and the role 
of mobility. 
 
Methods/Principle Findings: Semi-structured interviews were conducted with 406 adults 
in 25 randomly selected villages in northern Togo, to investigate migration trends and 
the utilisation of health, veterinary and education services. Around one quarter of Fulani 
adults were born outside of Togo, significantly more than the rest of the population 
(referred to as non-Fulani). In general, most new arrivals to villages were women. Most 
adults reported having accessed health care for themselves or their children within the 
previous year, with no difference between Fulani and non-Fulani. Satisfaction with the 
local health centre was generally high, except for the cost of services. More women of 
child-bearing age had used the services of skilled birth attendants than older women, but 
the distance to the health centre was an influential factor. Significantly less Fulani than 
non-Fulani sent their children to school, at 61.1% (95%CI: 52.0-69.7%) and 86.6% 
(96%CI: 81.1-91.0%) respectively. Few livestock herds had vaccination certificates from 
the previous 3 years. Around one third of Togolese herds undertook transhumance. 
Additionally, herdsmen from 18 transhumant herds from Burkina Faso were interviewed 
about their movements. Ten of these herds returned to the same zone annually because 
of pre-existing social contacts.     
 
Conclusions: This study provides a useful evidence base on which to develop research 
questions for a more in-depth assessment of mobility and access. Topics for further 
investigation include the needs of mobile sub-groups, such as women or transhumant 
herdsmen, the influence of the cost of services and distance to the health centre on 
health care access, and reasons for the scarcity of livestock vaccination certifications. 
 
8.2 Résumé  
Situation: Les mouvements transhumants et saisonniers sont un aspect important de 
l’élevage en Afrique de l’Ouest. Les Peuls forment l’ethnie la plus dispersée en Afrique 
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de l’Ouest et sont les principaux éleveurs de bétail au Togo. Il n’existe pas de donnée 
sur l’accès de ces communautés aux soins médicaux et autres services sociaux au 
Togo, ni sur le rôle de la mobilité.  
 
Méthodes / Principaux résultats: Des entretiens semi-structurés ont été réalisés avec 
406 adultes dans 25 villages sélectionnés aléatoirement dans le nord du Togo, afin 
d’étudier la migration et l’utilisation des services de santé, des services vétérinaires et la 
scolarisation des enfants. Environ un quart des adultes peuls étaient nés en dehors du 
Togo, ce qui est considérablement plus élevé que pour le reste de la population (non 
peul). En général, la plupart des individus récemment arrivés dans un village étaient des 
femmes. La majorité des adultes a rapporté avoir utilisé les services de santé pour eux-
mêmes ou pour leurs enfants pendant l’année précédente, sans différence entre peuls 
et non peuls. Les personnes interrogées étaient généralement satisfaites des centres de 
santé, mais pas du coût des services qu’elles jugeaient trop élevé. La proportion de 
femmes en âge d’avoir un enfant ayant déjà eu recours aux services d’un assistant 
d’accouchement était plus élevé que parmi les femmes plus âgées, néanmoins, la 
distance au centre de santé était un facteur influant. La proportion de peuls qui 
envoyaient leurs enfants à l’école, (61,1% ; IC95% : 52,0-69,7%) étaient plus faible que 
pour les non peuls (86,8% ; IC95% : 81,1-91,0%). Peu d’élevages avaient des certificats 
de vaccination pour les trois dernières années. Environ un tiers des troupeaux togolais 
pratiquaient la transhumance. De plus, les bouviers de 18 troupeaux transhumants du 
Burkina Faso ont été enquêtés. Dix de ces troupeaux retournaient à la même zone 
chaque année au vu des contacts sociaux préexistants. 
 
Conclusion: Cette étude fournit une base d’évidences pour développer des questions de 
recherche qui permettraient une évaluation plus précise de la mobilité et de son impact 
sur l’accès aux soins et la scolarisation. Les sujets qui pourraient faire l’objet de plus 
amples investigations comprennent les besoins des sous-populations mobiles, telles que 
les femmes ou les bouviers transhumants, l’influence des coûts des services et la 
distance au centre de santé sur l’accès aux soins médicaux, et les raisons de la rareté 
des certificats de vaccination du bétail. 
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8.3 Introduction 
 More than half of the world’s nomadic and semi-nomadic populations live in Africa, with 
poorer access to health services than settled communities (Sheik-Mahomed and Velema 
1999; Fokou et al. 2004). Combining outreach veterinary and human health services has 
been shown to be increase coverage amongst pastoral nomadic communities (Schelling 
et al. 2005). There is a need for more practical interventions addressing the priorities of 
communities beyond the reach of conventional services.  
 
A novel framework for analysing and improving access to health care has been 
developed in the context of malaria treatment and care in Tanzania. The Health Access 
Livelihood Framework considers access within the broader context of livelihood assets 
and the policies, institutions, and processes which govern health services (Obrist et al. 
2007). The following five dimensions are included: 
- Availability – the existing services and goods meet the client’s needs, with 
adequate supplies and appropriately skilled personnel 
- Accessibility – the location of services is convenient 
- Affordability – the prices of services meet the client’s ability to pay both direct and 
indirect costs 
- Adequacy – the organisation of health care meets client’s expectations in terms 
of opening hours, structure and cleanliness 
- Acceptability – the characteristics of health care providers match those expected 
by the client, in terms of social values and personality 
 
Togo is one of the world’s poorest countries, with a Gross National Income (GNI) at 
Purchasing Power Parity (PPP) per capita ranked at 201 out of 214 countries in 2011 
(The World Bank 2013). There is no high quality information available regarding the 
access of communities to health care and other social services in this low income, 
resource-poor setting. The Fulani are the most dispersed ethnic group in West Africa 
and are traditionally associated with livestock production activities. The previous 30 
years have seen significant migration of Fulani pastoral communities from the Sudano-
Sahelian zone into the more humid Sudano-Guinean savannahs of West Africa, as a 
result of social and agroecological adjustments (Bassett & Turner 2007; Oppong 2002).  
In Togo, the Fulani are the main keepers of livestock, either as hired caretakers or as 
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part or full owners of herds. They have been shown to have a greater level of exposure 
to zoonoses than the rest of the population (Dean et al. 2013a).  
 
Most of Togo’s livestock production takes place in the northernmost of five administrative 
regions, the Savannah Region, bordered by Ghana, Burkina Faso and Benin. This a 
dynamic zone where cross-border cattle trade and seasonal, semi-nomadic movements 
referred to as transhumance are integral to livestock production (Tezike & Dewa-Kassa 
2008; Grolimund 2010; Kulo & Kada 2011; Dean et al. 2013a; Dean et al. 2013b). The 
aim of this study was to assess the mobility of northern Togolese communities and their 
access to health care and other social services, including the way in which mobility 
influences access. 
 
8.4 Methods 
Survey 
This questionnaire-based survey was conducted in parallel with a brucellosis and Q 
Fever serosurvey in 25 villages in the Savannah Region of northern Togo in May-June 
2011. The random selection of villages and study participants, as well as ethics 
considerations, are described in Chapter 5. Trained interviewers conducted semi-
structured interviews with the adult participants (over 15 years of age) of the serosurvey, 
in the local language of the participant (Fulani, Moba, Gourma, Tchokossi, Gangan, or 
Yanga). Both open and closed questions were included, relating to migration as well as 
to the utilisation and opinions of health, veterinary and education services. Questions 
relating to all five dimensions of the Health Access Livelihood Framework were included. 
Additionally, 18 transhumant herds from Burkina Faso were identified through discussion 
with the local veterinary services and included in a brucellosis serosurvey in February-
March 2012, as described in Chapter 5. The accompanying herdsmen, all of whom were 
young men, were posed open questions about the organisational structure of their 
transhumance activities. 
 
Data Analysis  
Data were entered in duplicate into an Access 2003 database (Microsoft, USA), in order 
to detect data entry errors, and compared using the Data Compare function of Epi Info 
3.5.3 (Centers for Disease Control and Prevention, USA). The data were analysed in 
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Stata 10.1 (StataCorp LP, USA). This included a descriptive analysis and logistic 
regression for binary outcomes. Confidence intervals for proportions were calculated 
using the normal approximation to the binomial. 
 
8.5 Results 
Mobility 
Questionnaire data were available for 178 Fulani adults and 231 adults from the rest of 
the population, referred to hereafter as non-Fulani. The non-Fulani were predominantly 
from the Moba, Gourma, Tchokossi, and Gangan ethnic groups, as well as small 
numbers of Mossi, Yanga and Haoussa people. The sex and age distribution of the 
study participants is shown in Table 10. The Fulani communities were fairly well settled, 
with more than three quarters of interviewees born in Togo (78.4%, 95%CI: 71.6-84.2%). 
The majority of those not born in Togo were born in Burkina Faso. Moreover, half of the 
Fulani (50.8%, 95%CI: 43.3-58.4%) were either born in the village where they were 
interviewed or had been living there for over 20 years, compared with 83.3% (95%CI: 
77.9-87.9%) of the non-Fulani. Nearly all of the non-Fulani (92.2%, 95%CI: 88.0-95.3%) 
were born in Togo, with most of the remainder born in Ghana. Overall, most of the new 
arrivals to the villages within the previous 5 years were women (72.7%, 95%CI: 54.5-
86.7%). 
 
Ten of the 18 transhumant herdsmen interviewed reported that their cattle herd had 
returned to the same zone each year for the previous 4-9 years. The owners of these 
herds had long-standing relationships with local families, whose agricultural productivity 
benefited from the fertilisation of their fields by livestock manure. Livestock owners in 
Burkina Faso often sent their herds on transhumance together with the herds of their 
relatives or friends, rather than the herd travelling alone. 
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Table 12: Sex and age distribution of 409 study participants, by ethnicity 
 
Sex Number interviewed Median age in years (range) 
Fulani 
Men 85 40 (36-45) 
Women 93 32 (30-36) 
Non-Fulani 
Men 145 48 (46-53) 
Women 86 40 (36-42) 
 
 
Access to health care 
Most adults (81.3%, 95%CI: 77.1-85.0%), reported having accessed health care for 
themselves or for their children within the previous year, with no difference by ethnicity. 
Most people (89.4%, 95%CI: 86.0-92.2%) had visited the local health centre at least 
once.  The level of satisfaction with the local health centre was high. Less than 5% 
(range: 0.6-4.7%) of people who had visited the local health centre were dissatisfied with 
one of the following features: opening hours, quality of medication, competence of staff, 
or the welcome received from staff. However, 38.4% (95%CI: 33.2-43.5%) of people 
were dissatisfied with the cost of services.  
 
Nearly all (97.2%) of the interviewed women had previously given birth. Of these, nearly 
half (46.0%, 95%CI: 36.7-55.6%) of the women of child-bearing age (under 45 years of 
age) did not do so in the presence of a skilled attendant, either at a health centre or in 
the village with a midwife.  Women from the 14 villages without a health centre had a 
greater odds of not giving birth with the assistance of a skilled attendant compared to 
women from the 11 villages equipped with health centres, when adjusted for age (OR 
3.4, 95%CI: 1.8-6.4).  Of these 14 villages, women from the 7 villages that were more 
than 5km from a health centre had an odds 4.7 (95%CI: 1.8-12.2) times greater of not 
receiving assistance that women within 5km from a health centre.  No differences were 
noted according to ethnicity or the amount of time living in the village where the interview 
was conducted. For older mothers of at least 60 years of age, the majority had not used 
the services of a skilled attendant (80.8%, 95%CI: 60.6-93.4%). 
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Access to education 
Significantly less Fulani sent all of their children aged from 7-15 years of age to school, 
at 61.1% Fulani (95%CI: 52.0-69.7%) compared with 86.6% non-Fulani (96%CI: 81.1-
91.0%). The most common reason given by Fulani for not sending their children to 
school was that they were needed to herd livestock, whereas non-Fulani generally 
reported a lack of financial means. Other reasons provided were that children were 
needed to help in the home or in the agricultural fields, or that the child did not want to 
attend school. 
 
Access to veterinary services 
Approximately one third (35.2%, 95%CI: 26.9-44.2%) of owners or managers of milk-
producing cows reported selling some of their milk. The income was used to buy meat, 
soap and other household items, and to grind grain at the mill. 
 
Half of the livestock owners (54.2%, 95%CI: 45.3-62.9%) reported having used the 
animal health services during the previous year. However, only 6.9% could provide a 
vaccination certificate from any of the three previous years. Approximately one quarter 
(27.4%, 95%CI: 19.8-36.2%) of cattle owners reported that their cattle undertook 
seasonal transhumance locally within northern Togo.  
 
8.6 Discussion 
This exploratory study has some limitations in its design. The sampling strategy did not 
capture the most mobile sub-groups of the population, and the data collection tools were 
only able to investigate the topics of interest at a fairly superifical level. This research 
does, however, raise further research questions for a more in-depth assessment of 
mobility and access.  
 
In general, the Fulani communities in northern Togo were fairly well settled, with most of 
the interviewees born in Togo. Half were even born in the village where the interview 
was conducted, although this is nonetheless a significantly lower proportion than 
amongst non-Fulani. There may be specific sub-groups of the Fulani and non-Fulani 
populations which are more mobile but were not captured by this survey. Given that 
most of the recent arrivals to the study villages were women, migration within the study 
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zone may be primarily driven by marriage alliances. However, a more detailed 
exploration of the underlying drivers is needed. 
 
Togo receives many transhumant cattle herds from neighbouring countries from January 
to May each year, during the dry season. Most of these herds are managed by young 
Fulani men who travel without their families and remain in contact with the livestock 
owner via mobile phone (Grolimund 2010). Some of the interviewed Burkinabé 
herdsmen had a good network of long-standing social contacts, but others did not. 
During the implementation of the survey, the arrest and incarceration of several 
transhumant herdsmen was observed by the author, which was claimed to be due to 
unpaid taxes for accessing grazing pasture during the night. Resource-sharing between 
transhumant and local populations in limited geographical zones can result in conflict of 
varying degrees (Fokou et al. 2004; Grolimund 2010), and there is a need for more open 
dialogue between stakeholders regarding mitigation strategies. Additionally, the health, 
economic, and social needs of the visiting herdsmen was not assessed in this study and 
warrants further investigation. This is also a relevant question in terms of internal 
transhumance within Togo, undertaken by one quarter of Togolese cattle owners 
interviewed.  
 
Although more than three quarters of interviewees reported having accessed health care 
during the previous year for themselves or for their children, the underlying reasons are 
not known. This figure could, therefore, include door-to-door childhood vaccination 
campaigns rather than the active seeking of treatment. The high proportion of study 
participants who had ever visited their closest health centre suggests reasonable 
accessibility in the study zone. Based on an assessment using the five dimensions of 
access, the health system in northern Togo performed well. These results should, 
however, be treated somewhat cautiously. Questions were posed in a closed manner 
without probing and the nurse from the local health centre was often nearby during the 
interview, risking the introduction of reporting bias. The cost of health care was the main 
concern raised by participants. However, the actual financial barrier to accessing 
appropriate health care, including different treatment options, can not be quantified. 
Careful consideration of the objectives and design of any future studies assessing 
access is important, in order to ensure that the value of the research outputs is 
maximised. 
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Birthing practices have likely become safer in recent decades, with many more women 
aged under 45 years using skilled birth attendants compared to those over 60 years of 
age. Distance to the nearest health centre was shown to be an important factor in 
determining whether births were supervised by skilled attendants. Possible contributing 
factors such as a lack of transport should be explored.  
 
Although the Fulani communities are fairly settled and do not appear to be marginalised 
in terms of access to health care, cultural perceptions may influence school attendance. 
The poorer school attendance of Fulani compared to non-Fulani children is 
predominantly due to livestock herding activities, which is important both culturally and 
economically. The Food and Agricultural Organization of the United Nations (FAO) 
recognises that livestock herding activities undertaken by children can impair normal 
physical and social development and interfere with education. Under certain 
circumstances, such activities can be classified as a form of child labour (FAO 2013). 
There is a need to raise awareness regarding the importance of education, but 
communication activities must be conducted in a culturally appropriate manner.   
 
The scarcity of livestock vaccination certificates could reflect either low vaccination 
coverage or poor record-keeping. It would be useful to compare owner-reported and 
formally documented vaccination histories, and to validate findings by discussing with 
local veterinarians. In the Savannah Region, the government veterinary service 
organises annual anthrax vaccination campaigns in collaboration with veterinarians in 
the private sector, the latter being responsible for vaccine delivery. However, the 
campaigns are not subsidised by the state and livestock owners must pay for this 
service. Potential barriers to vaccination should be investigated, such as insufficient 
veterinary personnel, the high cost of vaccines, or a lack of owner awareness. Given that 
one third of cattle owners or managers sell milk for income generation, the organisation 
and structure of the milk production system for both small and large ruminants should be 
investigated, including aspects relating to local economies, social networks, and public 
health. 
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8.7 Conclusions 
This exploratory study is the first investigating the mobility of northern Togolese 
communities and their access to health care and social services. It provides useful 
background information on which to develop further research questions and 
observational studies.  
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9 Discussion 
 
9.1 Overall Significance of Research 
This research has direct practical applications as well as providing a much needed 
evidence base on which to develop more targeted research questions and public health 
interventions and policy. The content of the thesis is broad, incorporating global disease 
burden, regional mobility of livestock and people, local zoonotic disease epidemiology, 
and access to health care and social services. A variety of methods were employed, 
including desk-based systematic review, field epidemiology (see photos in Appendix 7), 
serological and molecular analyses, and statistical analyses and modelling. There was 
an almost complete absence of pre-existing high quality information from Togo across all 
areas considered in this thesis. Consequently, this research makes an important public 
health contribution to Togo. Furthermore, given the ECOWAS policy of free movement of 
people and livestock across borders of member countries (Adepoju 2005; Adepoju et al. 
2007), the findings are of direct relevance to the West African region. Cultural, 
economic, and epidemiological factors influencing human and animal health are not 
confined by national boundaries.  
 
9.2 Innovation, Validation, Application  
This work was conducted in the context of the public health continuum of “innovation, 
validation, application”, which forms the foundation of Swiss TPH’s research activities. 
Innovation refers to novel ideas, methods or approaches; validation refers to the testing 
of such an innovation; and application refers to the practical implementation of a 
validated innovation. This PhD thesis contributes to all three areas, as shown in Table 
13.
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Table 13: Classification of research in terms of innovation, validation and application 
Ch
. 
Title Innovation Validation Application 
3 Global burden of human 
brucellosis:  a systematic 
review of disease 
frequency  
  Systematic review 
methodology was used to 
assess global brucellosis 
incidence  
4 Clinical manifestations of 
human brucellosis:  a 
systematic review and 
meta-analysis 
The first informed brucellosis 
disability weight was 
calculated. 
 Systematic review 
methodology was used to 
asses brucellosis morbidity 
5 Epidemiology of 
Brucellosis and Q Fever in 
Linked 
Human and Animal 
Populations in Northern 
Togo 
The One Health concept was 
translated into a practical, in-
field approach to assessing 
the epidemiology zoonoses.  
Important zoonoses were 
confirmed to be circulating in 
northern Togo for the first 
time. The impact on livestock 
production and differences in 
human exposure according to 
ethnicity were demonstrated. 
 
6 Deletion in the gene 
BruAb2_0168 of Brucella 
abortus strains: diagnostic 
challenges  
A gene deletion with important 
diagnostic and possibly 
epidemiological 
consequences for West Africa 
was identified. A simpler, 
safer approach to Brucella 
diagnosis was trialled. 
PCR on Brucella DNA 
extracted from hygroma fluid 
preserved in a chaotrophic 
buffer was shown to be more 
sensitive than culture.  
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Ch Title Innovation Validation Application 
7 Potential risk of regional 
disease spread in West 
Africa through cross-
border cattle trade 
Quantitative data were 
captured from the cross-
border cattle market system in 
West Africa for the first time. 
Simulations demonstrated the 
risk of regional disease 
spread through the market 
system. 
 
8 Mobility and access to 
health care and other 
social services: an 
exploratory study in 
northern Togo 
  The Health Access Livelihood 
Framework was used to 
assess access in the context 
of livelihoods and mobility in 
communities northern Togo. 
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9.3 Research Outputs versus Objectives 
Despite the aforementioned achievements of this PhD research, not all of the objectives 
presented in Chapter 2 could be achieved. The contribution of this thesis to each 
research objective is considered below. 
 
9.3.1 Global burden of human brucellosis (Objective 1) 
The systematic review undertaken in the framework of the Global Burden of Disease 
Study 2010 highlighted the severe and chronic impact of brucellosis on the lives of its 
sufferers. The first informed estimates of acute and chronic disability weights for human 
brucellosis presented in Chapter 4 have led us one step closer to the calculation of the 
DALYs for brucellosis, which would in turn be a valuable advocacy tool for a greater 
investment of resources. However, Chapter 3 uncovered major knowledge gaps 
regarding the incidence of brucellosis. Due to heterogenous and patchy data, it was not 
possible to aggregate the data into regional estimates. The calculation of the global 
DALYs for brucellosis based on this data could risk significant bias. Herein lies a difficult 
question: whether it is better to produce a possibly biased DALYs estimate in order to 
advocate on behalf of those communities around the world affected by brucellosis, or 
whether strict scientific principles should always be upheld.  
 
9.3.2 Burden and epidemiology of brucellosis and Q Fever in northern Togo 
(Objective 2) 
By translating the One Health concept into a practical approach to zoonotic disease 
epidemiology in the field, the first high quality human and animal data for Togo were 
captured. Serological surveys are a useful starting point for investigating disease 
burden, providing information about the exposure of human and animal populations to 
pathogens. However, the interpretation of results is often not straight-forward. 
Seropositivity does not equate to clinical disease and, consequently, the impact of 
brucellosis and Q Fever on human and animal health and the economy could not be 
assessed by this research. Furthermore, most commercially available diagnostic kits 
have only been validated in countries with a low disease burden. Recommended positive 
and negative cut-off values may not be appropriate in different epidemiological settings, 
as was demonstrated by the assessment of human Q Fever seropositivity in Togo by 
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ELISA and IFA, presented in Chapter 5. There is a need to validate diagnostic tests for 
neglected zoonoses in developing countries, in order to improve their performance in the 
regions where they are most needed. 
 
The association between seropositivity and abortion in cows presented in Chapter 5 
indicates that these diseases likely have an important impact on livestock production. 
The absence of any small ruminants seropositive for brucellosis suggests that, 
surprisingly, B. melitensis is not circulating in northern Togo. The use of multiple testing 
methods was particularly valuable here, with RBT-positive small ruminants proving to be 
false positives when tested by ELISA and CFT. The RBT alone would have failed to 
capture this important epidemiological finding. People of Fulani ethnicity were shown to 
have greater exposure to zoonoses, highlighting the way in which cultural factors can 
influence disease epidemiology. This serosurvey therefore raises some important 
research questions, but does not provide enough information on which to plan disease 
control interventions or develop policy.  
 
Apart from one genotyped B. abortus strain from Gambia (Bankole et al. 2010), the three 
strains isolated from bovine hygromas in Togo are among the first genotypic data 
available from West Africa. The identification of three unique VNTR profiles from only a 
small geographical area reflects the dynamic nature of the study zone. African strains of 
Bacillus anthracis, the causative organism of anthrax, display some unexpected 
molecular characteristics compared with strains from other regions of the world 
(Tamborrini et al. 2011), and this also appears to be true for Brucella. The deletion 
detected in the BruAb2_0186 gene in Chapter 6 has important diagnostic implications, 
with the need for new species-specific PCR targets. Additionally, there may be 
epidemiological consequences in West Africa, in terms of the role of the BruAb2_0186 
gene in pathogen virulence. The use of the chaotrophic buffer to preserve and inactivate  
Brucella DNA in hygroma fluid was shown to be a safer and more sensitive diagnostic 
method than culture, and of particular relevance to countries with poor laboratory 
biosafety. There is a real need for more molecular epidemiological research in Africa, not 
just in relation to Brucella, but also other zoonoses. 
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9.3.3 Livestock movements in northern Togo (Objective 3) 
The first quantitative assessment of the risk of disease spread in West Africa through 
cross-border cattle trade, presented in Chapter 7, highlighted the importance of a 
regional, rather than national, approach to disease control. This is essential not only for 
the control of endemic diseases, including the Global Foot and Mouth Disease Control 
Strategy of the FAO and OIE, but also for rapid detection and containment of emerging 
and re-emerging diseases, such as Contagious Bovine Pleuropneumonia. The 
epidemiological system of one country was shown to be potentially linked to that of its 
neighbours through cattle trading activities. This research uncovered important 
biosecurity concerns in the region, although the role of informal trade was not accounted 
for. 
 
9.3.4 One Health in Togo (Objective 4) 
The research was conducted using a One Health approach, an important component of 
the broader concept of Ecohealth. Nurses and animal health workers from the study 
zone gained valuable experience working as part of a multidisciplinary field team. An 
intersectoral workshop was held in Lomé in November 2012 to discuss the research 
findings and consult stakeholders in relation to public health priorities and 
recommendations for future research. The workshop was attended by 35 
representatives from the health services, veterinary services, universities and 
government administration in Togo, as well as researchers from the CSRS in Abidjan, 
including a sociologist.  
 
The high level of participation at the workshop reflects the stakeholders’ interest in 
integrating One Health into research and public health in Togo. The enthusiasm of the 
administrative heads of the five provinces of the study zone to attend a technical, 
science-based workshop was particularly encouraging. Conversely, the health and 
veterinary personnel valued the opportunity to establish dialogue with the authorities 
regarding public health priorities and needs. The workshop received significant media 
attention (see Togo-Presse newspaper article in Appendix 6). 
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9.3.5 Mobile populations and access to health care in northern Togo      
(Objective 5) 
The ability of the research to meet this objective was compromised by the relocation of 
the study site to northern Togo. As mentioned in Chapter 2, this PhD research was 
initially planned to be conducted in northern Côte d’Ivoire. As a result of the political 
unrest in Côte d’Ivoire at the end of 2010, the study site was shifted to northern Togo in 
February 2011. Due to the time lost during this transition, the preliminary research that 
had been conducted in northern Côte d’Ivoire in May-August 2010, including focus group 
discussions and in-depth interviews with communities and other stakeholders, could not 
be repeated in Togo. Once all of the necessary permits and authorisations were 
obtained in late May 2011, rapid collection of the serum samples was a priority. This 
urgency was not only due to the need to now conduct the PhD research within only two 
years instead of three, but also because of climatic factors. The rainy season beginning 
in June results in much of the study zone becoming unreachable by road.  
 
Although the field work was ultimately successful with many important research findings 
for Togo and the West African region, the value of the outputs relating to mobility and 
access was compromised by inadequate planning. The Fulani in northern Togo were 
fairly well settled and integrated into the local communities, usually living in villages 
alongside other ethnic groups. In contrast, the Fulani in Côte d’Ivoire tended to form 
separate communities outside of villages. In this sense, a study interested in mobility in 
Togo may have been more fruitful if it had targeted pre-identified sub-groups for whom 
mobility was important, e.g. young men responsible for livestock, or women moving for 
marriage or other reasons. Secondly, the assessment of access to health care and other 
social services would have benefited from the input of social scientists, in order to refine 
the methodology. Nonetheless, the research outcomes presented in Chapter 8 do still 
provide useful background information about mobility and access, on which further 
research questions could be developed. Of particular interest were findings relating to 
the impact of the distance to the nearest health centre on birthing practices, concerns 
raised over the cost of health care, and differences in school attendance according to 
ethnicity. 
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9.4 Applications of Research 
The direct practical applications of the research are considered below. 
 The brucellosis disability weight estimation and the Togolese field data will 
strengthen advocacy efforts. This is of particular relevance to ADVANZ, an EU-
funded initiative to advocate for neglected zoonoses, of which Swiss TPH is a 
partner (ADVANZ 2012). 
 The findings relating to brucellosis and Q Fever seroprevalence in Togo, 
including the performance of the serological tests in an endemic setting, will 
guide the design of future population-based, epidemiological studies of neglected 
zoonoses in sub-Saharn Africa. 
 The deletion detected in the BruAb2_0186 gene of the B. abortus isolates will 
encourage further molecular studies of Brucella in sub-Saharan Africa and the 
development of more suitable diagnostic assays. 
 The simple, safe, and sensitive method developed and trialled in Togo for the 
diagnosis of active brucellosis in livestock can be applied to other developing 
country settings. 
 The strengthening of collaborative relationships between the animal health 
services of Togo and those of neighbouring countries will be encouraged by the 
findings relating to cross-border cattle trade. Additionally, this work will guide the 
design of future livestock mobility studies in West Africa. 
 By drawing on findings related to ethnicity (e.g. greater exposure to zoonoses 
and poorer school attendance of the Fulani) as well as more general community 
practices (e.g. the high level of consumption of unboiled milk), community health 
education activites in northern Togo can be more appropriately targeted. 
 By addressing concerns of the communities (e.g. the cost of health services) as 
well as identified influential factors (e.g. distance to the nearest health centre), 
strategies for improving the health care access of communities in northern Togo 
can be developed. 
 
9.5 General Recommendations and Future Research 
Recommendations arising from this research, as well as areas for further investigation, 
are considered below for each research objective. 
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9.5.1 Global burden of human brucellosis (Objective 1) 
General recommendations: 
 Advocacy targeting governments, international organisations, and funding bodies 
for greater investment in brucellosis prevention and control 
 Strengthening of health systems, leading to improved brucellosis surveillance 
and treatment 
 Integrated approach to brucellosis involving collaboration of human and animal 
health sectors 
 Epidemiological and statistical training of researchers from developing countries 
in order to ensure the design and implementation of high quality population-
based research studies 
 
Further research: 
 Regional disease incidence in Eastern Europe, Sub-Saharan Africa, Asia-Pacific, 
Central and South America 
 DALYs estimate for brucellosis, including an assessment of the uncertainty 
associated with the available data and an exploration of different scenarios 
 
9.5.2 Burden and epidemiology of brucellosis and Q Fever in northern Togo 
(Objective 2) 
General recommendations 
 Education of communities regarding ways in which to minimise the risk of 
exposure to zoonoses and to improve general hygiene, including boiling milk 
before consumption and avoiding contact with animal birthing materials. Verbal 
communication of health messages by the local nurse or the village chief or 
visual tools would be appropriate, given the low level of literacy. 
 
Further research: 
 Proportion of fevers associated with zoonotic diseases, including Q Fever, in 
northern Togo 
 Impact of brucellosis and Q Fever on livestock production and the economy in 
northern Togo 
9   Discussion 
 
- 133 - 
 Livestock serosurveys in West Africa, including investigation of whether B. 
melitensis is circulating  
 Genotyping of B. abortus strains from West Africa 
 Development of B. abortus  diagnostic assays using new targets 
 Validation of serological tests in developing countries 
 
9.5.3 Livestock movements in northern Togo (Objective 3) 
General recommendations: 
 Formal process for exchange between animal health departments of West 
African countries, ensuring a joint approach to disease surveillance, disease 
control interventions (e.g. vaccination) and border control. This could be 
mediated through ECOWAS or the African Union, in collaboration with non-
governmental organisations.  
 
Further research: 
 Impact of season, informal trade networks and population dynamics on cross-
border livestock flows and disease risk 
 West African trade networks extending beyond Togo and its immediate 
neighbours 
 Socioeconomic drivers of livestock trade 
 Association between transboundary animal trade and transboundary disease 
spread, potentially incorporating phylogenic data 
 Suitability and feasibility of interventions to improve border security   
 
9.5.4 One Health in Togo (Objective 4) 
General recommendations: 
 Increased collaboration between researchers and practitioners of human health, 
animal health, social science, and natural science in Togo 
 
Further research: 
 Appropriate mechanisms or tools for operationalising intersectoral collaboration 
in Togo, such as frameworks or formal agreements 
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 Resource sharing, including consideration of the carrying capacity of grazing 
lands, in relation to transhumance 
 
9.5.5 Mobile populations and access to health care in northern Togo     
(Objective 5) 
Further research: 
 Drivers of the greater mobility observed in women, as well as needs and 
challenges after arrival in a new community 
 Mobility of herdsmen during transhumance, including needs, social contacts, 
conflict with local communities, and access to health care and other services 
 Impact of distance to the health centre on access to health care and the role of 
outreach health services, particularly for birthing assistance 
 Vaccination coverage of livestock and barriers such as insufficient veterinary 
personnel, the high cost of vaccines, or a lack of owner awareness  
 Organisation and structure of the milk production system, including aspects 
relating to local economies, social networks, and public health 
 The role of child labour in the livestock sector and its impact on education and 
development 
 
9.6 Transitioning from Côte d’Ivoire to Togo 
As previously mentioned, this research was initially planned to be conducted in northern 
Côte d’Ivoire, in collaboration with the CSRS. Shifting the study site two countries 
eastward led to certain challenges as well as lessons learned. 
 
This PhD research commenced in January 2010 and four months were spent in the field 
during the first year of the PhD to prepare for data collection (May-August 2010 and 
November 2010). Although the CSRS is no stranger to “research in a war zone” (Bonfoh 
et al. 2011b), the post-electoral crisis in December 2010 posed a serious security 
concern. All foreign students were evacuated from the CSRS, but most were able to 
return by mid-2011 to continue their research. However, given the uncertainty of the 
situation, the remoteness of the study site from the CSRS, and the need to progress with 
data collection, the decision was made in February 2011 to completely relocate this PhD 
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project to northern Togo. This was a joint decision made by the supervisors of this 
thesis, Esther Schelling and Bassirou Bonfoh, in discussion with the author and a 
Togolese collaborator, Kulo Abalo.  
 
By March 2011, the author had already arrived in Togo to conduct the first field visit. This 
speedy relocation of the study site to northern Togo was only possible due to a pre-
existing, formal collaboration between the CSRS in Côte d’Ivoire and ESA in Togo. This 
highlights the importance of partnerships between institutions in developing countries, 
referred to as south-south partnerships. The two countries share similar ecological and 
social characteristics and, despite not being direct neighbours, are linked by the 
ECOWAS policy of free movement of people and goods. South-south partnerships are 
important not only for the sharing of ideas, research findings, and technical capacity, but 
also for a combined approach to the planning of interventions and policy. Health, mobility 
livestock production and trade are issues that should be considered at a regional level, 
rather than a purely national level. 
 
Swiss TPH has only limited experience conducting research activities in Togo. The local 
collaborating partner, ESA, had previously assisted a Masters student co-supervised by 
Swiss TPH and the Institute of Social Anthropology at the University of Basel. ESA 
provided invaluable administrative support for this PhD research. However, certain 
procedures, such as obtaining ethics approval from the Ministry of Health, were 
unknown to the school and proved to be a learning experience. The organisation of the 
fieldwork itself was predominantly the responsibility of the author, including finding 
accommodation in the study zone, obtaining a rental car, identifying and training a 
suitable field team, and managing other logistic issues such as establishing a cold chain. 
The materials and equipment needed for the fieldwork were, for a period of time, 
distributed across three countries along the Gulf of Guinea - Côte d’Ivoire, Ghana and 
Togo. Through a combination of air and long-distance road travel, much of which was 
personally carried out by Bassirou Bonfoh, all materials eventually arrived in Togo.   
 
Data collection began in May 2011. The first round was successfully completed by July 
2011, due to a delayed start to the rainy season. Although this was very fortunate for the 
study, the livelihoods and food security of the communities suffered from this extended 
dry season. This highlighted the precarious situation in which many local people live 
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from day to day. A second field visit was conducted between January-April 2012, 
completing the data collection. Ultimately, this research was successful but, as 
mentioned in section 9.3.5, time constraints did limit the planning of the study and the 
value of some of the research outputs. Photos taken during the field work in Togo are 
provided in Appendix 7. 
 
9.7 Final Conclusions 
This PhD thesis addresses global disease burden, regional mobility of livestock and 
people, local zoonotic disease epidemiology and access to health care and social 
services. The research was conduced across the continuum of innovation-validation-
application that forms the basis of the activities of Swiss TPH. The findings provide a 
public health contribution that is valuable from global to regional and national levels. In 
addition to the direct, pratical applications of this research, it also provides a much 
needed evidence base on which to advocate on behalf of communities, develop more 
targeted research questions, and, eventually, design public health interventions and 
policy. 
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Table 14: Selected brucellosis seroprevalence studies by region 
Country, 
Author 
Study design Study 
level 
Study 
population 
Diagnostic tests Seroprevalence 
(%), (95% CI) 
Number of 
subjects 
North Africa and Middle East 
Egypt  
(El Sherbini et al. 2007)  
Cross-sectional  Sub-district General 
population 
STAT  0.03 (0-3) 616 
Iran,   
(Alavi et al. 2007) 
Cross-sectional District Nomadic 
community 
RBT; sequential 
testing of all 
positives with 
WAT; sequential 
testing of all 
positives to both 
tests with 2ME 
8.0 (7.1-8.9) (RBT);        
7.9 (7.0-8.8) (RBT 
+ Wright);  
6.3 (5.5-7.1) (RBT 
+ Wright + 2ME) 
3,594 
Iran 
(Khorasgani et al. 2008) 
 
Unknown  Provincial  Healthy blood 
donors 
RBT; sequential 
testing of all 
positives with 
STAT  
0.08 (0-0.1) (RBT);     
0.06 (0-0.1) (RBT + 
STAT) 
10,500 
Iraq 
(Yacoub et al. 2006) 
Cross-sectional District General 
population: 
rural 
RBT 5.7 (3.5-7.8)  439 
Iraq 
(Yacoub et al. 2006)  
Cross-sectional District General 
population: 
urban 
RBT  12.2 (9.1-15.3) 435 
Iraq  
(Yacoub et al. 2006) 
Cross-sectional District General 
population: 
semi-rural 
RBT 29.3 (25.1-33.3) 465 
Jordan 
(Al-Ani et al. 2004) 
Longitudinal National Healthy blood 
donors and 
healthy 
people 
undergoing 
routine health 
exams 
 
MAT 4.1  (2.7-5.5) 800  
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Country, 
Author 
Study design Study 
level 
Study 
population 
Diagnostic tests Seroprevalence 
(%), (95% CI) 
Number of 
subjects 
Oman 
(Idris et al. 1993) 
Cross-sectional District  School 
children 
MAT, followed by 
testing of 
positives by 
STAT  
1.2 (0.1-2.3) 373 
Saudi Arabia 
(Alballa 1995) 
Cross-sectional Provincial General 
population 
MAT, followed by 
STAT of positives 
16.3 (15.3-17.3) 4794 
Saudi Arabia 
(Al Sekait 1999) 
Cross-sectional National General 
population 
CFT  15 (14.5-15.5) 23,613 
Sub-Saharan Africa 
Chad (Schelling et al. 
2003) 
Cross-sectional   Provincial  Nomadic 
community 
Parallel ELISA + 
RBT 
3.8 (2-5) 860 
Western Europe 
Turkey 
(Cetinkaya et al. 2005) 
Cross-sectional District General 
population 
RBT 4.8 (3.5-6.1) 1052 
Turkey 
(Karabay et al. 2004) 
Cross-sectional  Provincial General 
population  
Parallel RBT and 
STAT 
Overall:1.3 (0.8-
1.8); 
Urban:1.7 (1.0-2.4); 
Rural:1.0 (0.3-1.7) 
Overall:2,098  
Urban:1,298  
Rural:800 
Turkey 
(Vancelik et al. 2008) 
Cross-sectional  District General 
population 
STAT, RBT  5.4 (3.5-7.3) 
(STAT);    
11.9 (9.2-14.6) 
(RBT) 
573 
Central Asia 
Kyrgyzstan (Bonfoh et al. 
2011a) 
Cross-sectional National General 
population 
Parallel ELISA + 
RBT + 
Huddleson 
8.8 (4.5-16.5) 1,774 
Central and South America 
Argentina 
(Marder et al. 2005) 
Routine data District Healthy blood 
donors 
Huddleson 1.4 (1.3-1.5) 35,388 
Mexico 
(Hernandez et al. 1999) 
Longitudinal  Provincial  Healthy blood 
donors 
RBT 2.8  (2.5-3.1) 9590 
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Table 15: Selected brucellosis incidence studies by region 
 
 
 
Country, 
Author 
Study design Sampling 
methods 
Study 
level 
Reference 
population 
type and 
size 
Diagnostic 
tests 
Incidence 
(cases per 
100,000 per 
year) 
Number of 
cases 
North Africa and Middle East 
Egypt  
(Crump et al. 2003)  
Longitudinal  Non-random 
purposive 
sampling; 
active case-
finding 
District   General 
population: 
664,000; 
Acute febrile 
illness 
population: 
449 
STAT and/or 
culture 
18.0             31 
Egypt 2002-2003 
Jennings 
(Jennings et al. 2007)   
Longitudinal   Non-random 
purposive 
sampling; 
active case-
finding 
Provincial  General 
population: 
2,347,249; 
Acute febrile 
illness 
population: 
4490 
STAT and/or 
culture 
64.0 (2002)       
70.0 (2003)  
135 (2002)         
186 (2003) 
Iran  
(Haghdoost et al. 
2007)   
Routine data Non-random 
sampling; 
passive case-
finding 
 
District  General  
population: 
50,000 
Serology 141.6            97 
Iran    
(Hosseini et al. 2008)  
Routine data Non-random 
sampling; 
passive case-
finding 
Provincial  General 
population 
Wright 
Agglutination 
and 2ME 
13.1 145 
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Country, 
Author 
Study design Sampling 
methods 
Study 
level 
Reference 
population 
type and 
size 
Diagnostic 
tests 
Incidence 
(cases per 
100,000 per 
year) 
Number of 
cases 
Jordan  
(Abu Shaqra 2000)   
Routine data Non-random 
sampling; 
passive case-
finding 
National  General 
population 
Rose Bengal 
followed by 
STAT of 
positives 
16.7 (1988)       
21.4 (1989)        
24.1 (1990)       
29.9 (1991)       
22.3 (1992)       
22.6 (1993)       
22.6 (1994)       
27.3 (1995)       
26.1 (1996)       
25.7 (1997) 
7,842 
Jordan  
(Gargouri et al. 2009)   
Longitudinal  Non-random 
sampling; 
passive case-
finding 
National  General 
population 
STAT 130  31 (Sept. 2003);         
9 (May 2004) 
Palestine 
(Awad 1998)   
Longitudinal Non-random 
sampling; 
passive case-
finding 
National General 
population: 
860,000 
RBT 8 69 
Saudi Arabia 
(Elbeltagy 2001)    
Routine data  Non-random 
sampling; 
passive case-
finding 
Provincial General 
population: 
40,000 
Sympto-
matically or 
culture or 
paired 
serology or 
CFT 
34  137 
Saudi Arabia (Al 
Tawfiq & AbuKhamsin 
2009)    
Routine data Non-random 
sampling; 
passive case-
finding 
District  Company 
employees: 
37,000 
ELISA or 
STAT 
13 (1983)           
33.3 (1985)        
51.3 (1986)       
70.7 (1987)       
26.3 (1983-1992)              
6 (1993-2007) 
913 
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Country, 
Author 
Study design Sampling 
methods 
Study 
level 
Reference 
population 
type and 
size 
Diagnostic 
tests 
Incidence 
(cases per 
100,000 per 
year) 
Number of 
cases 
Western Europe 
Germany 
(Al Dahouk et al. 
2007b)   
  
Routine data Non-random 
sampling; 
passive case-
finding 
National General 
population 
Serology 
and/or culture 
0.03 (1998-2001)              
0.6 (1962-1965)  
245
Greece  
(Jelastopulu et al. 
2010)   
 
Routine data Non-random 
sampling; 
passive case-
finding 
Provincial General 
population: 
322,790 
Unknown 4 86 
Greece  
(Avdikou et al. 2005)    
Longitudinal  Non-random 
sampling; 
passive case-
finding 
Provincial  General 
population: 
353,820 
ELISA or 
RBT or  
STAT 
17.3         152 
Greece  
(Minas et al. 2007)   
Longitudinal Non-random 
sampling; 
passive case-
finding 
Provincial General 
population: 
278,000 
ELISA, CFT, 
STAT, IFA or 
Coombs 
32.5 821 
Italy  
(De Massis et al. 
2005)n}  
Routine data Non-random 
sampling; 
passive case-
finding 
National General 
population 
Unknown 1.4 (2002)        
2.7 (1990)        
3.3 (1996) 
- 
North America 
USA  
(Doyle & Bryan 2000)  
 
Routine data Non-random 
sampling; 
passive case-
finding 
National   General 
population: 
322,790;           
Zone 1: 
9,871,639; 
Zone 2: 
45,572,965; 
Zone 3: 
203,067,933 
Unknown Zone 1: 0.18  
Zone 2: 0.09  
Zone 3: 0.02 
Zone 1: 158 
Zone 2: 360  
Zone 3: 398 
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Appendix 2: Supplementary forest plots for    Chapter 4 
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Figure 17: Forest plot for fever
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Figure 18: Forest plot for sweats 
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Figure 19: Forest plot for chills
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Figure 20: Forest plot for fatigue 
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Figure 21: Forest plot for headache
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Figure 22: Forest plot for malaise
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Figure 23: Forest plot for nausea/vomiting 
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Figure 24: Forest plot for weight loss 
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Figure 25: Forest plot for abdominal pain 
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Figure 26: Forest plot for splenomegaly
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Figure 27: Forest plot for hepatomegaly 
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Figure 28: Forest plot for hepatitis 
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Figure 29: Forest plot for arthralgia 
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Figure 30: Forest plot for arthritis 
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Figure 31: Forest plot for myalgia
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Figure 32: Forest plot for back pain 
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Figure 33: Forest plot for sacroiliitis 
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Figure 34: Forest plot for spondylitis 
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Figure 35: Forest plot for epididymo-orchitis 
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Figure 36: Forest plot for endocarditis 
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Figure 37: Forest plot for neurological outcomes 
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Figure 38: Forest plot for respiratory outcomes 
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Figure 39: Forest plot for cutaneous outcomes
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Appendix 3: Supplementary methods for Chapter 7 
Accounting for the order of market visits in the analysis of the Savannah market 
network  
 
Methods 
The Savannah market network was constructed based on the results of the livestock 
flow simulations. The order in which the markets were visited by each trader was not 
known but could possibly influence the structure of the network. Potential orders of visits 
were constructed by running 1,000 stochastic simulations, whilst also ensuring that each 
scenario was plausible.  
 
This process is best explained using a hypothetical example. Consider a trader who 
reports purchasing 100 cattle in Market A and 200 in Market B, and selling 10 in Market 
C and 290 in Market D. The first market visited by this trader must be one where he 
purchases cattle, i.e. either A or B. If Market B is randomly selected as the first market 
and 200 cattle are purchased, the second market could theoretically be either a 
purchase or sale location, i.e. Markets A, C or D. However, Market D is not plausible 
because the trader does not yet have the 290 cattle that he reports selling there. If 
Market A is randomly selected as the second visited market, the third market could either 
be Market C or D. If Market C is randomly selected, the final market visited is D. 
Therefore, although this trader may sell cattle in Market D which were purchased in the 
first market that he visited, Market B, these cattle were in fact moved through Markets A 
and C before reaching their final sale destination. 
 
Results  
The results of this ordered analysis are similar to those presented in the manuscript 
where the market visiting order was not taken into account, except for an increase in the 
giant strongly connected component (GSCC). As the GSCC is an estimate of the lower 
bound of the maximum epidemic size for a given disease, an increase in the GSCC 
reflects a greater potential for spread of the disease to other markets in the network.   
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Dry season 
In the dry season, the market system consisted of 28 markets. They formed a well 
connected network incorporating all but one of the markets, such that the giant weakly 
connected component (GWCC) was 27 with most of these markets (median: 20, range: 
14-23) forming the GSCC. The majority of markets (17 of 28) received cattle from at 
least 2 other markets, with a maximum of 10 other markets. Approximately half of the 
markets (16 of 28) sent cattle to at least two other markets, with a maximum of 11 other 
markets. However, most cattle movements within the Savannah market network were 
mediated by a small number of markets: 5 markets accounted for 75.5% and 79.8% of 
the total weighted in- and out-degrees, respectively.  
 
Wet season 
In the wet season, the market system consisted of 26 markets. They formed a well 
connected network incorporating all but one of the markets, such that the GWCC was 25 
with most of these markets (median: 18, range: 13-21) forming the GSCC. The majority 
of markets (16 of 26) received cattle from at least 2 other markets, with a maximum of 10 
other markets. The majority (16 of 26) also sent cattle to at least two other markets, with 
a maximum of 10 other markets. However, most cattle movements during the wet 
season within the Savannah market network were mediated by a small number of 
markets: 5 markets accounted for 77.2% and 79.9% of the total weighted in- and out-
degrees, respectively.  
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Appendix 4: Supplementary results for Chapter 7 – wet 
season  
 
Wet season empirical data 
Of the 226 traders interviewed, 213 also traded in the wet season. Most interviewees 
(180 of 213) not only acted as traders, but also bought and sold cattle for their own 
private herds. However, the proportions of purchases and sales that involved their own 
herds were small. The proportion of purchases that represented cattle taken from their 
own herds was only 1.5% (IQR: 1.0-2.3%), and the proportion of sales corresponding to 
cattle being added to their own herds was 1.8% (IQR: 1.1-2.6%). 
 
The distribution of the average number of cattle traded per trader was right-skewed. 
Compared to the dry season, less cattle were traded with a median of 333 (IQR: 167-
660) and a maximum of 2,882. The median numbers of purchase and sale locations of 
the traders were 4 (IQR:3-5) and 3 (IQR:2-4), respectively, regardless of season, with a 
maximum of 8. Most of these sites were cattle markets within the Savannah Region. The 
median number of Savannah markets in which traders operated for purchase or sale 
was 2 (IQR: 1-4).   
 
Most of the herds (137 of 168) owned by traders from which cattle were being sold were 
located in the Savannah Region, as well as other areas of Togo (5 of 168), Burkina Faso 
(22 of 168) and Ghana (4 of 168). Similarly, most of the herds (134 of 167) which 
received purchased cattle were in the Savannah Region, as well as other areas of Togo 
(5 of 167), Burkina Faso (22 of 167), Ghana (4 of 167), Benin (1 of 167) and Niger (1 of 
167).  
 
Cattle purchases and sales took place in 26 Savannah markets. Nearly three quarters of 
traders (152 of 213, 71.4%) bought cattle in at least one Savannah market and sold 
cattle in at least one other Savannah market. Around half of the cattle purchases and 
sales reported by the traders (53.5% and 51.3%, respectively) took place in Savannah 
markets, whilst 37.1% and 21.9% of purchases and sales took place in another country. 
Of the sales and purchases in Savannah markets, 82.4% were conducted in only 4 
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markets. Outside of Togo, most of the foreign cattle purchases (85.5%) occurred in 
Burkina Faso and 34.9% of foreign cattle sales took place in Nigeria.  
 
More than half of the traders (116 of 213, 54.5%) operated in at least one other country 
outside of Togo. Among those traders operating in multiple countries, only one quarter 
(31 of 116, 26.7%) conducted both purchase and sale activities in at least two countries. 
Almost two thirds of the traders operating in Burkina Faso (49 of 81, 60.5%) conducted 
only purchases in Burkina Faso, without any sales. Half (11 of 22, 50.0%) of the traders 
operating in Ghana, three quarters (25 of 34, 73.5%) of the traders operating in Benin 
and all (27 of 27, 100%) of the traders operating in Nigeria only sold cattle in these 
countries, without purchasing.  The number of traders operating at different purchase 
and sale locations as well as the numbers of cattle traded at these sites are summarised 
in Table A. 
 
Wet season cattle flow simulations 
During the wet season, 71.3% (range: 70.0-72.4%) of inflow into the Savannah market 
system was from Burkina Faso, with 7.9% (range: 7.6-8.3%) from Ghana and 3.1% 
(range: 2.8-3.5%) from Benin. Half of the cattle leaving the Savannah market system in 
the dry season (50.7%, range: 48.8-52.8%) were sent to Togolese markets outside of 
the Savannah Region. In terms of outflow from the Savannah market system, 8.9% 
(range: 8.3-9.5%) flowed into Ghana, 11.1% (range: 10.1-12.0%) into Benin and 14.1% 
(range: 13.0-15.2%) into Nigeria. The results of Location Scenario 2 did not demonstrate 
any major differences, as shown in the supplementary file Appendix 5. 
 
In the wet season, 2,671 (range: 2,543-2,829) cattle flowed into herds in the Savannah 
Region, equating to 1.6% (range: 1.5-2.1%) of the estimated total cattle population size 
in the Savannah Region. Given that most herds likely breed their own replacement 
animals, many more animals flowed in the reverse direction from Savannah herds into 
the market system. There was a mean of 8,552 cattle (range: 7,899-9,363) leaving herds 
in the wet season, equating to 6.2% (range: 5.7-6.8%) of the estimated total cattle 
population size. Location Scenario 2 produced similar results with 2,667 cattle (range: 
2,515-2,793) flowing into herds and 8,611 (range: 7,923-9,394) leaving herds. Flows into 
and out of the Savannah herds followed the same trends as the aforementioned market 
system flows. 
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Market network in wet season 
The Savannah market system during the wet season consisted of 26 markets. They 
formed a well connected network incorporating all but one of the markets, such that the 
GWCC was 25 and nearly half of these markets (13) formed the GSCC. When using the 
alternative algorithm for reconstructing the order of market visits (see Appendix 3), the 
GSCC was even higher, with a median of 18 markets (range: 13-22).  
 
The majority of markets (16 of 26) received cattle from at least two other markets, with a 
maximum of 13 other markets. Approximately half of the markets (14 of 26) sent cattle to 
at least two other markets, with a maximum of 13. However, most cattle movements 
within the Savannah market network were mediated by a small number of markets: four 
markets accounted for 72.8% and 74.4% of the total weighted in- and out-degrees, 
respectively.  
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Appendix 5: Supplementary results for Chapter 7 – 
simulations for wet and dry season 
 
The results of the 10,000 model simulations of livestock flows through the market system 
in the dry and wet seasons are summarised in the Table 16 below for the independent 
and non-independent purchase and sale location scenarios, Location Scenario 1 and 
Location Scenario 2, respectively. 
 
Cattle flow into the Savannah market system: The data represent the mean proportion 
(%) of the total inflow  into the Savannah market system from each of the given 
locations. The range is given in parentheses as minimum and maximum proportions. 
 
Cattle flow into Savannah herds: The data represent the mean proportion (%) of the total 
inflow into Savannah herds from each of the given locations. The range is given in 
parentheses as minimum and maximum proportions. 
 
Cattle flow out of the Savannah market system: The data represent the mean proportion 
(%) of the total outflow from the Savannah market system going to each of the given 
locations. The range is given in parentheses as minimum and maximum proportions. 
 
Cattle flow out of Savannah herds: The data represent the mean proportion (%) of the 
total outflow from Savannah herds going to each of the given locations. The range is 
given in parentheses as minimum and maximum proportions 
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Table 16: Results of simulations of livestock flows 
Origin or Destination  Cattle Flows 
Savannah 
herds 
Savannah 
butchers 
Other 
Togo 
markets 
Other 
Togo 
herds 
Benin 
 
Burkina 
Faso 
Ghana 
 
Niger 
 
Nigeria 
 
 
Location Scenario 1 - Dry Season 
Into Savannah market system 14.3  
(11.9-17.7) 
0  
(0-0) 
6.2 
(5.8-6.9) 
0.3  
(0.2-0.3) 
3.6  
(3.1-4.7) 
68 
(65.2-
70.2) 
7.6  
(7.2-8.0) 
0 0 
Out of Savannah market 
system  
5.7  
(5.2-6.3) 
6.2 
 (5.6-6.9) 
49.3  
(47.0-
51.7) 
0.1  
(0.0-0.1) 
12.3  
(11.1-
13.8) 
3.9  
(3.5-4.4) 
7.8  
(7.3-8.4) 
0.0  
(0.0-
0.1) 
14.7  
(13.5-
15.9) 
Into Savannah herds 18.1  
(13.3-24.6) 
0  
(0-0) 
6.4  
(4.8-8.2) 
0.2  
(0.0-0.5) 
5.7  
(4.1-7.9) 
64.3  
(58.8-69) 
5.3  
(4.0-7.0) 
0 0 
Out of Savannah herds  4.0  
(2.5-6.4) 
4.9  
(2.6-8.2) 
46.4  
(39.4-
54.7) 
0.0  
(0.0-0.1) 
21.4  
(16.0-
25.7) 
1.5  
(0.9-2.3) 
4.0  
(2.6-5.8) 
0.1  
(0.0-
0.2) 
17.7  
(11.4-
25.5) 
 
Location Scenario 1 - Wet Season 
Into Savannah market system 11.6  
(10.6-13.0) 
0 5.7  
(5.4-6.0) 
0.3  
(0.3-0.4) 
3.1  
(2.8-3.5) 
71.3  
(70.0-
72.4) 
7.9  
(7.6-8.3) 
0 0 
Out of Savannah market 
system  
5.9  
(5.4-6.4) 
6.5  
(5.8-7.2) 
50.7  
(48.8-
52.8) 
0.1  
(0.1-0.2) 
11.1  
(10.1-
12.0) 
2.7  
(2.2-3.2) 
8.9  
(8.3-9.5) 
0.0  
(0.0-
0.1) 
14.1  
(13.0-
15.2) 
Into Savannah herds 13.7  
(11.0-16.8) 
0  
(0-0) 
6.3  
(4.7-7.9) 
0.2  
(0.0-0.6) 
5.6  
(4.2-7.2) 
68.5  
(64.9-
72.1) 
5.7  
(4.1-7.6) 
0 0 
Out of Savannah herds  4.3 
(3.5-5.2) 
6.2 (5.3-
7.3) 
48.5  
(44.6-
52.1) 
0.0  
(0.0-0.1) 
19.1  
(16.5-
22.1) 
1.3  
(0.9-1.8) 
5.8  
(5.0-6.8) 
0.1  
(0.0-
0.2) 
14.6  
(13.2-
16.4) 
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Location Scenario 2 - Dry Season 
Into Savannah market system 17.6  
(14.7-
21.8) 
0 6.7  
(6.0-7.7) 
0.2  
(0.2-
0.3) 
2.0  
(1.5-3.0) 
65.6  
(61.9-
68.3) 
7.9  
(7.4-8.4) 
0 0 
Out of Savannah market 
system  
7.5  
(6.5-8.6) 
7.4  
(5.7-8.8) 
47.9  
(40.8-
54.9) 
0 13.1  
(9.9-16.8) 
1.7  
(1.4-2.2) 
6.8  
(4.4-9.6) 
0.0  
(0.0-
0.1) 
15.5  
(10.8-20.2) 
Into Savannah herds 22.9  
(16.1-
29.7) 
0 5.0 
(3.2-6.9) 
0.2  
(0.0-
0.5) 
1.6  
(0.6-3.0) 
64.7  
(56.7-
70.7) 
5.7  
(3.8-7.7) 
0 0 
Out of Savannah herds  5.0  
(3.1-7.9) 
5.6 (3.4-
9.3) 
47.0  
(39.7-
59.0) 
0.0  
(0.0-
0.1) 
19.9  
(13.0-
25.6) 
0.6  
(0.4-1.1) 
3.7  
(2.0-6.3) 
0.0  
(0.0-
0.1) 
18.1  
(10.8-26.3) 
 
Location Scenario 2 - Wet Season 
Into Savannah market system 14.4  
(13.1-
16.2) 
0 6.0  
(5.5-6.3) 
0.3  
(0.3-
0.4) 
1.4  
(1.2-1.6) 
69.6  
(68.0-
71.2) 
8.3  
(7.8-8.8) 
0 0 
Out of Savannah market 
system  
8.0  
(6.9-9.0) 
7.8  
(6.5-9.3) 
49.9  
(43.4-
55.5) 
0.0  
(0.0-
0.1) 
11.8  
(9.0-13.9) 
0.5  
(0.2-0.9) 
7.9  
(5.1-
10.8) 
0.0  
(0.0-
0.1) 
14.1  
(9.4-19.1) 
Into Savannah herds 18.2  
(14.5-
23.0) 
0 4.6  
(3.1-6.0) 
0.2  
(0.0-
0.6) 
1.0  
(0.4-1.8) 
69.7  
(64.3-
74.6) 
6.2  
(4.3-8.1) 
0  0  
Out of Savannah herds  5.7  
(4.5-7.1) 
7.2 
 (6.0-8.7) 
48.9  
(44.0-
54.0) 
0.0  
(0.0-
0.1) 
17.5  
(14.3-
21.2) 
0.2 
 (0.0-0.5) 
5.4  
(3.5-7.5) 
0.0  
(0.0-
0.1) 
15.0  
(11.6.19-0) 
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Appendix 6: Newspaper article in Togo-Presse 
(November 2012)  
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Appendix 7: Photos from the field 
 
 
Figure 40: The author collecting blood from a cow 
 
 
Figure 41: The author collecting hygroma fluid from a cow 
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Figure 42: A cow with joint hygromas in right stifle and left and right carpi 
 
 
Figure 43: The author collecting blood from a goat
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Figure 44: Interviewers and nurse visiting households 
 
 
Figure 45: The author conducting a focus group discussion with Fulani women 
(Côte d'Ivoire) 
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Figure 46: Cattle roaming freely around a village 
 
 
 
Figure 47: Small ruminants roaming freely between households 
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Figure 48: Cattle market on the Togo / Burkina Faso border 
 
 
 
Figure 49: Cattle market 
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Figure 50: Temporary housing of transhumant herdsmen during the dry season 
 
 
Figure 51: ECOWAS International Transhumance Certificate 
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Figure 52: District health centre 
 
 
 
Figure 53: View over the Savannah Region of Togo during dry season 
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